ValueSet: CAPeCCQuestionCodes
Id: cap-ecc-question-codes
Title: "CAP eCC Question Codes"
Description: "This ValueSet is composed of Question codes."
* ^extension.url = "http://hl7.org/fhir/StructureDefinition/structuredefinition-wg"
* ^extension.valueCode = #oo
* ^status = #active
* ^experimental = false
* $CAPeCCCodeSystem#50854.100004300 "Patient Age Group"
* $CAPeCCCodeSystem#4156.100004300 "Clinical History (specify)"
* $CAPeCCCodeSystem#53772.100004300 "Functional Status (Notes A, B)"
* $CAPeCCCodeSystem#820603.100004300 "Procedure"
* $CAPeCCCodeSystem#52756.100004300 "Specimen Laterality"
* $CAPeCCCodeSystem#59852.100004300 "Histologic Subtype (Notes C, D)"
* $CAPeCCCodeSystem#43670.100004300 "Histologic Subtype Comment"
* $CAPeCCCodeSystem#820395.100004300 "?Mitotic Tumor Grade (required for adult patients only) (Notes C, D)"
* $CAPeCCCodeSystem#2129.100004300 "Tumor Size (Notes E, F)"
* $CAPeCCCodeSystem#2133.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#2132.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#820398.100004300 "Adrenal Gland Weight (Note G)"
* $CAPeCCCodeSystem#820404.100004300 "Site(s) Involved by Direct Tumor Extension"
* $CAPeCCCodeSystem#39990.100004300 "Lymphatic and / or Vascular Invasion (Note H)"
* $CAPeCCCodeSystem#48491.100004300 "Tumor Description"
* $CAPeCCCodeSystem#379219.100004300 "Tumor Comment"
* $CAPeCCCodeSystem#2153.100004300 "Margin Status"
* $CAPeCCCodeSystem#354249.100004300 "Closest Margin(s) to Carcinoma"
* $CAPeCCCodeSystem#354236.100004300 "Distance from Carcinoma to Closest Margin"
* $CAPeCCCodeSystem#354227.100004300 "Margin(s) Involved by Carcinoma"
* $CAPeCCCodeSystem#358407.100004300 "Margin Comment"
* $CAPeCCCodeSystem#372404.100004300 "Regional Lymph Node Status"
* $CAPeCCCodeSystem#45098.100004300 "Number of Lymph Nodes with Tumor"
* $CAPeCCCodeSystem#39296.100004300 "Extranodal Extension"
* $CAPeCCCodeSystem#42934.100004300 "Number of Lymph Nodes Examined"
* $CAPeCCCodeSystem#358408.100004300 "Regional Lymph Node Comment"
* $CAPeCCCodeSystem#354240.100004300 "?Distant Site(s) Involved, if applicable"
* $CAPeCCCodeSystem#820585.100004300 "?Modified Classification (required only if applicable)"
* $CAPeCCCodeSystem#327636.100004300 "pT Category"
* $CAPeCCCodeSystem#820586.100004300 "?T Suffix (required only if applicable)"
* $CAPeCCCodeSystem#327638.100004300 "pN Category (Note I)"
* $CAPeCCCodeSystem#2149.100004300 "?pM Category (required only if confirmed pathologically) (Note K)"
* $CAPeCCCodeSystem#39188.100004300 "Additional Findings"
* $CAPeCCCodeSystem#378869.100004300 "Ki-67 Labeling Index"
* $CAPeCCCodeSystem#820445.100004300 "?Biomarkers Confirming Adrenal Cortical Origin (select positive biomarker(s)) (required only if applicable)#"
* $CAPeCCCodeSystem#820454.100004300 "p53"
* $CAPeCCCodeSystem#820455.100004300 "Beta-catenin"
* $CAPeCCCodeSystem#378870.100004300 "Reticulin Stain Results (specify type(s) and result(s))"
* $CAPeCCCodeSystem#378871.100004300 "Other Ancillary Study Findings (specify type(s) and result(s))"
* $CAPeCCCodeSystem#2168.100004300 "?Comment(s)"
* $CAPeCCCodeSystem#15906.100004300 "Procedure"
* $CAPeCCCodeSystem#34390.100004300 "Tumor Site (Note A)"
* $CAPeCCCodeSystem#49614.100004300 "Histologic Type (Note B)"
* $CAPeCCCodeSystem#35588.100004300 "Histologic Type Comment"
* $CAPeCCCodeSystem#47180.100004300 "Histologic Grade (Note C)"
* $CAPeCCCodeSystem#2238.100004300 "Tumor Size (Note D)"
* $CAPeCCCodeSystem#2241.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#2242.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#540508.100004300 "Tumor Extent"
* $CAPeCCCodeSystem#2296.100004300 "Lymphovascular Invasion (Note D)"
* $CAPeCCCodeSystem#2300.100004300 "Perineural Invasion (Note D)"
* $CAPeCCCodeSystem#379440.100004300 "Tumor Comment"
* $CAPeCCCodeSystem#367359.100004300 "Margin Status for Invasive Carcinoma"
* $CAPeCCCodeSystem#367365.100004300 "Closest Margin(s) to Invasive Carcinoma"
* $CAPeCCCodeSystem#367374.100004300 "Distance from Invasive Carcinoma to Closest Margin"
* $CAPeCCCodeSystem#367388.100004300 "Margin(s) Involved by Invasive Carcinoma"
* $CAPeCCCodeSystem#367399.100004300 "Margin Status for Dysplasia and Intraepithelial Neoplasia"
* $CAPeCCCodeSystem#367426.100004300 "Margin(s) Involved by High-Grade Dysplasia"
* $CAPeCCCodeSystem#367370.100004300 "Margin Comment"
* $CAPeCCCodeSystem#372413.100004300 "Regional Lymph Node Status"
* $CAPeCCCodeSystem#34182.100004300 "Number of Lymph Nodes with Tumor"
* $CAPeCCCodeSystem#34181.100004300 "Number of Lymph Nodes Examined"
* $CAPeCCCodeSystem#364888.100004300 "Regional Lymph Node Comment"
* $CAPeCCCodeSystem#353509.100004300 "?Distant Site(s) Involved, if applicable"
* $CAPeCCCodeSystem#15918.100004300 "?TNM Descriptors"
* $CAPeCCCodeSystem#327641.100004300 "pT Category"
* $CAPeCCCodeSystem#327643.100004300 "pN Category"
* $CAPeCCCodeSystem#2278.100004300 "?pM Category (required only if confirmed pathologically)"
* $CAPeCCCodeSystem#2303.100004300 "Additional Findings"
* $CAPeCCCodeSystem#15921.100004300 "Ancillary Studies (Note G)"
* $CAPeCCCodeSystem#2312.100004300 "?Comment(s)"
* $CAPeCCCodeSystem#2452.100004300 "Procedure#"
* $CAPeCCCodeSystem#51516.100004300 "Tumor Site (Note B)"
* $CAPeCCCodeSystem#763181.100004300 "Histologic Type (Note C)"
* $CAPeCCCodeSystem#54453.100004300 "Histologic Type Comment"
* $CAPeCCCodeSystem#2480.100004300 "Histologic Grade (Note D)"
* $CAPeCCCodeSystem#2460.100004300 "Tumor Size"
* $CAPeCCCodeSystem#2463.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#2464.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#59591.100004300 "Tumor Extent"
* $CAPeCCCodeSystem#379441.100004300 "Treatment Effect (Note E)"
* $CAPeCCCodeSystem#2536.100004300 "Lymphovascular Invasion"
* $CAPeCCCodeSystem#2533.100004300 "Perineural Invasion"
* $CAPeCCCodeSystem#379443.100004300 "Tumor Comment"
* $CAPeCCCodeSystem#354865.100004300 "Margin Status for Invasive Carcinoma"
* $CAPeCCCodeSystem#354871.100004300 "Closest Margin(s) to Invasive Carcinoma"
* $CAPeCCCodeSystem#354876.100004300 "Distance from Invasive Carcinoma to Closest Margin"
* $CAPeCCCodeSystem#354887.100004300 "Margin(s) Involved by Invasive Carcinoma"
* $CAPeCCCodeSystem#354893.100004300 "Margin Status for High-Grade Intraepithelial Neoplasia"
* $CAPeCCCodeSystem#354914.100004300 "Margin(s) Involved by High-Grade Intraepithelial Neoplasia"
* $CAPeCCCodeSystem#354918.100004300 "Margin Comment"
* $CAPeCCCodeSystem#372415.100004300 "Regional Lymph Node Status"
* $CAPeCCCodeSystem#52452.100004300 "Number of External Iliac Nodes with Tumor"
* $CAPeCCCodeSystem#51027.100004300 "Number of All Other Regional Nodes with Tumor"
* $CAPeCCCodeSystem#763188.100004300 "Other Regional Nodal Site(s) with Tumor"
* $CAPeCCCodeSystem#55209.100004300 "Number of External Iliac Nodes Examined"
* $CAPeCCCodeSystem#49882.100004300 "Number of All Other Regional Nodes Examined"
* $CAPeCCCodeSystem#763191.100004300 "?Other Regional Nodal Site(s) Examined, if applicable"
* $CAPeCCCodeSystem#358478.100004300 "Regional Lymph Node Comment"
* $CAPeCCCodeSystem#354921.100004300 "?Distant Site(s) Involved, if applicable"
* $CAPeCCCodeSystem#17178.100004300 "?TNM Descriptors"
* $CAPeCCCodeSystem#763201.100004300 "pT Category"
* $CAPeCCCodeSystem#763209.100004300 "pN Category"
* $CAPeCCCodeSystem#2504.100004300 "?pM Category (required only if confirmed pathologically)"
* $CAPeCCCodeSystem#2540.100004300 "Additional Findings"
* $CAPeCCCodeSystem#18373.100004300 "Ancillary Studies (specify) (Note H)"
* $CAPeCCCodeSystem#2547.100004300 "?Comment(s)"
* $CAPeCCCodeSystem#2355.100004300 "Specimen"
* $CAPeCCCodeSystem#2361.100004300 "Procedure"
* $CAPeCCCodeSystem#2367.100004300 "Specimen Integrity (Note A)"
* $CAPeCCCodeSystem#379445.100004300 "Number of Fragments"
* $CAPeCCCodeSystem#51055.100004300 "Tumor Site (Note B)"
* $CAPeCCCodeSystem#50422.100004300 "Histologic Type (Note C)"
* $CAPeCCCodeSystem#38077.100004300 "Histologic Type Comment"
* $CAPeCCCodeSystem#2407.100004300 "Histologic Grade (Note D)"
* $CAPeCCCodeSystem#2387.100004300 "Tumor Size"
* $CAPeCCCodeSystem#2390.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#2391.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#55495.100004300 "Tumor Extent"
* $CAPeCCCodeSystem#379449.100004300 "Treatment Effect (Note E)"
* $CAPeCCCodeSystem#2434.100004300 "Lymphatic and / or Vascular Invasion"
* $CAPeCCCodeSystem#2438.100004300 "Perineural Invasion"
* $CAPeCCCodeSystem#379451.100004300 "Tumor Comment"
* $CAPeCCCodeSystem#354627.100004300 "Margin Status for Invasive Carcinoma"
* $CAPeCCCodeSystem#354641.100004300 "Distance from Invasive Carcinoma to Closest Deep Margin"
* $CAPeCCCodeSystem#367344.100004300 "Distance from Invasive Carcinoma to Closest Mucosal Margin"
* $CAPeCCCodeSystem#354655.100004300 "Margin(s) Involved by Invasive Carcinoma"
* $CAPeCCCodeSystem#354666.100004300 "Margin Status for High-Grade Dysplasia"
* $CAPeCCCodeSystem#354702.100004300 "Margin Comment"
* $CAPeCCCodeSystem#891460.100004300 "?Modified Classification (required only if applicable)"
* $CAPeCCCodeSystem#891467.100004300 "pT Category"
* $CAPeCCCodeSystem#891455.100004300 "?T Suffix (required only if applicable)"
* $CAPeCCCodeSystem#42248.100004300 "Additional Findings (Note G)"
* $CAPeCCCodeSystem#18342.100004300 "Ancillary Studies (Note H)"
* $CAPeCCCodeSystem#2448.100004300 "?Comment(s)"
* $CAPeCCCodeSystem#52841.100004300 "Procedure"
* $CAPeCCCodeSystem#19745.100004300 "Tumor Site (Note A)"
* $CAPeCCCodeSystem#939944.100004300 "Histologic Type and Grade# (Notes B, C)"
* $CAPeCCCodeSystem#40722.100004300 "Histologic Type and Grade Comment"
* $CAPeCCCodeSystem#379272.100004300 "?Mitotic Rate (required only when Ki-67 labeling index is not reported)#"
* $CAPeCCCodeSystem#379276.100004300 "?Ki-67 Labeling Index (required only when mitotic rate is not reported)"
* $CAPeCCCodeSystem#19756.100004300 "Tumor Size (Note D)"
* $CAPeCCCodeSystem#19760.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#19759.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#379256.100004300 "Tumor Extent"
* $CAPeCCCodeSystem#19795.100004300 "Lymphatic and / or Vascular Invasion"
* $CAPeCCCodeSystem#19804.100004300 "Perineural Invasion"
* $CAPeCCCodeSystem#379230.100004300 "Tumor Comment"
* $CAPeCCCodeSystem#365921.100004300 "Margin Status"
* $CAPeCCCodeSystem#938256.100004300 "Closest Margin(s) to Tumor"
* $CAPeCCCodeSystem#365932.100004300 "Distance from Tumor to Closest Margin"
* $CAPeCCCodeSystem#938259.100004300 "Margin(s) Involved by Tumor"
* $CAPeCCCodeSystem#365941.100004300 "Margin Comment"
* $CAPeCCCodeSystem#372417.100004300 "Regional Lymph Node Status"
* $CAPeCCCodeSystem#52180.100004300 "Number of Lymph Nodes with Tumor"
* $CAPeCCCodeSystem#48350.100004300 "Number of Lymph Nodes Examined"
* $CAPeCCCodeSystem#358484.100004300 "Regional Lymph Node Comment"
* $CAPeCCCodeSystem#356310.100004300 "?Distant Site(s) Involved, if applicable"
* $CAPeCCCodeSystem#936929.100004300 "?Modified Classification (required only if applicable)"
* $CAPeCCCodeSystem#936924.100004300 "pT Category#"
* $CAPeCCCodeSystem#936932.100004300 "?T Suffix (required only if applicable)"
* $CAPeCCCodeSystem#936926.100004300 "pN Category"
* $CAPeCCCodeSystem#936910.100004300 "?pM Category (required only if confirmed pathologically)"
* $CAPeCCCodeSystem#19844.100004300 "Additional Findings"
* $CAPeCCCodeSystem#19853.100004300 "?Comment(s)"
* $CAPeCCCodeSystem#763213.100004300 "Procedure"
* $CAPeCCCodeSystem#2581.100004300 "Tumor Site (Note B)"
* $CAPeCCCodeSystem#19718.100004300 "Base of Appendix Involvement"
* $CAPeCCCodeSystem#763218.100004300 "Histologic Type (Note C)"
* $CAPeCCCodeSystem#35587.100004300 "Histologic Type Comment"
* $CAPeCCCodeSystem#47240.100004300 "Histologic Grade# (Note D)"
* $CAPeCCCodeSystem#2590.100004300 "Tumor Size"
* $CAPeCCCodeSystem#2593.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#2607.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#2328.100004300 "Tumor Deposits (Note E)"
* $CAPeCCCodeSystem#56191.100004300 "Number of Deposits"
* $CAPeCCCodeSystem#820497.100004300 "Tumor Extent (Note I)"
* $CAPeCCCodeSystem#2713.100004300 "Lymphatic and / or Vascular Invasion (Note F)"
* $CAPeCCCodeSystem#2727.100004300 "Perineural Invasion (Note G)"
* $CAPeCCCodeSystem#379452.100004300 "Tumor Comment"
* $CAPeCCCodeSystem#355055.100004300 "Margin Status for Invasive Carcinoma"
* $CAPeCCCodeSystem#355071.100004300 "Distance from Invasive Carcinoma to Closest Mesenteric Margin"
* $CAPeCCCodeSystem#355061.100004300 "Margin(s) Involved by Invasive Carcinoma"
* $CAPeCCCodeSystem#763222.100004300 "Margin Status for Non-Invasive Tumor (including LAMN and HAMN)#"
* $CAPeCCCodeSystem#355095.100004300 "Margin(s) Involved by Low-grade Appendiceal Mucinous Neoplasm"
* $CAPeCCCodeSystem#355101.100004300 "Margin(s) Involved by High-grade Appendiceal Mucinous Neoplasm"
* $CAPeCCCodeSystem#355112.100004300 "Margin Comment"
* $CAPeCCCodeSystem#372419.100004300 "Regional Lymph Node Status"
* $CAPeCCCodeSystem#34184.100004300 "Number of Lymph Nodes with Tumor"
* $CAPeCCCodeSystem#34183.100004300 "Number of Lymph Nodes Examined"
* $CAPeCCCodeSystem#358480.100004300 "Regional Lymph Node Comment"
* $CAPeCCCodeSystem#763225.100004300 "?Distant Site(s) Involved, if applicable"
* $CAPeCCCodeSystem#820581.100004300 "?Modified Classification (required only if applicable)"
* $CAPeCCCodeSystem#327676.100004300 "pT Category"
* $CAPeCCCodeSystem#820582.100004300 "?T Suffix (required only if applicable)"
* $CAPeCCCodeSystem#327680.100004300 "pN Category"
* $CAPeCCCodeSystem#53000.100004300 "?pM Category (required only if confirmed pathologically)#"
* $CAPeCCCodeSystem#763234.100004300 "Additional Findings"
* $CAPeCCCodeSystem#18390.100004300 "Ancillary Studies"
* $CAPeCCCodeSystem#2778.100004300 "?Comment(s)"
* $CAPeCCCodeSystem#4259.100004300 "Procedure"
* $CAPeCCCodeSystem#379454.100004300 "Tumor Site"
* $CAPeCCCodeSystem#49443.100004300 "Histologic Type (Note C)"
* $CAPeCCCodeSystem#35624.100004300 "Histologic Type Comment"
* $CAPeCCCodeSystem#54608.100004300 "Histologic Grade (Note D)"
* $CAPeCCCodeSystem#4276.100004300 "Tumor Size"
* $CAPeCCCodeSystem#4279.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#4280.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#18514.100004300 "Tumor Extent"
* $CAPeCCCodeSystem#51599.100004300 "Depth of Tumor Invasion"
* $CAPeCCCodeSystem#4341.100004300 "Lymphovascular Invasion (Note E)"
* $CAPeCCCodeSystem#4333.100004300 "Perineural Invasion (Note E)"
* $CAPeCCCodeSystem#379456.100004300 "Tumor Comment"
* $CAPeCCCodeSystem#366339.100004300 "Margin Status for Invasive Carcinoma"
* $CAPeCCCodeSystem#366345.100004300 "Closest Margin(s) to Invasive Carcinoma"
* $CAPeCCCodeSystem#366354.100004300 "Distance from Invasive Carcinoma to Closest Margin"
* $CAPeCCCodeSystem#366368.100004300 "Margin(s) Involved by Invasive Carcinoma"
* $CAPeCCCodeSystem#366379.100004300 "Margin Status for High-Grade Intraepithelial Neoplasia"
* $CAPeCCCodeSystem#366406.100004300 "Margin(s) Involved by High-Grade Intraepithelial Neoplasia"
* $CAPeCCCodeSystem#366350.100004300 "Margin Comment"
* $CAPeCCCodeSystem#372423.100004300 "Regional Lymph Node Status"
* $CAPeCCCodeSystem#34188.100004300 "Number of Lymph Nodes with Tumor"
* $CAPeCCCodeSystem#34187.100004300 "Number of Lymph Nodes Examined"
* $CAPeCCCodeSystem#358483.100004300 "Regional Lymph Node Comment"
* $CAPeCCCodeSystem#356688.100004300 "?Distant Site(s) Involved, if applicable"
* $CAPeCCCodeSystem#18525.100004300 "?TNM Descriptors"
* $CAPeCCCodeSystem#327806.100004300 "pT Category"
* $CAPeCCCodeSystem#327808.100004300 "pN Category"
* $CAPeCCCodeSystem#4315.100004300 "?pM Category (required only if confirmed pathologically)"
* $CAPeCCCodeSystem#4345.100004300 "Additional Findings"
* $CAPeCCCodeSystem#18495.100004300 "Ancillary Studies (specify)"
* $CAPeCCCodeSystem#4351.100004300 "?Comment(s)"
* $CAPeCCCodeSystem#51782.100004300 "Procedure"
* $CAPeCCCodeSystem#379005.100004300 "Histologic Type (Note B)"
* $CAPeCCCodeSystem#54596.100004300 "Histologic Type Comment"
* $CAPeCCCodeSystem#58134.100004300 "Histologic Grade (Note C)"
* $CAPeCCCodeSystem#20174.100004300 "Tumor Focality (Note D)"
* $CAPeCCCodeSystem#19896.100004300 "Tumor Size"
* $CAPeCCCodeSystem#19899.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#19900.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#19901.100004300 "Tumor Extent"
* $CAPeCCCodeSystem#20175.100004300 "Tumor Growth Pattern (Note E)"
* $CAPeCCCodeSystem#51725.100004300 "Lymphovascular Invasion"
* $CAPeCCCodeSystem#19926.100004300 "Perineural Invasion"
* $CAPeCCCodeSystem#379459.100004300 "Tumor Comment"
* $CAPeCCCodeSystem#366417.100004300 "Margin Status for Invasive Carcinoma"
* $CAPeCCCodeSystem#366423.100004300 "Closest Margin(s) to Invasive Carcinoma"
* $CAPeCCCodeSystem#366432.100004300 "Distance from Invasive Carcinoma to Closest Margin"
* $CAPeCCCodeSystem#366446.100004300 "Margin(s) Involved by Invasive Carcinoma"
* $CAPeCCCodeSystem#366457.100004300 "Margin Status for High-Grade Intraepithelial Neoplasia"
* $CAPeCCCodeSystem#366428.100004300 "Margin Comment"
* $CAPeCCCodeSystem#372421.100004300 "Regional Lymph Node Status"
* $CAPeCCCodeSystem#52020.100004300 "Number of Lymph Nodes with Tumor"
* $CAPeCCCodeSystem#52243.100004300 "Number of Lymph Nodes Examined"
* $CAPeCCCodeSystem#358475.100004300 "Regional Lymph Node Comment"
* $CAPeCCCodeSystem#356491.100004300 "?Distant Site(s) Involved, if applicable"
* $CAPeCCCodeSystem#19944.100004300 "?TNM Descriptors"
* $CAPeCCCodeSystem#327838.100004300 "pT Category"
* $CAPeCCCodeSystem#327840.100004300 "pN Category (Note H)"
* $CAPeCCCodeSystem#19960.100004300 "?pM Category (required only if confirmed pathologically)"
* $CAPeCCCodeSystem#379460.100004300 "Additional Findings"
* $CAPeCCCodeSystem#20187.100004300 "Ancillary Studies (specify)"
* $CAPeCCCodeSystem#19973.100004300 "?Comment(s)"
* $CAPeCCCodeSystem#19995.100004300 "Procedure"
* $CAPeCCCodeSystem#20000.100004300 "Tumor Site"
* $CAPeCCCodeSystem#49211.100004300 "Histologic Type (Note C)"
* $CAPeCCCodeSystem#58077.100004300 "Histologic Type Comment"
* $CAPeCCCodeSystem#59989.100004300 "Histologic Grade (Note D)"
* $CAPeCCCodeSystem#20024.100004300 "Tumor Size"
* $CAPeCCCodeSystem#20026.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#20027.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#42712.100004300 "Tumor Extent"
* $CAPeCCCodeSystem#20078.100004300 "Lymphovascular Invasion (Note E)"
* $CAPeCCCodeSystem#20082.100004300 "Perineural Invasion (Note E)"
* $CAPeCCCodeSystem#379462.100004300 "Tumor Comment"
* $CAPeCCCodeSystem#366495.100004300 "Margin Status for Invasive Carcinoma"
* $CAPeCCCodeSystem#366501.100004300 "Closest Margin(s) to Invasive Carcinoma"
* $CAPeCCCodeSystem#366510.100004300 "Distance from Invasive Carcinoma to Closest Margin"
* $CAPeCCCodeSystem#366524.100004300 "Margin(s) Involved by Invasive Carcinoma"
* $CAPeCCCodeSystem#366535.100004300 "Margin Status for High-Grade Intraepithelial Neoplasia"
* $CAPeCCCodeSystem#366562.100004300 "Margin(s) Involved by High-Grade Intraepithelial Neoplasia"
* $CAPeCCCodeSystem#366506.100004300 "Margin Comment"
* $CAPeCCCodeSystem#374345.100004300 "Regional Lymph Node Status"
* $CAPeCCCodeSystem#46126.100004300 "Number of Lymph Nodes with Tumor"
* $CAPeCCCodeSystem#48336.100004300 "Number of Lymph Nodes Examined"
* $CAPeCCCodeSystem#358479.100004300 "Regional Lymph Node Comment"
* $CAPeCCCodeSystem#356481.100004300 "?Distant Site(s) Involved, if applicable"
* $CAPeCCCodeSystem#20092.100004300 "?TNM Descriptors"
* $CAPeCCCodeSystem#327890.100004300 "pT Category"
* $CAPeCCCodeSystem#327891.100004300 "pN Category"
* $CAPeCCCodeSystem#20108.100004300 "?pM Category (required only if confirmed pathologically)"
* $CAPeCCCodeSystem#20114.100004300 "Additional Findings"
* $CAPeCCCodeSystem#20198.100004300 "Ancillary Studies (specify)"
* $CAPeCCCodeSystem#20121.100004300 "?Comment(s)"
* $CAPeCCCodeSystem#22251.100004300 "Procedure"
* $CAPeCCCodeSystem#44057.100004300 "Tumor Site"
* $CAPeCCCodeSystem#868422.100004300 "Histologic Type (Note B)"
* $CAPeCCCodeSystem#868398.100004300 "Specify Percentages of Histologic Subtypes and Divergent Differentiations Present (totaling 100%)#"
* $CAPeCCCodeSystem#53483.100004300 "Histologic Type Comment"
* $CAPeCCCodeSystem#56918.100004300 "Histologic Grade (Note C)"
* $CAPeCCCodeSystem#868423.100004300 "Tumor Extent (Note D)"
* $CAPeCCCodeSystem#22353.100004300 "Lymphatic and / or Vascular Invasion (Note E)"
* $CAPeCCCodeSystem#22346.100004300 "Tumor Configuration"
* $CAPeCCCodeSystem#22437.100004300 "Muscularis Propria (detrusor muscle) (Note D)"
* $CAPeCCCodeSystem#379571.100004300 "Tumor Comment"
* $CAPeCCCodeSystem#868427.100004300 "Associated Epithelial Lesions (Note C)"
* $CAPeCCCodeSystem#868428.100004300 "Additional Findings"
* $CAPeCCCodeSystem#22400.100004300 "?Comment(s)"
* $CAPeCCCodeSystem#55410.100004300 "Procedure"
* $CAPeCCCodeSystem#13606.100004300 "Tumor Site"
* $CAPeCCCodeSystem#868355.100004300 "Histologic Type (Note B)"
* $CAPeCCCodeSystem#868356.100004300 "Specify Percentages of Histologic Subtypes and Divergent Differentiations Present (totaling 100%)#"
* $CAPeCCCodeSystem#38861.100004300 "Histologic Type Comment"
* $CAPeCCCodeSystem#49057.100004300 "Histologic Grade (Note C)"
* $CAPeCCCodeSystem#13742.100004300 "Tumor Size"
* $CAPeCCCodeSystem#13747.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#13745.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#381454.100004300 "Tumor Extent (Note D)"
* $CAPeCCCodeSystem#14232.100004300 "Lymphatic and / or Vascular Invasion (Note E)"
* $CAPeCCCodeSystem#14034.100004300 "Tumor Configuration"
* $CAPeCCCodeSystem#868389.100004300 "Treatment Effect Post Neoadjuvant Chemotherapy (BCG not included)"
* $CAPeCCCodeSystem#379570.100004300 "Tumor Comment"
* $CAPeCCCodeSystem#365846.100004300 "Margin Status for Invasive Tumor"
* $CAPeCCCodeSystem#365852.100004300 "Closest Margin(s) to Invasive tumor"
* $CAPeCCCodeSystem#365857.100004300 "Distance from Invasive Tumor to Closest Margin"
* $CAPeCCCodeSystem#365872.100004300 "Margin(s) Involved by Invasive Tumor"
* $CAPeCCCodeSystem#365882.100004300 "Margin Status for Carcinoma in Situ / Noninvasive Papillary Urothelial Carcinoma"
* $CAPeCCCodeSystem#365902.100004300 "Margin(s) Involved by Carcinoma in Situ / Noninvasive Papillary Urothelial Carcinoma"
* $CAPeCCCodeSystem#365903.100004300 "Margin Comment"
* $CAPeCCCodeSystem#374347.100004300 "Regional Lymph Node Status"
* $CAPeCCCodeSystem#14357.100004300 "Number of Lymph Nodes with Tumor"
* $CAPeCCCodeSystem#359381.100004300 "Size of Largest Nodal Metastatic Deposit"
* $CAPeCCCodeSystem#56983.100004300 "Nodal Site with Largest Metastatic Deposit (specify site)"
* $CAPeCCCodeSystem#359386.100004300 "Size of Largest Lymph Node with Tumor"
* $CAPeCCCodeSystem#53986.100004300 "Largest Lymph Node with Tumor (specify site)"
* $CAPeCCCodeSystem#38959.100004300 "Extranodal Extension (ENE)"
* $CAPeCCCodeSystem#868397.100004300 "Specify Location of Involved Lymph Nodes"
* $CAPeCCCodeSystem#14354.100004300 "Number of Lymph Nodes Examined"
* $CAPeCCCodeSystem#364930.100004300 "Regional Lymph Node Comment"
* $CAPeCCCodeSystem#380215.100004300 "?Distant Site(s) Involved, if applicable#"
* $CAPeCCCodeSystem#868385.100004300 "?Modified Classification (required only if applicable)"
* $CAPeCCCodeSystem#327772.100004300 "pT Category"
* $CAPeCCCodeSystem#868386.100004300 "?T Suffix (required only if applicable)"
* $CAPeCCCodeSystem#327774.100004300 "pN Category"
* $CAPeCCCodeSystem#58954.100004300 "?pM Category (required only if confirmed pathologically)"
* $CAPeCCCodeSystem#868395.100004300 "Associated Epithelial Lesions (Note C)"
* $CAPeCCCodeSystem#868396.100004300 "Additional Findings"
* $CAPeCCCodeSystem#14325.100004300 "?Comment(s)"
* $CAPeCCCodeSystem#2814.100004300 "Radiographic Findings (Note B)"
* $CAPeCCCodeSystem#2792.100004300 "Procedure (Note C)"
* $CAPeCCCodeSystem#54728.100004300 "Tumor Site (Note D)"
* $CAPeCCCodeSystem#2801.100004300 "Tumor Location and Extent (Note B)"
* $CAPeCCCodeSystem#347521.100004300 "Histologic Type (World Health Organization [WHO] Classification of Malignant Bone Tumors) (Note E)"
* $CAPeCCCodeSystem#25475.100004300 "Precipitating Factor for Secondary Osteosarcoma"
* $CAPeCCCodeSystem#46510.100004300 "Histologic Type Comment"
* $CAPeCCCodeSystem#50898.100004300 "Histologic Grade (Note F)"
* $CAPeCCCodeSystem#539901.100004300 "Mitotic Rate (Note G)"
* $CAPeCCCodeSystem#2831.100004300 "Necrosis (Note C)"
* $CAPeCCCodeSystem#374401.100004300 "Extent of Necrosis"
* $CAPeCCCodeSystem#2952.100004300 "Lymphovascular Invasion (Note H)"
* $CAPeCCCodeSystem#379548.100004300 "Tumor Comment"
* $CAPeCCCodeSystem#2956.100004300 "Additional Findings (specify)"
* $CAPeCCCodeSystem#18426.100004300 "?Immunohistochemistry"
* $CAPeCCCodeSystem#18440.100004300 "?Cytogenetics"
* $CAPeCCCodeSystem#18434.100004300 "?Molecular Pathology"
* $CAPeCCCodeSystem#2957.100004300 "?Comment(s)"
* $CAPeCCCodeSystem#3905.100004300 "Radiographic Findings (Note B)"
* $CAPeCCCodeSystem#3873.100004300 "Preresection Treatment"
* $CAPeCCCodeSystem#3882.100004300 "Procedure (Note C)"
* $CAPeCCCodeSystem#348261.100004300 "?Multiple Sites"
* $CAPeCCCodeSystem#41223.100004300 "Tumor Site (Note D)"
* $CAPeCCCodeSystem#352624.100004300 "Tumor Size"
* $CAPeCCCodeSystem#3911.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#3912.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#3894.100004300 "Tumor Location and Extent (Note B)"
* $CAPeCCCodeSystem#347474.100004300 "Histologic Type (World Health Organization [WHO] Classification of Malignant Bone Tumors) (Note E)"
* $CAPeCCCodeSystem#20291.100004300 "Precipitating Factor for Secondary Osteosarcoma"
* $CAPeCCCodeSystem#58395.100004300 "Histologic Type Comment"
* $CAPeCCCodeSystem#53282.100004300 "Histologic Grade (Note F)"
* $CAPeCCCodeSystem#366676.100004300 "Mitotic Rate (Note G)"
* $CAPeCCCodeSystem#3922.100004300 "Necrosis (macroscopic or microscopic) (Note C)"
* $CAPeCCCodeSystem#374390.100004300 "Extent of Necrosis"
* $CAPeCCCodeSystem#18444.100004300 "Treatment Effect (Note H)"
* $CAPeCCCodeSystem#374411.100004300 "Extent of Treatment Effect (compared with pretreatment biopsy, if available)"
* $CAPeCCCodeSystem#3965.100004300 "Lymphovascular Invasion (Note I)"
* $CAPeCCCodeSystem#379547.100004300 "Tumor Comment"
* $CAPeCCCodeSystem#367437.100004300 "Margin Status"
* $CAPeCCCodeSystem#367443.100004300 "Closest Margin(s) to Tumor"
* $CAPeCCCodeSystem#367448.100004300 "Distance from Tumor to Closest Margin"
* $CAPeCCCodeSystem#367465.100004300 "Other Close Margin(s) to Tumor (less than 2 cm)"
* $CAPeCCCodeSystem#367455.100004300 "Margin(s) Involved by Tumor"
* $CAPeCCCodeSystem#367453.100004300 "Margin Comment"
* $CAPeCCCodeSystem#374349.100004300 "Regional Lymph Node Status"
* $CAPeCCCodeSystem#58563.100004300 "Number of Lymph Nodes with Tumor"
* $CAPeCCCodeSystem#55337.100004300 "Number of Lymph Nodes Examined"
* $CAPeCCCodeSystem#358327.100004300 "Regional Lymph Node Comment"
* $CAPeCCCodeSystem#352591.100004300 "?Distant Site(s) Involved, if applicable"
* $CAPeCCCodeSystem#17049.100004300 "?TNM Descriptors"
* $CAPeCCCodeSystem#52466.100004300 "pT Category"
* $CAPeCCCodeSystem#516213.100004300 "pT Category"
* $CAPeCCCodeSystem#327708.100004300 "pT Category"
* $CAPeCCCodeSystem#516215.100004300 "pT Category"
* $CAPeCCCodeSystem#327715.100004300 "pN Category (Note K)"
* $CAPeCCCodeSystem#38762.100004300 "?pM Category (required only if confirmed pathologically)"
* $CAPeCCCodeSystem#3969.100004300 "Additional Findings (specify)"
* $CAPeCCCodeSystem#16029.100004300 "?Immunohistochemistry"
* $CAPeCCCodeSystem#18447.100004300 "?Cytogenetics"
* $CAPeCCCodeSystem#18448.100004300 "?Molecular Pathology"
* $CAPeCCCodeSystem#3970.100004300 "?Comment(s)"
* $CAPeCCCodeSystem#758212.100004300 "Test(s) Performed (Note A)"
* $CAPeCCCodeSystem#49025.100004300 "Estrogen Receptor (ER) Status"
* $CAPeCCCodeSystem#48899.100004300 "Percentage of Cells with Nuclear Positivity#"
* $CAPeCCCodeSystem#29749.100004300 "Average Intensity of Staining"
* $CAPeCCCodeSystem#48936.100004300 "Specify Percentage of Cells with Nuclear Positivity"
* $CAPeCCCodeSystem#49033.100004300 "Average Intensity of Staining"
* $CAPeCCCodeSystem#48924.100004300 "Status of Internal Controls"
* $CAPeCCCodeSystem#31089.100004300 "Test Type"
* $CAPeCCCodeSystem#31092.100004300 "Primary Antibody"
* $CAPeCCCodeSystem#31107.100004300 "Scoring System"
* $CAPeCCCodeSystem#31054.100004300 "Proportion Score"
* $CAPeCCCodeSystem#31055.100004300 "Intensity Score"
* $CAPeCCCodeSystem#31056.100004300 "Total Allred Score"
* $CAPeCCCodeSystem#31057.100004300 "Specify System"
* $CAPeCCCodeSystem#31058.100004300 "Specify Score Result"
* $CAPeCCCodeSystem#30524.100004300 "Progesterone Receptor (PgR) Status"
* $CAPeCCCodeSystem#32094.100004300 "Percentage of Cells with Nuclear Positivity"
* $CAPeCCCodeSystem#30564.100004300 "Average Intensity of Staining"
* $CAPeCCCodeSystem#31099.100004300 "Test Type"
* $CAPeCCCodeSystem#31102.100004300 "Primary Antibody"
* $CAPeCCCodeSystem#25903.100004300 "Scoring System"
* $CAPeCCCodeSystem#31059.100004300 "Proportion Score"
* $CAPeCCCodeSystem#31060.100004300 "Intensity Score"
* $CAPeCCCodeSystem#31061.100004300 "Total Allred Score"
* $CAPeCCCodeSystem#31063.100004300 "Specify System"
* $CAPeCCCodeSystem#31064.100004300 "Specify Score Result"
* $CAPeCCCodeSystem#31012.100004300 "HER2 by Immunohistochemistry"
* $CAPeCCCodeSystem#379824.100004300 "Percentage of Cells with Uniform Intense Complete Membrane Staining"
* $CAPeCCCodeSystem#379830.100004300 "Percentage of Cells with Uniform Intense Complete Membrane Staining"
* $CAPeCCCodeSystem#31110.100004300 "Test Type"
* $CAPeCCCodeSystem#31116.100004300 "Primary Antibody"
* $CAPeCCCodeSystem#49055.100004300 "HER2 by in situ Hybridization"
* $CAPeCCCodeSystem#25908.100004300 "?Number of Observers (required only if applicable)"
* $CAPeCCCodeSystem#31037.100004300 "?Number of Invasive Tumor Cells Counted (required only if applicable)"
* $CAPeCCCodeSystem#31038.100004300 "?Method (required only if applicable)"
* $CAPeCCCodeSystem#25910.100004300 "Average Number of HER2 Signals per Cell"
* $CAPeCCCodeSystem#25911.100004300 "Average Number of CEP17 Signals per Cell"
* $CAPeCCCodeSystem#25912.100004300 "HER2 / CEP17 Ratio"
* $CAPeCCCodeSystem#25913.100004300 "Average Number of HER2 Signals per Cell"
* $CAPeCCCodeSystem#30478.100004300 "Aneusomy (as defined by vendor kit used)"
* $CAPeCCCodeSystem#30482.100004300 "Heterogeneous Signals"
* $CAPeCCCodeSystem#379835.100004300 "Percentage of Cells with Amplified HER2 Signals"
* $CAPeCCCodeSystem#31113.100004300 "Test Type"
* $CAPeCCCodeSystem#31075.100004300 "Ki-67 Percentage of Positive Nuclei"
* $CAPeCCCodeSystem#31124.100004300 "Primary Antibody"
* $CAPeCCCodeSystem#52536.100004300 "Cold Ischemia and Fixation Times"
* $CAPeCCCodeSystem#32777.100004300 "Cold Ischemia Time (minutes)"
* $CAPeCCCodeSystem#21465.100004300 "Fixation Time (hours)"
* $CAPeCCCodeSystem#32778.100004300 "Testing Performed on Block Number(s) (specify)"
* $CAPeCCCodeSystem#31086.100004300 "Fixative"
* $CAPeCCCodeSystem#31128.100004300 "Image Analysis"
* $CAPeCCCodeSystem#26436.100004300 "Specify Method"
* $CAPeCCCodeSystem#31131.100004300 "Biomarkers Scored by Image Analysis"
* $CAPeCCCodeSystem#31137.100004300 "?Comment(s)"
* $CAPeCCCodeSystem#45529.100004300 "Procedure"
* $CAPeCCCodeSystem#52267.100004300 "Specimen Laterality"
* $CAPeCCCodeSystem#42501.100004300 "Tumor Site"
* $CAPeCCCodeSystem#44049.100004300 "Specify Clock Position"
* $CAPeCCCodeSystem#57637.100004300 "Histologic Type (Note A)"
* $CAPeCCCodeSystem#42550.100004300 "Architectural Patterns (Note B)"
* $CAPeCCCodeSystem#42658.100004300 "Nuclear Grade (Note C)"
* $CAPeCCCodeSystem#57136.100004300 "Necrosis (Note D)"
* $CAPeCCCodeSystem#54019.100004300 "Microcalcifications (Note E)"
* $CAPeCCCodeSystem#45128.100004300 "Additional Findings (specify)"
* $CAPeCCCodeSystem#380260.100004300 "Breast Biomarker Studies (specify pending studies)"
* $CAPeCCCodeSystem#56243.100004300 "?Comment(s)"
* $CAPeCCCodeSystem#38425.100004300 "Procedure (Note A)"
* $CAPeCCCodeSystem#5422.100004300 "Specimen Laterality"
* $CAPeCCCodeSystem#42676.100004300 "Tumor Site (Note B)"
* $CAPeCCCodeSystem#5442.100004300 "Specify Clock Position"
* $CAPeCCCodeSystem#40336.100004300 "Histologic Type (Note C)"
* $CAPeCCCodeSystem#41204.100004300 "Size (Extent) of DCIS (Note D)"
* $CAPeCCCodeSystem#31339.100004300 "Additional Dimension in Millimeters (mm)"
* $CAPeCCCodeSystem#31340.100004300 "Additional Dimension in Millimeters (mm)"
* $CAPeCCCodeSystem#5487.100004300 "Number of Blocks with DCIS"
* $CAPeCCCodeSystem#5495.100004300 "Number of Blocks Examined"
* $CAPeCCCodeSystem#5496.100004300 "Architectural Patterns (Note E)"
* $CAPeCCCodeSystem#5525.100004300 "Nuclear Grade (Note F)"
* $CAPeCCCodeSystem#5526.100004300 "Necrosis (Note G)"
* $CAPeCCCodeSystem#38426.100004300 "Microcalcifications (Note H)"
* $CAPeCCCodeSystem#350809.100004300 "Margin Status"
* $CAPeCCCodeSystem#350814.100004300 "Distance from DCIS to Closest Margin"
* $CAPeCCCodeSystem#42415.100004300 "?Closest Margin(s) to DCIS (required only if less than 2mm)"
* $CAPeCCCodeSystem#350825.100004300 "Margin(s) Involved by DCIS"
* $CAPeCCCodeSystem#350837.100004300 "Distance from DCIS to Anterior Margin"
* $CAPeCCCodeSystem#350844.100004300 "Distance from DCIS to Posterior Margin"
* $CAPeCCCodeSystem#350851.100004300 "Distance from DCIS to Superior Margin"
* $CAPeCCCodeSystem#350858.100004300 "Distance from DCIS to Inferior Margin"
* $CAPeCCCodeSystem#350865.100004300 "Distance from DCIS to Medial Margin"
* $CAPeCCCodeSystem#350872.100004300 "Distance from DCIS to Lateral Margin"
* $CAPeCCCodeSystem#350879.100004300 "Distance from DCIS to Other Margin(s)"
* $CAPeCCCodeSystem#351701.100004300 "Margin Comment"
* $CAPeCCCodeSystem#350886.100004300 "Regional Lymph Node Status"
* $CAPeCCCodeSystem#42640.100004300 "Number of Lymph Nodes with Macrometastases (greater than 2 mm)"
* $CAPeCCCodeSystem#50672.100004300 "Number of Lymph Nodes with Micrometastases (greater than 0.2 mm to 2 mm and / or greater than 200 cells)"
* $CAPeCCCodeSystem#55000.100004300 "?Number of Lymph Nodes with Isolated Tumor Cells (0.2 mm or less OR 200 cells or less)#"
* $CAPeCCCodeSystem#351426.100004300 "Size of Largest Nodal Metastatic Deposit"
* $CAPeCCCodeSystem#351447.100004300 "Extranodal Extension"
* $CAPeCCCodeSystem#350902.100004300 "Total Number of Lymph Nodes Examined (sentinel and non-sentinel)"
* $CAPeCCCodeSystem#350907.100004300 "?Number of Sentinel Nodes Examined (if applicable)"
* $CAPeCCCodeSystem#358332.100004300 "Regional Lymph Node Comment"
* $CAPeCCCodeSystem#352347.100004300 "?Distant Site(s) Involved, if applicable"
* $CAPeCCCodeSystem#47098.100004300 "?TNM Descriptors"
* $CAPeCCCodeSystem#38402.100004300 "pT Category"
* $CAPeCCCodeSystem#45290.100004300 "?Regional Lymph Nodes Modifier"
* $CAPeCCCodeSystem#327737.100004300 "pN Category"
* $CAPeCCCodeSystem#6430.100004300 "?pM Category (required only if confirmed pathologically)"
* $CAPeCCCodeSystem#49402.100004300 "Specify Case Number (if from a previous procedure)"
* $CAPeCCCodeSystem#6641.100004300 "Additional Findings (specify)"
* $CAPeCCCodeSystem#47438.100004300 "Breast Biomarker Testing Performed on Previous Biopsy"
* $CAPeCCCodeSystem#41287.100004300 "Estrogen Receptor (ER) Status"
* $CAPeCCCodeSystem#41288.100004300 "Percentage of Cells with Nuclear Positivity#"
* $CAPeCCCodeSystem#41396.100004300 "Progesterone Receptor (PgR) Status"
* $CAPeCCCodeSystem#42885.100004300 "Percentage of Cells with Nuclear Positivity#"
* $CAPeCCCodeSystem#49737.100004300 "Testing Performed on Case Number"
* $CAPeCCCodeSystem#6435.100004300 "?Comment(s)"
* $CAPeCCCodeSystem#47315.100004300 "Procedure"
* $CAPeCCCodeSystem#57892.100004300 "Specimen Laterality"
* $CAPeCCCodeSystem#42544.100004300 "Tumor Site"
* $CAPeCCCodeSystem#51795.100004300 "Specify Clock Position"
* $CAPeCCCodeSystem#50983.100004300 "Histologic Type (Note A)"
* $CAPeCCCodeSystem#54892.100004300 "Histologic Type Comment"
* $CAPeCCCodeSystem#380262.100004300 "?Histologic Grade (Nottingham Histologic Score) (required only if applicable) (Note B)"
* $CAPeCCCodeSystem#59220.100004300 "Glandular (Acinar) / Tubular Differentiation"
* $CAPeCCCodeSystem#59612.100004300 "Nuclear Pleomorphism"
* $CAPeCCCodeSystem#50066.100004300 "Mitotic Rate"
* $CAPeCCCodeSystem#48875.100004300 "Overall Grade"
* $CAPeCCCodeSystem#847276.100004300 "Largest Invasive Focus in this Limited Biopsy Sample"
* $CAPeCCCodeSystem#51082.100004300 "Ductal Carcinoma In Situ (DCIS) (Note C)"
* $CAPeCCCodeSystem#45237.100004300 "Architectural Patterns"
* $CAPeCCCodeSystem#38788.100004300 "Nuclear Grade"
* $CAPeCCCodeSystem#43697.100004300 "Necrosis"
* $CAPeCCCodeSystem#41699.100004300 "Lymphatic and / or Vascular Invasion"
* $CAPeCCCodeSystem#55416.100004300 "Microcalcifications (Note D)"
* $CAPeCCCodeSystem#50567.100004300 "Additional Findings (specify)"
* $CAPeCCCodeSystem#380264.100004300 "Breast Biomarker Studies (specify pending studies)"
* $CAPeCCCodeSystem#51835.100004300 "?Comment(s)"
* $CAPeCCCodeSystem#58807.100004300 "Procedure (Note A)"
* $CAPeCCCodeSystem#16214.100004300 "Specimen Laterality"
* $CAPeCCCodeSystem#51180.100004300 "Tumor Site (Note B)"
* $CAPeCCCodeSystem#16259.100004300 "Specify Clock Position"
* $CAPeCCCodeSystem#41794.100004300 "Histologic Type (Note C)"
* $CAPeCCCodeSystem#35589.100004300 "Histologic Type Comment"
* $CAPeCCCodeSystem#380281.100004300 "?Histologic Grade (Nottingham Histologic Score) (required only if applicable) (Note D)"
* $CAPeCCCodeSystem#38124.100004300 "Glandular (Acinar) / Tubular Differentiation"
* $CAPeCCCodeSystem#38125.100004300 "Nuclear Pleomorphism"
* $CAPeCCCodeSystem#38390.100004300 "Mitotic Rate"
* $CAPeCCCodeSystem#38391.100004300 "Overall Grade"
* $CAPeCCCodeSystem#30148.100004300 "Tumor Size (Note E)"
* $CAPeCCCodeSystem#31359.100004300 "Additional Dimension in Millimeters (mm)"
* $CAPeCCCodeSystem#31360.100004300 "Additional Dimension in Millimeters (mm)"
* $CAPeCCCodeSystem#38392.100004300 "Tumor Focality (Note F)"
* $CAPeCCCodeSystem#44564.100004300 "Number of Foci"
* $CAPeCCCodeSystem#820566.100004300 "Sizes of Individual Foci in Millimeters (mm) (values may be recorded on a single line using units (mm) and semicolons (;) as separators)"
* $CAPeCCCodeSystem#44040.100004300 "Ductal Carcinoma In Situ (DCIS) (Note G)"
* $CAPeCCCodeSystem#49860.100004300 "Size (Extent) of DCIS"
* $CAPeCCCodeSystem#31343.100004300 "Additional Dimension in Millimeters (mm)"
* $CAPeCCCodeSystem#31344.100004300 "Additional Dimension in Millimeters (mm)"
* $CAPeCCCodeSystem#16325.100004300 "Architectural Patterns (if DCIS is present in specimen select all that apply)"
* $CAPeCCCodeSystem#16321.100004300 "Nuclear Grade (if DCIS is present in specimen, see Table 2 in CAP Protocol)"
* $CAPeCCCodeSystem#16333.100004300 "Necrosis (If DCIS is present in specimen)"
* $CAPeCCCodeSystem#16319.100004300 "Number of Blocks with DCIS"
* $CAPeCCCodeSystem#16320.100004300 "Number of Blocks Examined"
* $CAPeCCCodeSystem#16337.100004300 "Lobular Carcinoma In Situ (LCIS)"
* $CAPeCCCodeSystem#350913.100004300 "?Tumor Extent (required only if skin, nipple, or skeletal muscle are present and involved)"
* $CAPeCCCodeSystem#820568.100004300 "Skin Invasion"
* $CAPeCCCodeSystem#21799.100004300 "Skin Satellite Foci"
* $CAPeCCCodeSystem#352357.100004300 "Skeletal Muscle"
* $CAPeCCCodeSystem#16430.100004300 "Lymphatic and / or Vascular Invasion (Note I)"
* $CAPeCCCodeSystem#16434.100004300 "Dermal Lymphatic and / or Vascular Invasion"
* $CAPeCCCodeSystem#16440.100004300 "Microcalcifications (Note J)"
* $CAPeCCCodeSystem#16455.100004300 "Treatment Effect in the Breast (Note K)"
* $CAPeCCCodeSystem#37850.100004300 "?Treatment Effect in the Lymph Nodes (required if nodes are submitted and it is known that the patient had presurgical therapy)"
* $CAPeCCCodeSystem#868254.100004300 "?Residual Cancer Burden (RCB) Calculation (for institutions that wish to report treatment effect using the RCB calculator)# (Note K)"
* $CAPeCCCodeSystem#868259.100004300 "Greatest Dimension of Primary Tumor Bed Area in Millimeters (mm) (involved by residual viable carcinoma)"
* $CAPeCCCodeSystem#868260.100004300 "Second Greatest Dimension of Primary Tumor Bed Area in Millimeters (mm)"
* $CAPeCCCodeSystem#868261.100004300 "Specify Percentage of Overall Cancer Cellularity (in the area measured above)"
* $CAPeCCCodeSystem#868262.100004300 "Specify Percentage of Cancer that is in situ Disease"
* $CAPeCCCodeSystem#868264.100004300 "Number of Positive Lymph Nodes"
* $CAPeCCCodeSystem#868265.100004300 "Diameter of Largest Nodal Metastasis in Millimeters (mm)"
* $CAPeCCCodeSystem#868266.100004300 "Residual Cancer Burden"
* $CAPeCCCodeSystem#868267.100004300 "Residual Cancer Burden Class"
* $CAPeCCCodeSystem#351503.100004300 "?Margin Status for Invasive Carcinoma (required only if residual invasive carcinoma is present in specimen)"
* $CAPeCCCodeSystem#351505.100004300 "Distance from Invasive Carcinoma to Closest Margin"
* $CAPeCCCodeSystem#351495.100004300 "Closest Margin(s) to Invasive Carcinoma"
* $CAPeCCCodeSystem#351514.100004300 "Margin(s) Involved by Invasive Carcinoma"
* $CAPeCCCodeSystem#351526.100004300 "Distance from Invasive Carcinoma to Anterior Margin"
* $CAPeCCCodeSystem#351533.100004300 "Distance from Invasive Carcinoma to Posterior Margin"
* $CAPeCCCodeSystem#351540.100004300 "Distance from Invasive Carcinoma to Superior Margin"
* $CAPeCCCodeSystem#351547.100004300 "Distance from Invasive Carcinoma to Inferior Margin"
* $CAPeCCCodeSystem#351554.100004300 "Distance from Invasive Carcinoma to Medial Margin"
* $CAPeCCCodeSystem#351561.100004300 "Distance from Invasive Carcinoma to Lateral Margin"
* $CAPeCCCodeSystem#351568.100004300 "Distance from Invasive Carcinoma to Other Margin(s)"
* $CAPeCCCodeSystem#351632.100004300 "?Margin Status for DCIS (required only if DCIS is present in specimen)"
* $CAPeCCCodeSystem#351634.100004300 "Distance from DCIS to Closest Margin"
* $CAPeCCCodeSystem#351624.100004300 "?Closest Margin(s) to DCIS (required only if less than 2mm)"
* $CAPeCCCodeSystem#351643.100004300 "Margin(s) Involved by DCIS"
* $CAPeCCCodeSystem#351655.100004300 "Distance from DCIS to Anterior Margin"
* $CAPeCCCodeSystem#351662.100004300 "Distance from DCIS to Posterior Margin"
* $CAPeCCCodeSystem#351669.100004300 "Distance from DCIS to Superior Margin"
* $CAPeCCCodeSystem#351676.100004300 "Distance from DCIS to Inferior Margin"
* $CAPeCCCodeSystem#351683.100004300 "Distance from DCIS to Medial Margin"
* $CAPeCCCodeSystem#351690.100004300 "Distance from DCIS to Lateral Margin"
* $CAPeCCCodeSystem#351697.100004300 "Distance from DCIS to Other Margin(s)"
* $CAPeCCCodeSystem#351700.100004300 "Margin Comment"
* $CAPeCCCodeSystem#351589.100004300 "Regional Lymph Node Status"
* $CAPeCCCodeSystem#33611.100004300 "Number of Lymph Nodes with Macrometastases (greater than 2 mm)"
* $CAPeCCCodeSystem#33613.100004300 "Number of Lymph Nodes with Micrometastases (greater than 0.2 mm to 2 mm and / or greater than 200 cells)"
* $CAPeCCCodeSystem#33615.100004300 "?Number of Lymph Nodes with Isolated Tumor Cells (0.2 mm or less OR 200 cells or less) (required only if applicable)#"
* $CAPeCCCodeSystem#352296.100004300 "Size of Largest Nodal Metastatic Deposit"
* $CAPeCCCodeSystem#352303.100004300 "Extranodal Extension"
* $CAPeCCCodeSystem#351702.100004300 "Specify Amount"
* $CAPeCCCodeSystem#351602.100004300 "Total Number of Lymph Nodes Examined (sentinel and non-sentinel)"
* $CAPeCCCodeSystem#351607.100004300 "?Number of Sentinel Nodes Examined (if applicable)"
* $CAPeCCCodeSystem#358333.100004300 "Regional Lymph Node Comment"
* $CAPeCCCodeSystem#352334.100004300 "?Distant Site(s) Involved, if applicable"
* $CAPeCCCodeSystem#820562.100004300 "?Modified Classification (required only if applicable)"
* $CAPeCCCodeSystem#327740.100004300 "pT Category"
* $CAPeCCCodeSystem#820563.100004300 "?T Suffix (required only if applicable)"
* $CAPeCCCodeSystem#763178.100004300 "pN Category"
* $CAPeCCCodeSystem#42996.100004300 "?N Suffix (required only if applicable)"
* $CAPeCCCodeSystem#16775.100004300 "?pM Category (required only if confirmed pathologically)"
* $CAPeCCCodeSystem#352625.100004300 "Specify Case Number (if from a previous procedure)"
* $CAPeCCCodeSystem#16783.100004300 "Additional Findings (specify)"
* $CAPeCCCodeSystem#43789.100004300 "Breast Biomarker Testing Performed on Previous Biopsy"
* $CAPeCCCodeSystem#45138.100004300 "Estrogen Receptor (ER) Status"
* $CAPeCCCodeSystem#41411.100004300 "Percentage of Cells with Nuclear Positivity"
* $CAPeCCCodeSystem#42928.100004300 "Progesterone Receptor (PgR) Status"
* $CAPeCCCodeSystem#42936.100004300 "Percentage of Cells with Nuclear Positivity#"
* $CAPeCCCodeSystem#52399.100004300 "HER2 (by immunohistochemistry)"
* $CAPeCCCodeSystem#847268.100004300 "Percentage of Cells with Uniform Intense Complete Membrane Staining"
* $CAPeCCCodeSystem#847272.100004300 "Percentage of Cells with Uniform Intense Complete Membrane Staining"
* $CAPeCCCodeSystem#48698.100004300 "HER2 (by in situ hybridization)"
* $CAPeCCCodeSystem#43798.100004300 "Ki-67 Percentage of Positive Nuclei"
* $CAPeCCCodeSystem#43743.100004300 "Testing Performed on Case Number"
* $CAPeCCCodeSystem#16784.100004300 "?Comment(s)"
* $CAPeCCCodeSystem#592850.100004300 "Procedure"
* $CAPeCCCodeSystem#592856.100004300 "Specimen Laterality"
* $CAPeCCCodeSystem#592863.100004300 "Tumor Site"
* $CAPeCCCodeSystem#705997.100004300 "Specify Clock Position"
* $CAPeCCCodeSystem#593080.100004300 "Tumor Size"
* $CAPeCCCodeSystem#593083.100004300 "Additional Dimension in Millimeters (mm)"
* $CAPeCCCodeSystem#593084.100004300 "Additional Dimension in Millimeters (mm)"
* $CAPeCCCodeSystem#592879.100004300 "Histologic Type (Note A)"
* $CAPeCCCodeSystem#592889.100004300 "Stromal Cellularity (Note B)"
* $CAPeCCCodeSystem#592893.100004300 "Stromal Atypia (Note C)"
* $CAPeCCCodeSystem#592897.100004300 "Stromal Overgrowth (Note D)"
* $CAPeCCCodeSystem#592901.100004300 "Mitotic Rate (Note E)"
* $CAPeCCCodeSystem#592908.100004300 "Histologic Tumor Border"
* $CAPeCCCodeSystem#592916.100004300 "Malignant Heterologous Elements (Note F)"
* $CAPeCCCodeSystem#592923.100004300 "Margin Status for Phyllodes Tumor"
* $CAPeCCCodeSystem#592926.100004300 "Closest Margin(s) to Phyllodes Tumor"
* $CAPeCCCodeSystem#592935.100004300 "Distance from Phyllodes Tumor to Closest Margin"
* $CAPeCCCodeSystem#593067.100004300 "Margin(s) Involved by Phyllodes Tumor"
* $CAPeCCCodeSystem#706009.100004300 "Margin Comment"
* $CAPeCCCodeSystem#592958.100004300 "Regional Lymph Node Status"
* $CAPeCCCodeSystem#593048.100004300 "Number of Lymph Nodes with Tumor"
* $CAPeCCCodeSystem#593055.100004300 "Number of Lymph Nodes Examined"
* $CAPeCCCodeSystem#592973.100004300 "Regional Lymph Node Comment"
* $CAPeCCCodeSystem#592981.100004300 "?Distant Site(s) Involved, if applicable"
* $CAPeCCCodeSystem#592997.100004300 "?Pathologic Stage Classification (pTNM, AJCC 8th Edition) (required only if the tumor is malignant)"
* $CAPeCCCodeSystem#593008.100004300 "?TNM Descriptors"
* $CAPeCCCodeSystem#593013.100004300 "pT Category"
* $CAPeCCCodeSystem#769534.100004300 "pN Category"
* $CAPeCCCodeSystem#593030.100004300 "?pM Category (required only if confirmed pathologically)"
* $CAPeCCCodeSystem#593033.100004300 "Additional Findings"
* $CAPeCCCodeSystem#593042.100004300 "?Comment(s)"
* $CAPeCCCodeSystem#804105.100004300 "History of Prior Therapy for this Neoplasm (Note A)"
* $CAPeCCCodeSystem#804110.100004300 "History of Previous Tumor and / or Familial Syndrome (not the current neoplasm) (Note A)"
* $CAPeCCCodeSystem#804099.100004300 "Neuroimaging Findings (Note B)"
* $CAPeCCCodeSystem#804120.100004300 "Procedure (Note C)"
* $CAPeCCCodeSystem#804127.100004300 "Specimen Size, Gross Description (Note D)"
* $CAPeCCCodeSystem#804125.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#804118.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#804464.100004300 "Tumor Site (Note E)"
* $CAPeCCCodeSystem#804202.100004300 "Specify Precise Location, if known"
* $CAPeCCCodeSystem#804285.100004300 "Specify Precise Location, if known"
* $CAPeCCCodeSystem#804166.100004300 "Specify Precise Location, if known"
* $CAPeCCCodeSystem#804481.100004300 "Specify Precise Location, if known"
* $CAPeCCCodeSystem#804408.100004300 "Specify Precise Location, if known"
* $CAPeCCCodeSystem#804248.100004300 "Specify Precise Location, if known"
* $CAPeCCCodeSystem#804130.100004300 "Specify Precise Location, if known"
* $CAPeCCCodeSystem#804293.100004300 "Specify I-XII, if known"
* $CAPeCCCodeSystem#804335.100004300 "Specify Precise Location, if known"
* $CAPeCCCodeSystem#804406.100004300 "Specify Precise Location, if known"
* $CAPeCCCodeSystem#804305.100004300 "Specify Precise Location, if known"
* $CAPeCCCodeSystem#804473.100004300 "Tumor Laterality (Note E)"
* $CAPeCCCodeSystem#804227.100004300 "Tumor Focality (Note E)"
* $CAPeCCCodeSystem#804331.100004300 "Integrated Diagnosis (CNS WHO 2021) (Notes F, G)"
* $CAPeCCCodeSystem#804654.100004300 "Specify Histologic Type"
* $CAPeCCCodeSystem#804326.100004300 "Histologic Type Comments"
* $CAPeCCCodeSystem#804194.100004300 "Integrated Histologic Molecular Grade (CNS WHO 2021) (Note H)"
* $CAPeCCCodeSystem#804397.100004300 "Treatment Effect (Histological Evidence of Prior Therapy) (Note I)"
* $CAPeCCCodeSystem#804452.100004300 "Specify Percentage of Tumor that is Necrotic"
* $CAPeCCCodeSystem#804496.100004300 "Additional Pathologic Findings (specify)"
* $CAPeCCCodeSystem#804501.100004300 "Molecular Information (Note J)"
* $CAPeCCCodeSystem#804503.100004300 "Designate Block(s) for Future Studies"
* $CAPeCCCodeSystem#804560.100004300 "?Comment(s)"
* $CAPeCCCodeSystem#18464.100004300 "Procedure (Note A)"
* $CAPeCCCodeSystem#27212.100004300 "Tumor Site"
* $CAPeCCCodeSystem#14686.100004300 "Tumor Size (Note B)"
* $CAPeCCCodeSystem#14690.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#14691.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#327951.100004300 "Histologic Type (Note C)"
* $CAPeCCCodeSystem#35702.100004300 "Histologic Type Comment"
* $CAPeCCCodeSystem#14709.100004300 "Histologic Grade (Note D)"
* $CAPeCCCodeSystem#379580.100004300 "Depth of Stromal Invasion"
* $CAPeCCCodeSystem#42487.100004300 "Horizontal Extent of Stromal Invasion"
* $CAPeCCCodeSystem#42636.100004300 "Number of Blocks Involved"
* $CAPeCCCodeSystem#45229.100004300 "Number of Blocks Involved"
* $CAPeCCCodeSystem#45415.100004300 "Silva System for Invasion#"
* $CAPeCCCodeSystem#330086.100004300 "Lymphatic and / or Vascular Invasion (Note E)"
* $CAPeCCCodeSystem#379531.100004300 "Tumor Comment"
* $CAPeCCCodeSystem#327967.100004300 "Margin Status for Invasive Carcinoma"
* $CAPeCCCodeSystem#327973.100004300 "Closest Margin(s) to Invasive Carcinoma"
* $CAPeCCCodeSystem#327980.100004300 "Distance from Invasive Carcinoma to Closest Margin"
* $CAPeCCCodeSystem#327989.100004300 "Margin(s) Involved by Invasive Carcinoma"
* $CAPeCCCodeSystem#379069.100004300 "Margin Status for HSIL or AIS#"
* $CAPeCCCodeSystem#328004.100004300 "Margin(s) Involved by HSIL"
* $CAPeCCCodeSystem#328009.100004300 "Margin(s) Involved by AIS"
* $CAPeCCCodeSystem#328015.100004300 "Margin Comment"
* $CAPeCCCodeSystem#330089.100004300 "Additional Findings"
* $CAPeCCCodeSystem#330135.100004300 "p16 Immunohistochemistry"
* $CAPeCCCodeSystem#14766.100004300 "?Comment(s)"
* $CAPeCCCodeSystem#58945.100004300 "Procedure"
* $CAPeCCCodeSystem#44606.100004300 "Hysterectomy Type"
* $CAPeCCCodeSystem#27754.100004300 "Tumor Site"
* $CAPeCCCodeSystem#14578.100004300 "Tumor Size (Note B)"
* $CAPeCCCodeSystem#14581.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#14582.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#327028.100004300 "Histologic Type (Note C)"
* $CAPeCCCodeSystem#35703.100004300 "Histologic Type Comment"
* $CAPeCCCodeSystem#14612.100004300 "Histologic Grade (Note D)"
* $CAPeCCCodeSystem#379602.100004300 "Depth of Stromal Invasion"
* $CAPeCCCodeSystem#42078.100004300 "Extent of Depth of Stromal Invasion"
* $CAPeCCCodeSystem#492908.100004300 "Horizontal Extent of Stromal Invasion"
* $CAPeCCCodeSystem#45633.100004300 "Number of Blocks Involved"
* $CAPeCCCodeSystem#45824.100004300 "Number of Blocks Involved"
* $CAPeCCCodeSystem#45638.100004300 "Silva System for Invasion#"
* $CAPeCCCodeSystem#381305.100004300 "Other Tissue / Organ Involvement#"
* $CAPeCCCodeSystem#328092.100004300 "Lymphatic and / or Vascular Invasion (Note E)"
* $CAPeCCCodeSystem#379530.100004300 "Tumor Comment"
* $CAPeCCCodeSystem#327043.100004300 "Margin Status for Invasive Carcinoma"
* $CAPeCCCodeSystem#327050.100004300 "Closest Margin(s) to Invasive Carcinoma"
* $CAPeCCCodeSystem#327057.100004300 "Distance from Invasive Carcinoma to Closest Margin"
* $CAPeCCCodeSystem#327067.100004300 "Margin(s) Involved by Invasive Carcinoma"
* $CAPeCCCodeSystem#327119.100004300 "Margin Status for HSIL or AIS#"
* $CAPeCCCodeSystem#327127.100004300 "Margin(s) Involved by HSIL"
* $CAPeCCCodeSystem#327134.100004300 "Margin(s) Involved by AIS"
* $CAPeCCCodeSystem#327940.100004300 "Margin Comment"
* $CAPeCCCodeSystem#374354.100004300 "Regional Lymph Node Status#"
* $CAPeCCCodeSystem#328101.100004300 "Total Number of Pelvic Nodes with Macrometastasis (greater than 2 mm) (sentinel and non-sentinel)"
* $CAPeCCCodeSystem#330951.100004300 "Number of Pelvic Sentinel Nodes with Macrometastasis"
* $CAPeCCCodeSystem#328132.100004300 "Total Number of Pelvic Nodes with Micrometastasis (greater than 0.2 mm up to 2 mm and / or greater than 200 cells) (sentinel and non-sentinel)"
* $CAPeCCCodeSystem#330956.100004300 "Number of Pelvic Sentinel Nodes with Micrometastasis"
* $CAPeCCCodeSystem#328112.100004300 "?Total Number of Pelvic Nodes with Isolated Tumor Cells (0.2 mm or less and not more than 200 cells) (required only if present)###"
* $CAPeCCCodeSystem#330962.100004300 "Number of Pelvic Sentinel Nodes with ITCs"
* $CAPeCCCodeSystem#328130.100004300 "?Laterality of Pelvic Node(s) with Tumor (required only if present)"
* $CAPeCCCodeSystem#350624.100004300 "Size of Largest Pelvic Nodal Metastatic Deposit"
* $CAPeCCCodeSystem#328134.100004300 "?Total Number of Para-aortic Nodes with Macrometastasis (greater than 2 mm) (sentinel and non-sentinel) (required only if present)"
* $CAPeCCCodeSystem#330982.100004300 "Number of Para-aortic Sentinel Nodes with Macrometastasis"
* $CAPeCCCodeSystem#328144.100004300 "?Total Number of Para-aortic Nodes with Micrometastasis (greater than 0.2 mm up to 2 mm and/or greater than 200 cells) (sentinel and non-sentinel) (required only if present)"
* $CAPeCCCodeSystem#330987.100004300 "Number of Para-aortic Sentinel Nodes with Micrometastasis"
* $CAPeCCCodeSystem#328137.100004300 "?Total Number of Para-aortic Nodes with Isolated Tumor Cells (0.2 mm or less and not more than 200 cells) (required only if present)####"
* $CAPeCCCodeSystem#330992.100004300 "Number of Para-aortic Sentinel Nodes with ITCs"
* $CAPeCCCodeSystem#328114.100004300 "?Laterality of Para-aortic Node(s) with Tumor (required only if present)"
* $CAPeCCCodeSystem#350633.100004300 "Size of Largest Para-aortic Nodal Metastatic Deposit"
* $CAPeCCCodeSystem#328159.100004300 "Total Number of Pelvic Nodes Examined (sentinel and non-sentinel)"
* $CAPeCCCodeSystem#328158.100004300 "?Number of Pelvic Sentinel Nodes Examined (required only if present)"
* $CAPeCCCodeSystem#328143.100004300 "Total Number of Para-aortic Nodes Examined (sentinel and non-sentinel)"
* $CAPeCCCodeSystem#328148.100004300 "?Number of Para-aortic Sentinel Nodes Examined (required only if present)"
* $CAPeCCCodeSystem#358320.100004300 "Regional Lymph Node Comment"
* $CAPeCCCodeSystem#331100.100004300 "?Distant Site(s) Involved, if applicable#"
* $CAPeCCCodeSystem#847260.100004300 "?Modified Classification (required only if applicable)"
* $CAPeCCCodeSystem#328018.100004300 "pT Category"
* $CAPeCCCodeSystem#847261.100004300 "?T Suffix (required only if applicable)"
* $CAPeCCCodeSystem#328074.100004300 "pN Category"
* $CAPeCCCodeSystem#847264.100004300 "?N Suffix (required only if applicable)"
* $CAPeCCCodeSystem#14645.100004300 "?pM Category (required only if confirmed pathologically)"
* $CAPeCCCodeSystem#328060.100004300 "FIGO Stage (2018 FIGO Cancer Report)#"
* $CAPeCCCodeSystem#330097.100004300 "Additional Findings"
* $CAPeCCCodeSystem#17218.100004300 "Ancillary Studies (specify) (Note H)"
* $CAPeCCCodeSystem#33591.100004300 "p16 Immunohistochemistry"
* $CAPeCCCodeSystem#14673.100004300 "?Comment(s)"
* $CAPeCCCodeSystem#29485.100004300 "Immunohistochemistry (IHC) Testing for Mismatch Repair (MMR) Proteins"
* $CAPeCCCodeSystem#29999.100004300 "MLH1 Result"
* $CAPeCCCodeSystem#30000.100004300 "MSH2 Result"
* $CAPeCCCodeSystem#30001.100004300 "MSH6 Result"
* $CAPeCCCodeSystem#30002.100004300 "PMS2 Result"
* $CAPeCCCodeSystem#29505.100004300 "IHC Interpretation#"
* $CAPeCCCodeSystem#29512.100004300 "Microsatellite Instability (MSI)"
* $CAPeCCCodeSystem#29524.100004300 "Loci Testing"
* $CAPeCCCodeSystem#29527.100004300 "BAT-25"
* $CAPeCCCodeSystem#29531.100004300 "BAT-26"
* $CAPeCCCodeSystem#29493.100004300 "NR-21"
* $CAPeCCCodeSystem#29538.100004300 "NR-24"
* $CAPeCCCodeSystem#29542.100004300 "Mono-27"
* $CAPeCCCodeSystem#29547.100004300 "BAT-25"
* $CAPeCCCodeSystem#29551.100004300 "BAT-26"
* $CAPeCCCodeSystem#29555.100004300 "D2S123"
* $CAPeCCCodeSystem#29559.100004300 "D5S346"
* $CAPeCCCodeSystem#29563.100004300 "D17S250"
* $CAPeCCCodeSystem#21557.100004300 "Specify Marker"
* $CAPeCCCodeSystem#30382.100004300 "MLH1 Promoter Methylation Analysis"
* $CAPeCCCodeSystem#29571.100004300 "KRAS Mutational Analysis"
* $CAPeCCCodeSystem#29937.100004300 "Codon 12"
* $CAPeCCCodeSystem#29938.100004300 "Codon 13"
* $CAPeCCCodeSystem#29940.100004300 "Codon 61"
* $CAPeCCCodeSystem#29944.100004300 "Codon 146"
* $CAPeCCCodeSystem#26279.100004300 "Other Codon (specify)"
* $CAPeCCCodeSystem#30391.100004300 "Codons Assessed"
* $CAPeCCCodeSystem#32184.100004300 "NRAS Mutational Analysis"
* $CAPeCCCodeSystem#32187.100004300 "Codon 12"
* $CAPeCCCodeSystem#32196.100004300 "Codon 13"
* $CAPeCCCodeSystem#32204.100004300 "Codon 61"
* $CAPeCCCodeSystem#32209.100004300 "Codon 146"
* $CAPeCCCodeSystem#32213.100004300 "Other Codon (specify)"
* $CAPeCCCodeSystem#32216.100004300 "Codons Assessed"
* $CAPeCCCodeSystem#32231.100004300 "BRAF Cytoplasmic Expression (by immunohistochemistry) (Note B)"
* $CAPeCCCodeSystem#29602.100004300 "BRAF Mutational Analysis"
* $CAPeCCCodeSystem#29675.100004300 "BRAF Mutations Assessed"
* $CAPeCCCodeSystem#29609.100004300 "PIK3CA Mutational Analysis"
* $CAPeCCCodeSystem#29614.100004300 "PTEN Expression (by immunohistochemistry)"
* $CAPeCCCodeSystem#29618.100004300 "PTEN Mutational Analysis"
* $CAPeCCCodeSystem#29623.100004300 "Specify Type"
* $CAPeCCCodeSystem#29624.100004300 "Results"
* $CAPeCCCodeSystem#29628.100004300 "Recurrence Score"
* $CAPeCCCodeSystem#364818.100004300 "Test(s) Performed"
* $CAPeCCCodeSystem#364826.100004300 "Results"
* $CAPeCCCodeSystem#380982.100004300 "Scoring System"
* $CAPeCCCodeSystem#380988.100004300 "Staining Intensity"
* $CAPeCCCodeSystem#380994.100004300 "Percentage of Tumor Cells with Specific Membrane Staining (i.e., complete, basolateral, or lateral membrane)"
* $CAPeCCCodeSystem#364843.100004300 "Results"
* $CAPeCCCodeSystem#380999.100004300 "Scoring System"
* $CAPeCCCodeSystem#364857.100004300 "Number of Invasive Cancer Cells Counted"
* $CAPeCCCodeSystem#364847.100004300 "Method"
* $CAPeCCCodeSystem#364852.100004300 "HER2 (ERBB2):CEP17 Ratio"
* $CAPeCCCodeSystem#364855.100004300 "Average Number of HER2 (ERBB2) Signals per Cancer Cell"
* $CAPeCCCodeSystem#364856.100004300 "Average Number of CEP17 Signals per Cancer Cell"
* $CAPeCCCodeSystem#364822.100004300 "Range of Number of HER2 (ERBB2) Signals per Cancer Cell"
* $CAPeCCCodeSystem#364854.100004300 "Average Number of HER2 (ERBB2) Signals per Cancer Cell"
* $CAPeCCCodeSystem#364813.100004300 "Range of Number of HER2 (ERBB2) Signals per Cancer Cell"
* $CAPeCCCodeSystem#364816.100004300 "Results"
* $CAPeCCCodeSystem#29630.100004300 "Dissection Method(s)#"
* $CAPeCCCodeSystem#29645.100004300 "Percent Tumor Cells Present in Specimen"
* $CAPeCCCodeSystem#29941.100004300 "Whole Genome or Exome Sequencing"
* $CAPeCCCodeSystem#29643.100004300 "Number of MSI Markers Tested (specify number)"
* $CAPeCCCodeSystem#29647.100004300 "MLH1 Promoter Methylation Testing Method"
* $CAPeCCCodeSystem#29656.100004300 "KRAS Testing Method(s)#"
* $CAPeCCCodeSystem#32223.100004300 "NRAS Testing Method(s)#"
* $CAPeCCCodeSystem#29919.100004300 "BRAF Testing Method(s)"
* $CAPeCCCodeSystem#29926.100004300 "PIK3CA Testing Method"
* $CAPeCCCodeSystem#29930.100004300 "PTEN Testing Method"
* $CAPeCCCodeSystem#381004.100004300 "HER2 protein expression by immunohistochemistry"
* $CAPeCCCodeSystem#381030.100004300 "Primary Antibody"
* $CAPeCCCodeSystem#381016.100004300 "HER2 (ERBB2) by in situ hybridization"
* $CAPeCCCodeSystem#381020.100004300 "Method"
* $CAPeCCCodeSystem#381012.100004300 "HER2 (ERBB2) by genomic test for amplification or mutation"
* $CAPeCCCodeSystem#29935.100004300 "?Comment(s)"
* $CAPeCCCodeSystem#936935.100004300 "Procedure"
* $CAPeCCCodeSystem#46673.100004300 "Tumor Site (Note B)"
* $CAPeCCCodeSystem#939946.100004300 "Histologic Type and Grade# (Notes C, D)"
* $CAPeCCCodeSystem#38558.100004300 "Histologic Type and Grade Comment"
* $CAPeCCCodeSystem#379312.100004300 "?Mitotic Rate (required only when Ki-67 labeling index is not reported)#"
* $CAPeCCCodeSystem#379313.100004300 "?Ki-67 Labeling Index (required only when mitotic rate is not reported)"
* $CAPeCCCodeSystem#21188.100004300 "Tumor Size (Note E)"
* $CAPeCCCodeSystem#21192.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#21191.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#379326.100004300 "Tumor Focality"
* $CAPeCCCodeSystem#379330.100004300 "Number of Tumors"
* $CAPeCCCodeSystem#378858.100004300 "?Multiple Primary Sites (e.g., hepatic flexure and transverse colon)"
* $CAPeCCCodeSystem#44557.100004300 "Tumor Extent"
* $CAPeCCCodeSystem#21264.100004300 "Lymphatic and / or Vascular Invasion (Note F)"
* $CAPeCCCodeSystem#21260.100004300 "Perineural Invasion"
* $CAPeCCCodeSystem#379319.100004300 "Tumor Comment"
* $CAPeCCCodeSystem#366162.100004300 "Margin Status"
* $CAPeCCCodeSystem#938231.100004300 "Closest Margin(s) to Tumor"
* $CAPeCCCodeSystem#366173.100004300 "Distance from Tumor to Closest Margin"
* $CAPeCCCodeSystem#938234.100004300 "Margin(s) Involved by Tumor"
* $CAPeCCCodeSystem#366178.100004300 "Margin Comment"
* $CAPeCCCodeSystem#374356.100004300 "Regional Lymph Node Status"
* $CAPeCCCodeSystem#52635.100004300 "Number of Lymph Nodes with Tumor"
* $CAPeCCCodeSystem#50139.100004300 "Number of Lymph Nodes Examined"
* $CAPeCCCodeSystem#358485.100004300 "Regional Lymph Node Comment"
* $CAPeCCCodeSystem#359036.100004300 "?Distant Site(s) Involved, if applicable"
* $CAPeCCCodeSystem#936966.100004300 "?Modified Classification (required only if applicable)"
* $CAPeCCCodeSystem#936961.100004300 "pT Category#"
* $CAPeCCCodeSystem#936969.100004300 "?T Suffix (required only if applicable)"
* $CAPeCCCodeSystem#936963.100004300 "pN Category"
* $CAPeCCCodeSystem#936947.100004300 "?pM Category (required only if confirmed pathologically)"
* $CAPeCCCodeSystem#21403.100004300 "Additional Findings"
* $CAPeCCCodeSystem#21411.100004300 "?Comment(s)"
* $CAPeCCCodeSystem#939927.100004300 "Procedure"
* $CAPeCCCodeSystem#16006.100004300 "Specimen Integrity"
* $CAPeCCCodeSystem#49029.100004300 "Tumor Site (Note A)"
* $CAPeCCCodeSystem#50757.100004300 "Histologic Type (Note B)"
* $CAPeCCCodeSystem#35590.100004300 "Histologic Type Comment"
* $CAPeCCCodeSystem#35916.100004300 "Histologic Grade (Note C)"
* $CAPeCCCodeSystem#16016.100004300 "Size of Invasive Carcinoma"
* $CAPeCCCodeSystem#16024.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#16027.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#44753.100004300 "Tumor Extent (Note D)"
* $CAPeCCCodeSystem#939887.100004300 "Depth of Sub-mucosal Invasion (Note D)"
* $CAPeCCCodeSystem#545132.100004300 "Lymphatic and / or Vascular Invasion (Note E)"
* $CAPeCCCodeSystem#939935.100004300 "Perineural Invasion (Note E)"
* $CAPeCCCodeSystem#379472.100004300 "Tumor Budding Score (Note F)"
* $CAPeCCCodeSystem#379470.100004300 "Number of Tumor Buds (Note F)"
* $CAPeCCCodeSystem#939893.100004300 "Type of Polyp in which Invasive Carcinoma Arose (Note G)"
* $CAPeCCCodeSystem#2039.100004300 "?Polyp Size (required only for polypectomy specimens)"
* $CAPeCCCodeSystem#2042.100004300 "Additional Polyp Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#2043.100004300 "Additional Polyp Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#2044.100004300 "?Polyp Configuration (required only for polypectomy specimens)"
* $CAPeCCCodeSystem#379476.100004300 "Stalk Length"
* $CAPeCCCodeSystem#939897.100004300 "?Tumor Dimension(s) (required only for intact endoscopic mucosal resections / transanal disk excision / endoscopic mucosal dissection)"
* $CAPeCCCodeSystem#939900.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#939899.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#939903.100004300 "?Margin Orientation Status (required only if applicable)"
* $CAPeCCCodeSystem#939907.100004300 "?Number of Specimen Fragments (required only if specimen is fragmented)"
* $CAPeCCCodeSystem#939911.100004300 "Dimension of Largest Fragment"
* $CAPeCCCodeSystem#939914.100004300 "Additional Dimension of the Largest Fragment in Centimeters (cm)"
* $CAPeCCCodeSystem#939913.100004300 "Additional Dimension of the Largest Fragment in Centimeters (cm)"
* $CAPeCCCodeSystem#379480.100004300 "Tumor Comment"
* $CAPeCCCodeSystem#366573.100004300 "Margin Status for Invasive Carcinoma"
* $CAPeCCCodeSystem#939917.100004300 "Distance from Invasive Carcinoma to Deep / Stalk Margin"
* $CAPeCCCodeSystem#939918.100004300 "Distance from Invasive Carcinoma to Peripheral / Lateral Mucosal Margin"
* $CAPeCCCodeSystem#939919.100004300 "Margin(s) Involved by Invasive Carcinoma"
* $CAPeCCCodeSystem#366600.100004300 "Margin Status for Non-Invasive Tumor"
* $CAPeCCCodeSystem#366583.100004300 "Margin Comment"
* $CAPeCCCodeSystem#42643.100004300 "Additional Findings"
* $CAPeCCCodeSystem#2111.100004300 "?Comment(s)"
* $CAPeCCCodeSystem#939864.100004300 "Procedure"
* $CAPeCCCodeSystem#1457.100004300 "?Macroscopic Evaluation of Mesorectum (required for rectal cancers) (Note A)"
* $CAPeCCCodeSystem#56314.100004300 "Tumor Site (Note B)"
* $CAPeCCCodeSystem#26667.100004300 "Rectal Tumor Location (applicable only to rectal primaries) (Note B)"
* $CAPeCCCodeSystem#939940.100004300 "Histologic Type (Note C)"
* $CAPeCCCodeSystem#35594.100004300 "Histologic Type Comment"
* $CAPeCCCodeSystem#38111.100004300 "Histologic Grade (Note D)"
* $CAPeCCCodeSystem#1452.100004300 "Tumor Size"
* $CAPeCCCodeSystem#1455.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#1456.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#378887.100004300 "?Multiple Primary Sites (e.g., hepatic flexure and transverse colon)"
* $CAPeCCCodeSystem#378883.100004300 "Tumor Extent"
* $CAPeCCCodeSystem#939924.100004300 "?Sub-mucosal Invasion (required only for pT1 tumors)"
* $CAPeCCCodeSystem#939866.100004300 "Depth of Sub-mucosal Invasion (Note L)"
* $CAPeCCCodeSystem#939872.100004300 "Extent of Sub-mucosal Invasion (Note L)"
* $CAPeCCCodeSystem#15358.100004300 "Macroscopic Tumor Perforation (Note E)"
* $CAPeCCCodeSystem#545134.100004300 "Lymphatic and / or Vascular Invasion (Note F)"
* $CAPeCCCodeSystem#1558.100004300 "Perineural Invasion (Note F)"
* $CAPeCCCodeSystem#38106.100004300 "Tumor Budding Score (Note G)"
* $CAPeCCCodeSystem#38057.100004300 "Number of Tumor Buds (per hotspot field) (Note G)"
* $CAPeCCCodeSystem#38114.100004300 "Type of Polyp in which Invasive Carcinoma Arose (Note H)"
* $CAPeCCCodeSystem#379466.100004300 "Treatment Effect (Note I)"
* $CAPeCCCodeSystem#379465.100004300 "Tumor Comment"
* $CAPeCCCodeSystem#364711.100004300 "Margin Status for Invasive Carcinoma"
* $CAPeCCCodeSystem#939877.100004300 "Closest Margin(s) to Invasive Carcinoma"
* $CAPeCCCodeSystem#364742.100004300 "Distance from Invasive Carcinoma to Closest Margin"
* $CAPeCCCodeSystem#364722.100004300 "?Distance from Invasive Carcinoma to Radial (Circumferential) Margin (required for rectal tumors)"
* $CAPeCCCodeSystem#364754.100004300 "Distance from Invasive Carcinoma to Distal Margin (recommended for rectal tumors)"
* $CAPeCCCodeSystem#939880.100004300 "Margin(s) Involved by Invasive Carcinoma"
* $CAPeCCCodeSystem#364784.100004300 "Margin Status for Non-Invasive Tumor"
* $CAPeCCCodeSystem#364795.100004300 "Margin(s) Involved by High-Grade Dysplasia / Intramucosal Carcinoma"
* $CAPeCCCodeSystem#364801.100004300 "Margin(s) Involved by Low-Grade Dysplasia"
* $CAPeCCCodeSystem#364791.100004300 "Margin Comment"
* $CAPeCCCodeSystem#374359.100004300 "Regional Lymph Node Status"
* $CAPeCCCodeSystem#34186.100004300 "Number of Lymph Nodes with Tumor"
* $CAPeCCCodeSystem#34185.100004300 "Number of Lymph Nodes Examined"
* $CAPeCCCodeSystem#15388.100004300 "Tumor Deposits (Note K)"
* $CAPeCCCodeSystem#25321.100004300 "Number of Tumor Deposits"
* $CAPeCCCodeSystem#362465.100004300 "Regional Lymph Node Comment"
* $CAPeCCCodeSystem#356550.100004300 "?Distant Site(s) Involved, if applicable"
* $CAPeCCCodeSystem#939883.100004300 "?Modified Classification (required only if applicable)"
* $CAPeCCCodeSystem#327745.100004300 "pT Category"
* $CAPeCCCodeSystem#939884.100004300 "?T Suffix (required only if applicable)"
* $CAPeCCCodeSystem#327747.100004300 "pN Category"
* $CAPeCCCodeSystem#46170.100004300 "?pM Category (required only if confirmed pathologically)"
* $CAPeCCCodeSystem#42470.100004300 "Additional Findings"
* $CAPeCCCodeSystem#1576.100004300 "?Comment(s)"
* $CAPeCCCodeSystem#40797.100004300 "Specimen Site"
* $CAPeCCCodeSystem#44289.100004300 "Testing Performed on Block Number(s) (specify)"
* $CAPeCCCodeSystem#57837.100004300 "Immunohistochemistry (IHC) Results for Mismatch Repair (MMR) Proteins"
* $CAPeCCCodeSystem#44372.100004300 "MLH1 Result"
* $CAPeCCCodeSystem#51700.100004300 "MSH2 Result"
* $CAPeCCCodeSystem#47598.100004300 "MSH6 Result"
* $CAPeCCCodeSystem#37468.100004300 "PMS2 Result"
* $CAPeCCCodeSystem#51531.100004300 "Mismatch Repair (MMR) Interpretation"
* $CAPeCCCodeSystem#40213.100004300 "Microsatellite Instability (MSI) Interpretation"
* $CAPeCCCodeSystem#48809.100004300 "?Comment(s)"
* $CAPeCCCodeSystem#52924.100004300 "Procedure"
* $CAPeCCCodeSystem#39250.100004300 "Tumor Site (Note C)"
* $CAPeCCCodeSystem#938263.100004300 "Histologic Type and Grade# (Notes D, E)"
* $CAPeCCCodeSystem#379339.100004300 "?Mitotic Rate (required only when Ki-67 labeling index is not reported)#"
* $CAPeCCCodeSystem#379340.100004300 "?Ki-67 Labeling Index (required only when mitotic rate is not reported)"
* $CAPeCCCodeSystem#43432.100004300 "Histologic Subtype (Notes C, D)"
* $CAPeCCCodeSystem#39671.100004300 "Tumor Size (Note F)"
* $CAPeCCCodeSystem#51138.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#45659.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#41669.100004300 "Tumor Focality"
* $CAPeCCCodeSystem#379345.100004300 "Number of Tumors"
* $CAPeCCCodeSystem#43047.100004300 "Tumor Extent"
* $CAPeCCCodeSystem#50096.100004300 "Lymphatic and / or Vascular Invasion"
* $CAPeCCCodeSystem#55609.100004300 "Perineural Invasion"
* $CAPeCCCodeSystem#379335.100004300 "Tumor Comment"
* $CAPeCCCodeSystem#366196.100004300 "Margin Status"
* $CAPeCCCodeSystem#938237.100004300 "Closest Margin(s) to Tumor"
* $CAPeCCCodeSystem#366207.100004300 "Distance from Tumor to Closest Margin"
* $CAPeCCCodeSystem#938240.100004300 "Margin(s) Involved by Tumor"
* $CAPeCCCodeSystem#366212.100004300 "Margin Comment"
* $CAPeCCCodeSystem#374361.100004300 "Regional Lymph Node Status"
* $CAPeCCCodeSystem#50265.100004300 "Number of Lymph Nodes with Tumor"
* $CAPeCCCodeSystem#56651.100004300 "Number of Lymph Nodes Examined"
* $CAPeCCCodeSystem#358486.100004300 "Regional Lymph Node Comment"
* $CAPeCCCodeSystem#359047.100004300 "?Distant Site(s) Involved, if applicable"
* $CAPeCCCodeSystem#937055.100004300 "?Modified Classification (required only if applicable)"
* $CAPeCCCodeSystem#937050.100004300 "pT Category#"
* $CAPeCCCodeSystem#937058.100004300 "?T Suffix (required only if applicable)"
* $CAPeCCCodeSystem#937052.100004300 "pN Category"
* $CAPeCCCodeSystem#937036.100004300 "?pM Category (required only if confirmed pathologically)"
* $CAPeCCCodeSystem#41254.100004300 "Additional Findings"
* $CAPeCCCodeSystem#52323.100004300 "?Comment(s)"
* $CAPeCCCodeSystem#4158.100004300 "Procedure"
* $CAPeCCCodeSystem#59090.100004300 "Tumor Site (Note B)"
* $CAPeCCCodeSystem#54796.100004300 "Relationship of Tumor to Esophagogastric Junction (Note B)"
* $CAPeCCCodeSystem#18583.100004300 "?Distance of Tumor Center from Esophagogastric Junction"
* $CAPeCCCodeSystem#48873.100004300 "Histologic Type (Note C)"
* $CAPeCCCodeSystem#35613.100004300 "Histologic Type Comment"
* $CAPeCCCodeSystem#43209.100004300 "?Histologic Grade# (Note D)"
* $CAPeCCCodeSystem#4166.100004300 "Tumor Size"
* $CAPeCCCodeSystem#4169.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#4170.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#41171.100004300 "Tumor Extent (Note E)"
* $CAPeCCCodeSystem#379505.100004300 "Treatment Effect (Note F)"
* $CAPeCCCodeSystem#4244.100004300 "Lymphovascular Invasion"
* $CAPeCCCodeSystem#17686.100004300 "Perineural Invasion"
* $CAPeCCCodeSystem#379507.100004300 "Tumor Comment"
* $CAPeCCCodeSystem#367143.100004300 "Margin Status for Invasive Carcinoma"
* $CAPeCCCodeSystem#367149.100004300 "Closest Margin(s) to Invasive Carcinoma"
* $CAPeCCCodeSystem#367154.100004300 "Distance from Invasive Carcinoma to Closest Margin"
* $CAPeCCCodeSystem#367162.100004300 "Margin(s) Involved by Invasive Carcinoma"
* $CAPeCCCodeSystem#367173.100004300 "Margin Status for Dysplasia and Intestinal Metaplasia"
* $CAPeCCCodeSystem#367179.100004300 "Margin(s) Involved by Low-Grade Squamous Dysplasia"
* $CAPeCCCodeSystem#367186.100004300 "Margin(s) Involved by High-Grade Squamous Dysplasia"
* $CAPeCCCodeSystem#367201.100004300 "Margin(s) Involved by Low-Grade Glandular Dysplasia"
* $CAPeCCCodeSystem#367208.100004300 "Margin(s) Involved by High-Grade Glandular Dysplasia"
* $CAPeCCCodeSystem#367215.100004300 "Margin(s) Involved by Intestinal Metaplasia"
* $CAPeCCCodeSystem#367159.100004300 "Margin Comment"
* $CAPeCCCodeSystem#374363.100004300 "Regional Lymph Node Status"
* $CAPeCCCodeSystem#33422.100004300 "Number of Lymph Nodes with Tumor"
* $CAPeCCCodeSystem#33418.100004300 "Number of Lymph Nodes Examined"
* $CAPeCCCodeSystem#362484.100004300 "Regional Lymph Node Comment"
* $CAPeCCCodeSystem#362469.100004300 "?Distant Site(s) Involved, if applicable"
* $CAPeCCCodeSystem#18664.100004300 "?TNM Descriptors"
* $CAPeCCCodeSystem#327821.100004300 "pT Category"
* $CAPeCCCodeSystem#327823.100004300 "pN Category (Note I)"
* $CAPeCCCodeSystem#4207.100004300 "?pM Category (required only if confirmed pathologically)"
* $CAPeCCCodeSystem#42820.100004300 "Additional Findings"
* $CAPeCCCodeSystem#4255.100004300 "?Comment(s)"
* $CAPeCCCodeSystem#702210.100004300 "Expert Consultation (Note A)"
* $CAPeCCCodeSystem#891395.100004300 "Patient Age (Note B)"
* $CAPeCCCodeSystem#39864.100004300 "Procedure"
* $CAPeCCCodeSystem#890992.100004300 "Tumor Site (Note C)"
* $CAPeCCCodeSystem#890994.100004300 "Histologic Type (Note D)"
* $CAPeCCCodeSystem#379076.100004300 "Percentage of Teratoma Composed of Immature Elements"
* $CAPeCCCodeSystem#379070.100004300 "Histologic Type Comment"
* $CAPeCCCodeSystem#40969.100004300 "?Histologic Grade (applicable to immature teratomas only) (Note E)"
* $CAPeCCCodeSystem#43070.100004300 "Lymphatic and / or Vascular Invasion"
* $CAPeCCCodeSystem#56369.100004300 "Perineural Invasion"
* $CAPeCCCodeSystem#379552.100004300 "Tumor Comment"
* $CAPeCCCodeSystem#891019.100004300 "Associated Syndrome(s)"
* $CAPeCCCodeSystem#891001.100004300 "Germ Cell Associated Hematologic Malignancy (not part of the extragonadal germ cell tumor)"
* $CAPeCCCodeSystem#379080.100004300 "Other Clinical Findings (specify)"
* $CAPeCCCodeSystem#364675.100004300 "SALL4 IHC"
* $CAPeCCCodeSystem#364680.100004300 "OCT3/4 IHC"
* $CAPeCCCodeSystem#364690.100004300 "CD30 IHC"
* $CAPeCCCodeSystem#364685.100004300 "AFP IHC"
* $CAPeCCCodeSystem#364700.100004300 "Glypican-3 IHC"
* $CAPeCCCodeSystem#364695.100004300 "Beta-HCG IHC"
* $CAPeCCCodeSystem#891002.100004300 "LIN28 IHC"
* $CAPeCCCodeSystem#891007.100004300 "CD117 IHC"
* $CAPeCCCodeSystem#891012.100004300 "D2-40 IHC"
* $CAPeCCCodeSystem#364705.100004300 "Other Immunohistochemistry (IHC) Studies (specify)"
* $CAPeCCCodeSystem#379081.100004300 "Results of Cytogenetic Studies"
* $CAPeCCCodeSystem#58012.100004300 "Serologic Marker Testing"
* $CAPeCCCodeSystem#45572.100004300 "?Comment(s)"
* $CAPeCCCodeSystem#702195.100004300 "Expert Consultation (Note A)"
* $CAPeCCCodeSystem#36780.100004300 "Treatment History"
* $CAPeCCCodeSystem#891392.100004300 "Patient Age (Note B)"
* $CAPeCCCodeSystem#890648.100004300 "Procedure"
* $CAPeCCCodeSystem#890651.100004300 "Tumor Site (Note C)"
* $CAPeCCCodeSystem#890653.100004300 "Histologic Type (Note D)"
* $CAPeCCCodeSystem#379145.100004300 "Percentage of Teratoma Composed of Immature Elements"
* $CAPeCCCodeSystem#379149.100004300 "Histologic Type Comment"
* $CAPeCCCodeSystem#21016.100004300 "?Histologic Grade (applicable to immature teratomas only) (Note E)"
* $CAPeCCCodeSystem#4589.100004300 "Tumor Size (Note F)"
* $CAPeCCCodeSystem#4591.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#4592.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#380036.100004300 "?Microscopic Coccyx Involvement (applicable to sacrococcygeal resections only)"
* $CAPeCCCodeSystem#891398.100004300 "Tumor Extent (applicable to adult [post-pubertal] extragonadal germ cell tumors)"
* $CAPeCCCodeSystem#4625.100004300 "Lymphatic and / or Vascular Invasion"
* $CAPeCCCodeSystem#21176.100004300 "Perineural Invasion"
* $CAPeCCCodeSystem#890662.100004300 "Treatment Effect (Note G)"
* $CAPeCCCodeSystem#890665.100004300 "Percentage of Residual Viable Tumor"
* $CAPeCCCodeSystem#379846.100004300 "Percentage of Necrosis"
* $CAPeCCCodeSystem#890671.100004300 "Percentage of Stroma (includes fibrosis and inflammation)"
* $CAPeCCCodeSystem#379551.100004300 "Tumor Comment"
* $CAPeCCCodeSystem#4606.100004300 "Margin Status"
* $CAPeCCCodeSystem#358548.100004300 "Closest Margin(s) to Tumor"
* $CAPeCCCodeSystem#358602.100004300 "Distance from Tumor to Closest Margin"
* $CAPeCCCodeSystem#358761.100004300 "Margin(s) Involved by Tumor"
* $CAPeCCCodeSystem#358532.100004300 "Margin Comment"
* $CAPeCCCodeSystem#374368.100004300 "Regional Lymph Node Status"
* $CAPeCCCodeSystem#1845.100004300 "Number of Lymph Nodes with Tumor"
* $CAPeCCCodeSystem#358972.100004300 "?Nodal Site(s) with Tumor, if known"
* $CAPeCCCodeSystem#380022.100004300 "Histologic Type Present in Involved Node(s)"
* $CAPeCCCodeSystem#1842.100004300 "Number of Lymph Nodes Examined"
* $CAPeCCCodeSystem#365146.100004300 "Regional Lymph Node Comment"
* $CAPeCCCodeSystem#379990.100004300 "?Distant Site(s) Involved, if applicable"
* $CAPeCCCodeSystem#380013.100004300 "Size of Largest Distant Metastasis"
* $CAPeCCCodeSystem#380008.100004300 "Histologic Type Present in Distant Metastasis"
* $CAPeCCCodeSystem#21201.100004300 "Childrens Oncology Group Staging for any Malignant Extragonadal Germ Cell Tumor (see also specific staging systems for mediastinal germ cell tumors)"
* $CAPeCCCodeSystem#41052.100004300 "Moran and Suster Proposed Clinical Staging for Mediastinal Germ Cell Tumors#"
* $CAPeCCCodeSystem#891018.100004300 "Associated Syndrome(s)"
* $CAPeCCCodeSystem#890921.100004300 "Germ Cell Associated Hematologic Malignancy (not part of the extragonadal germ cell tumor)"
* $CAPeCCCodeSystem#379150.100004300 "Other Clinical Findings (specify)"
* $CAPeCCCodeSystem#364637.100004300 "SALL4 IHC"
* $CAPeCCCodeSystem#364642.100004300 "OCT3/4 IHC"
* $CAPeCCCodeSystem#364652.100004300 "CD30 IHC"
* $CAPeCCCodeSystem#364647.100004300 "AFP IHC"
* $CAPeCCCodeSystem#364663.100004300 "Glypican-3 IHC"
* $CAPeCCCodeSystem#364658.100004300 "Beta-HCG IHC"
* $CAPeCCCodeSystem#890974.100004300 "LIN28 IHC"
* $CAPeCCCodeSystem#890979.100004300 "CD117 IHC"
* $CAPeCCCodeSystem#890984.100004300 "D2-40 IHC"
* $CAPeCCCodeSystem#364673.100004300 "Other Immunohistochemistry (IHC) Studies (specify)"
* $CAPeCCCodeSystem#379153.100004300 "Results of Cytogenetic Studies"
* $CAPeCCCodeSystem#21205.100004300 "Serologic Marker Testing"
* $CAPeCCCodeSystem#8229.100004300 "?Comment(s)"
* $CAPeCCCodeSystem#4460.100004300 "Procedure"
* $CAPeCCCodeSystem#49427.100004300 "Tumor Site"
* $CAPeCCCodeSystem#411248.100004300 "Histologic Type (Note B)"
* $CAPeCCCodeSystem#42245.100004300 "Histologic Type Comment"
* $CAPeCCCodeSystem#54276.100004300 "Histologic Grade (Note C)"
* $CAPeCCCodeSystem#4471.100004300 "Tumor Size"
* $CAPeCCCodeSystem#4474.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#4475.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#40081.100004300 "Tumor Extent"
* $CAPeCCCodeSystem#4530.100004300 "Lymphovascular Invasion (Note D)"
* $CAPeCCCodeSystem#4534.100004300 "Perineural Invasion (Note E)"
* $CAPeCCCodeSystem#379508.100004300 "Tumor Comment"
* $CAPeCCCodeSystem#367067.100004300 "Margin Status for Invasive Carcinoma"
* $CAPeCCCodeSystem#367117.100004300 "Distance from Invasive Carcinoma to Cystic Duct Margin"
* $CAPeCCCodeSystem#367078.100004300 "Distance from Invasive Carcinoma to Liver Parenchymal Margin"
* $CAPeCCCodeSystem#367086.100004300 "Margin(s) Involved by Invasive Carcinoma"
* $CAPeCCCodeSystem#367097.100004300 "Margin Status for Intraepithelial Neoplasia"
* $CAPeCCCodeSystem#367083.100004300 "Margin Comment"
* $CAPeCCCodeSystem#374370.100004300 "Regional Lymph Node Status"
* $CAPeCCCodeSystem#59726.100004300 "Number of Lymph Nodes with Tumor"
* $CAPeCCCodeSystem#37868.100004300 "Number of Lymph Nodes Examined"
* $CAPeCCCodeSystem#362475.100004300 "Regional Lymph Node Comment"
* $CAPeCCCodeSystem#362478.100004300 "?Distant Site(s) Involved, if applicable"
* $CAPeCCCodeSystem#18748.100004300 "?TNM Descriptors"
* $CAPeCCCodeSystem#327826.100004300 "pT Category"
* $CAPeCCCodeSystem#327828.100004300 "pN Category"
* $CAPeCCCodeSystem#4515.100004300 "?pM Category (required only if confirmed pathologically)"
* $CAPeCCCodeSystem#53755.100004300 "Additional Findings"
* $CAPeCCCodeSystem#18746.100004300 "Ancillary Studies"
* $CAPeCCCodeSystem#4545.100004300 "?Comment(s)"
* $CAPeCCCodeSystem#820238.100004300 "Testing Performed on Block Number(s) (specify)"
* $CAPeCCCodeSystem#820239.100004300 "Specimen Type"
* $CAPeCCCodeSystem#820230.100004300 "Appropriate Controls Verified"
* $CAPeCCCodeSystem#820227.100004300 "Immunohistochemical Tests Performed (Note A)"
* $CAPeCCCodeSystem#820234.100004300 "Estrogen Receptor (ER) Status"
* $CAPeCCCodeSystem#820237.100004300 "Percentage of Cells with Nuclear Positivity"
* $CAPeCCCodeSystem#820244.100004300 "Average Intensity of Staining"
* $CAPeCCCodeSystem#820247.100004300 "Progesterone Receptor (PgR) Status"
* $CAPeCCCodeSystem#820250.100004300 "Percentage of Cells with Nuclear Positivity"
* $CAPeCCCodeSystem#820252.100004300 "Average Intensity of Staining"
* $CAPeCCCodeSystem#820258.100004300 "HER2 Status"
* $CAPeCCCodeSystem#820268.100004300 "Mismatch Repair (MMR) Protein Status"
* $CAPeCCCodeSystem#820273.100004300 "Nuclear MLH1 Expression"
* $CAPeCCCodeSystem#820285.100004300 "Nuclear PMS2 Expression"
* $CAPeCCCodeSystem#820277.100004300 "Nuclear MSH2 Expression"
* $CAPeCCCodeSystem#820281.100004300 "Nuclear MSH6 Expression"
* $CAPeCCCodeSystem#820292.100004300 "Additional Comment (specify percentage loss or other)"
* $CAPeCCCodeSystem#820294.100004300 "Immunohistochemistry (IHC) Interpretation for Mismatch Repair (MMR) Proteins# (Note D)"
* $CAPeCCCodeSystem#820301.100004300 "p53 Status"
* $CAPeCCCodeSystem#820332.100004300 "HER2 by in situ Hybridization (Note C)"
* $CAPeCCCodeSystem#820326.100004300 "?Number of Observers (required only if applicable)"
* $CAPeCCCodeSystem#820342.100004300 "?Number of Invasive Tumor Cells Counted (required only if applicable)"
* $CAPeCCCodeSystem#820317.100004300 "?Method (required only if applicable)"
* $CAPeCCCodeSystem#820328.100004300 "Average Number of HER2 Signals per Cell"
* $CAPeCCCodeSystem#820329.100004300 "Average Number of CEP17 Signals per Cell"
* $CAPeCCCodeSystem#820330.100004300 "HER2 / CEP17 Ratio"
* $CAPeCCCodeSystem#820331.100004300 "Average Number of HER2 Signals per Cell"
* $CAPeCCCodeSystem#820333.100004300 "Aneusomy (as defined by vendor kit used)"
* $CAPeCCCodeSystem#820319.100004300 "Heterogeneous Signals"
* $CAPeCCCodeSystem#820337.100004300 "Percentage of Cells with Amplified HER2 Signals"
* $CAPeCCCodeSystem#820347.100004300 "Microsatellite Instability (MSI) Interpretation (Note F)"
* $CAPeCCCodeSystem#820375.100004300 "MLH1 Promoter Methylation Analysis (Note G)"
* $CAPeCCCodeSystem#820381.100004300 "Image Analysis"
* $CAPeCCCodeSystem#820391.100004300 "Specify Method"
* $CAPeCCCodeSystem#820384.100004300 "Biomarkers Scored by Image Analysis"
* $CAPeCCCodeSystem#847256.100004300 "?Comment(s)"
* $CAPeCCCodeSystem#866828.100004300 "Site(s) of Tumor Involvement in Sample (Notes A, C)"
* $CAPeCCCodeSystem#866137.100004300 "Final Integrated Diagnosis (Note B)"
* $CAPeCCCodeSystem#866825.100004300 "Specify Name of Lesion"
* $CAPeCCCodeSystem#866826.100004300 "Specify Virus Status"
* $CAPeCCCodeSystem#866827.100004300 "Specify Type of Immunodeficiency"
* $CAPeCCCodeSystem#866836.100004300 "Possible Transformation from Indolent Lymphoma (Note C)"
* $CAPeCCCodeSystem#866841.100004300 "Immunohistochemistry"
* $CAPeCCCodeSystem#866842.100004300 "Flow Cytometry"
* $CAPeCCCodeSystem#866843.100004300 "Conventional Cytogenetics"
* $CAPeCCCodeSystem#866844.100004300 "Fluorescence in situ Hybridization"
* $CAPeCCCodeSystem#866845.100004300 "Molecular Alterations Detected#"
* $CAPeCCCodeSystem#867172.100004300 "Specify Molecular Alterations Assayed"
* $CAPeCCCodeSystem#866928.100004300 "?Comment(s)"
* $CAPeCCCodeSystem#866930.100004300 "Site of Tumor Involvement in Sample (select most involved site)"
* $CAPeCCCodeSystem#866938.100004300 "Specify Percent Blasts / Blast Equivalents"
* $CAPeCCCodeSystem#866939.100004300 "Specify Percent Marrow Cellularity"
* $CAPeCCCodeSystem#867100.100004300 "Specify Percent Blasts / Blast Equivalents"
* $CAPeCCCodeSystem#866940.100004300 "Final Integrated Diagnosis (Note B)"
* $CAPeCCCodeSystem#867052.100004300 "?Dysplasia#"
* $CAPeCCCodeSystem#867061.100004300 "Ring Sideroblasts / Iron Stain"
* $CAPeCCCodeSystem#867067.100004300 "Bone Marrow Fibrosis Grade"
* $CAPeCCCodeSystem#867078.100004300 "Flow Cytometry"
* $CAPeCCCodeSystem#867088.100004300 "Conventional Cytogenetics"
* $CAPeCCCodeSystem#867093.100004300 "Fluorescence in situ Hybridization"
* $CAPeCCCodeSystem#867101.100004300 "Molecular Alterations Detected#"
* $CAPeCCCodeSystem#867171.100004300 "Specify Molecular Alterations Assayed"
* $CAPeCCCodeSystem#867098.100004300 "?Comment(s)"
* $CAPeCCCodeSystem#867173.100004300 "Site(s) of Tumor Involvement in Sample (Note A)"
* $CAPeCCCodeSystem#867182.100004300 "?Specify Percent Involvement of Clonal Cells, if possible"
* $CAPeCCCodeSystem#867183.100004300 "?Specify Percent Involvement of Clonal Cells, if possible"
* $CAPeCCCodeSystem#867184.100004300 "Final Integrated Diagnosis (Note B)"
* $CAPeCCCodeSystem#867211.100004300 "Immunoglobulin Depositions"
* $CAPeCCCodeSystem#891373.100004300 "Immunohistochemistry"
* $CAPeCCCodeSystem#867216.100004300 "Flow Cytometry"
* $CAPeCCCodeSystem#867221.100004300 "Conventional Cytogenetics"
* $CAPeCCCodeSystem#867232.100004300 "Fluorescence in situ Hybridization"
* $CAPeCCCodeSystem#867228.100004300 "Molecular Alterations Detected"
* $CAPeCCCodeSystem#867181.100004300 "Specify Molecular Alterations Assayed"
* $CAPeCCCodeSystem#867248.100004300 "?Comment(s)"
* $CAPeCCCodeSystem#367235.100004300 "Diagnosis"
* $CAPeCCCodeSystem#891741.100004300 "p16 IHC as a Surrogate for Transcriptionally Active High-Risk HPV"
* $CAPeCCCodeSystem#330169.100004300 "HPV E6 / E7 mRNA ISH"
* $CAPeCCCodeSystem#330173.100004300 "Specify Subtypes (if available)"
* $CAPeCCCodeSystem#330174.100004300 "HPV-DNA ISH"
* $CAPeCCCodeSystem#330181.100004300 "Specify Subtypes (if available)"
* $CAPeCCCodeSystem#891589.100004300 "HPV-DNA PCR"
* $CAPeCCCodeSystem#330187.100004300 "Specify Subtypes (if available)"
* $CAPeCCCodeSystem#891594.100004300 "HPV E6 / E7 mRNA RT-PCR"
* $CAPeCCCodeSystem#330192.100004300 "Specify Subtypes (if available)"
* $CAPeCCCodeSystem#330193.100004300 "EBV Early mRNA (EBER) ISH"
* $CAPeCCCodeSystem#330200.100004300 "NUT IHC"
* $CAPeCCCodeSystem#330204.100004300 "NUT Rearrangements (by Molecular Methods)"
* $CAPeCCCodeSystem#330208.100004300 "Specify Fusion Partner (if available)"
* $CAPeCCCodeSystem#330255.100004300 "MAML2 Rearrangements (by Molecular Methods)"
* $CAPeCCCodeSystem#330259.100004300 "Specify Fusion Partner (if available)"
* $CAPeCCCodeSystem#330284.100004300 "MYB IHC"
* $CAPeCCCodeSystem#330261.100004300 "MYB Rearrangements (by Molecular Methods)"
* $CAPeCCCodeSystem#330265.100004300 "Specify Fusion Partner (if available)"
* $CAPeCCCodeSystem#330271.100004300 "MYB-L1 IHC"
* $CAPeCCCodeSystem#330279.100004300 "MYB-L1 Rearrangements (by Molecular Methods)"
* $CAPeCCCodeSystem#330283.100004300 "Specify Fusion Partner (if available)"
* $CAPeCCCodeSystem#330971.100004300 "AR IHC"
* $CAPeCCCodeSystem#348245.100004300 "HER2 Immunohistochemistry Interpretation"
* $CAPeCCCodeSystem#348238.100004300 "HER2 Immunohistochemistry Scoring System"
* $CAPeCCCodeSystem#348239.100004300 "HER2 Immunohistochemistry Score"
* $CAPeCCCodeSystem#348255.100004300 "Specify Percentage of Cells with Uniform Intense Complete Membrane Staining"
* $CAPeCCCodeSystem#348233.100004300 "HER2 Immunohistochemistry Antibody"
* $CAPeCCCodeSystem#348249.100004300 "HER2 Immunohistochemistry Assay Information"
* $CAPeCCCodeSystem#330378.100004300 "HER2 by in situ Hybridization"
* $CAPeCCCodeSystem#330348.100004300 "Aneusomy (as defined by vendor kit used)"
* $CAPeCCCodeSystem#330353.100004300 "Heterogeneous Signals"
* $CAPeCCCodeSystem#330364.100004300 "Specify Percentage of Cells with Amplified HER2 Signals"
* $CAPeCCCodeSystem#330303.100004300 "PLAG1 IHC"
* $CAPeCCCodeSystem#330289.100004300 "PLAG1 Rearrangements (by Molecular Methods)"
* $CAPeCCCodeSystem#330293.100004300 "Specify Fusion Partner (if available)"
* $CAPeCCCodeSystem#330294.100004300 "HMGA2 IHC"
* $CAPeCCCodeSystem#330298.100004300 "HMGA2 Rearrangements (by Molecular Methods)"
* $CAPeCCCodeSystem#330302.100004300 "Specify Fusion Partner (if available)"
* $CAPeCCCodeSystem#330217.100004300 "ETV6 Rearrangements (by Molecular Methods)"
* $CAPeCCCodeSystem#330221.100004300 "Specify Fusion Partner (if available)"
* $CAPeCCCodeSystem#330222.100004300 "NTRK Rearrangements (by Molecular Methods)"
* $CAPeCCCodeSystem#330399.100004300 "NTRK Type"
* $CAPeCCCodeSystem#330398.100004300 "Specify Fusion Partner (if available)"
* $CAPeCCCodeSystem#330250.100004300 "EWSR1 Rearrangements (by Molecular Methods)"
* $CAPeCCCodeSystem#330254.100004300 "Specify Fusion Partner (if available)"
* $CAPeCCCodeSystem#330380.100004300 "INI1 IHC"
* $CAPeCCCodeSystem#330385.100004300 "BRG1 IHC"
* $CAPeCCCodeSystem#330394.100004300 "PAX Rearrangements (by Molecular Methods)"
* $CAPeCCCodeSystem#330235.100004300 "PAX Type"
* $CAPeCCCodeSystem#330226.100004300 "Specify Fusion Partner (if available)"
* $CAPeCCCodeSystem#330404.100004300 "SDHB IHC"
* $CAPeCCCodeSystem#365445.100004300 "Specify Other Marker and Results"
* $CAPeCCCodeSystem#365443.100004300 "?Comment(s)"
* $CAPeCCCodeSystem#45033.100004300 "Procedure"
* $CAPeCCCodeSystem#52215.100004300 "Tumor Focality"
* $CAPeCCCodeSystem#378908.100004300 "?Multiple Primary Sites (e.g., anterior epiglottis and glottis)"
* $CAPeCCCodeSystem#866521.100004300 "Tumor Site (Note B)"
* $CAPeCCCodeSystem#41775.100004300 "Tumor Subsite"
* $CAPeCCCodeSystem#378890.100004300 "Tumor Subsite"
* $CAPeCCCodeSystem#378891.100004300 "Subglottic Extension"
* $CAPeCCCodeSystem#27283.100004300 "Transglottic Extension"
* $CAPeCCCodeSystem#24126.100004300 "Tumor Laterality"
* $CAPeCCCodeSystem#22960.100004300 "Tumor Size"
* $CAPeCCCodeSystem#22964.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#22963.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#866173.100004300 "Histologic Type (Note C)"
* $CAPeCCCodeSystem#866177.100004300 "Architectural Type"
* $CAPeCCCodeSystem#866183.100004300 "Malignant Component Histologic Type(s)"
* $CAPeCCCodeSystem#378902.100004300 "Percentage of Solid Component for Adenoid Cystic Carcinoma"
* $CAPeCCCodeSystem#866197.100004300 "Percentage of Papillary Component for Polymorphous Adenocarcinoma"
* $CAPeCCCodeSystem#866201.100004300 "Percentage of Cribriform Component for Polymorphous Adenocarcinoma"
* $CAPeCCCodeSystem#866226.100004300 "Type of Combined Histology#"
* $CAPeCCCodeSystem#38815.100004300 "Histologic Type Comment"
* $CAPeCCCodeSystem#23032.100004300 "?Histologic Grade# (Note D)"
* $CAPeCCCodeSystem#866527.100004300 "?Grade / Intrinsic Biologic Potential#"
* $CAPeCCCodeSystem#45565.100004300 "Tumor Extent (specify other structures / spaces involved)"
* $CAPeCCCodeSystem#23167.100004300 "Lymphatic and / or Vascular Invasion"
* $CAPeCCCodeSystem#23171.100004300 "Perineural Invasion (Note E)"
* $CAPeCCCodeSystem#866538.100004300 "Extent / Type of Perineural Invasion"
* $CAPeCCCodeSystem#866542.100004300 "Specify Diameter of Involved Nerve in Millimeters (mm)"
* $CAPeCCCodeSystem#379540.100004300 "Tumor Comment"
* $CAPeCCCodeSystem#362699.100004300 "Margin Status for Invasive Tumor"
* $CAPeCCCodeSystem#362710.100004300 "Distance from Invasive Tumor to Closest Margin"
* $CAPeCCCodeSystem#30428.100004300 "Closest Margin(s) to Invasive Tumor (use orientation when provided)"
* $CAPeCCCodeSystem#362729.100004300 "Other Close Margin(s) to Invasive Tumor"
* $CAPeCCCodeSystem#362721.100004300 "Margin(s) Involved by Invasive Tumor (per orientation)"
* $CAPeCCCodeSystem#866547.100004300 "?Margin Status for Noninvasive Tumor (High-grade Dysplasia)"
* $CAPeCCCodeSystem#362740.100004300 "Distance from Noninvasive Tumor to Closest Margin"
* $CAPeCCCodeSystem#362733.100004300 "Closest Margin(s) to Noninvasive Tumor (use orientation when provided)"
* $CAPeCCCodeSystem#362747.100004300 "Margin(s) Involved by Noninvasive Tumor (per orientation)"
* $CAPeCCCodeSystem#362726.100004300 "Margin Comment"
* $CAPeCCCodeSystem#362755.100004300 "Regional Lymph Node Status"
* $CAPeCCCodeSystem#362762.100004300 "Number of Lymph Nodes with Tumor"
* $CAPeCCCodeSystem#42508.100004300 "?Laterality of Lymph Node(s) with Tumor (not applicable for mucosal melanoma)"
* $CAPeCCCodeSystem#866552.100004300 "Nodal Site(s) with Tumor"
* $CAPeCCCodeSystem#362837.100004300 "?Size of Largest Nodal Metastatic Deposit (not applicable for mucosal melanoma)"
* $CAPeCCCodeSystem#50560.100004300 "?Extranodal Extension (ENE) (not applicable for mucosal melanoma) (Note H)"
* $CAPeCCCodeSystem#362844.100004300 "Distance of ENE from Lymph Node Capsule"
* $CAPeCCCodeSystem#362830.100004300 "Number of Lymph Nodes Examined"
* $CAPeCCCodeSystem#364932.100004300 "Regional Lymph Node Comment"
* $CAPeCCCodeSystem#362852.100004300 "?Distant Site(s) Involved, if applicable"
* $CAPeCCCodeSystem#866561.100004300 "?Modified Classification (required only if applicable)"
* $CAPeCCCodeSystem#56302.100004300 "pTNM Classification"
* $CAPeCCCodeSystem#59349.100004300 "pT Category"
* $CAPeCCCodeSystem#866565.100004300 "?T Suffix (required only if applicable)"
* $CAPeCCCodeSystem#327853.100004300 "pN Category# (Note H)"
* $CAPeCCCodeSystem#23150.100004300 "?pM Category (required only if confirmed pathologically)"
* $CAPeCCCodeSystem#42137.100004300 "pT Category"
* $CAPeCCCodeSystem#866568.100004300 "?T Suffix (required only if applicable)"
* $CAPeCCCodeSystem#327856.100004300 "pN Category"
* $CAPeCCCodeSystem#24394.100004300 "?pM Category (required only if confirmed pathologically)"
* $CAPeCCCodeSystem#866571.100004300 "Additional Findings"
* $CAPeCCCodeSystem#374365.100004300 "Specify Test and Results"
* $CAPeCCCodeSystem#23181.100004300 "?Comment(s)"
* $CAPeCCCodeSystem#59531.100004300 "Procedure"
* $CAPeCCCodeSystem#43682.100004300 "Tumor Focality"
* $CAPeCCCodeSystem#378929.100004300 "Tumor Site (Note B)"
* $CAPeCCCodeSystem#45070.100004300 "Tumor Laterality"
* $CAPeCCCodeSystem#5106.100004300 "Tumor Size"
* $CAPeCCCodeSystem#5110.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#5109.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#866228.100004300 "Histologic Type (Note C)"
* $CAPeCCCodeSystem#548135.100004300 "Architectural Type"
* $CAPeCCCodeSystem#866232.100004300 "Malignant Component Histologic Type(s)"
* $CAPeCCCodeSystem#378938.100004300 "Percentage of Solid Component for Adenoid Cystic Carcinoma"
* $CAPeCCCodeSystem#866242.100004300 "Percentage of Papillary Component for Polymorphous Adenocarcinoma"
* $CAPeCCCodeSystem#866246.100004300 "Percentage of Cribriform Component for Polymorphous Adenocarcinoma"
* $CAPeCCCodeSystem#40367.100004300 "Histologic Type Comment"
* $CAPeCCCodeSystem#866421.100004300 "?Grade / Intrinsic Biologic Potential (required only if applicable) (Note C)"
* $CAPeCCCodeSystem#378842.100004300 "Macroscopic Tumor Extent"
* $CAPeCCCodeSystem#5179.100004300 "Lymphatic and / or Vascular Invasion"
* $CAPeCCCodeSystem#5183.100004300 "Perineural Invasion (Note D)"
* $CAPeCCCodeSystem#866426.100004300 "Extent / Type of Perineural Invasion#"
* $CAPeCCCodeSystem#866430.100004300 "Specify Diameter of Involved Nerve in Millimeters (mm)"
* $CAPeCCCodeSystem#379542.100004300 "Tumor Comment"
* $CAPeCCCodeSystem#5172.100004300 "Margin Status"
* $CAPeCCCodeSystem#364477.100004300 "Distance from Invasive Tumor to Closest Margin"
* $CAPeCCCodeSystem#364486.100004300 "Closest Margin(s) to Carcinoma"
* $CAPeCCCodeSystem#364489.100004300 "Margin(s) Involved by Carcinoma"
* $CAPeCCCodeSystem#364502.100004300 "Margin Comment"
* $CAPeCCCodeSystem#367557.100004300 "Regional Lymph Node Status"
* $CAPeCCCodeSystem#41386.100004300 "Number of Lymph Nodes with Tumor"
* $CAPeCCCodeSystem#50909.100004300 "Laterality of Lymph Node(s) with Tumor"
* $CAPeCCCodeSystem#866478.100004300 "Nodal Site(s) with Tumor"
* $CAPeCCCodeSystem#364989.100004300 "?Size of Largest Nodal Metastatic Deposit"
* $CAPeCCCodeSystem#46003.100004300 "Extranodal Extension (ENE) (Note F)"
* $CAPeCCCodeSystem#364994.100004300 "Distance of ENE from Lymph Node Capsule"
* $CAPeCCCodeSystem#44317.100004300 "Number of Lymph Nodes Examined"
* $CAPeCCCodeSystem#364984.100004300 "Regional Lymph Node Comment"
* $CAPeCCCodeSystem#364371.100004300 "?Distant Site(s) Involved, if applicable"
* $CAPeCCCodeSystem#866509.100004300 "?Modified Classification (required only if applicable)"
* $CAPeCCCodeSystem#327873.100004300 "pT Category"
* $CAPeCCCodeSystem#866511.100004300 "?T Suffix (required only if applicable)"
* $CAPeCCCodeSystem#327875.100004300 "pN Category# (Note F)"
* $CAPeCCCodeSystem#5168.100004300 "?pM Category (required only if confirmed pathologically)"
* $CAPeCCCodeSystem#866535.100004300 "Additional Findings"
* $CAPeCCCodeSystem#5187.100004300 "?Comment(s)"
* $CAPeCCCodeSystem#40232.100004300 "Procedure"
* $CAPeCCCodeSystem#57513.100004300 "Tumor Focality"
* $CAPeCCCodeSystem#378971.100004300 "?Multiple Primary Sites (e.g., nasal cavity and paranasal sinus, maxillary)"
* $CAPeCCCodeSystem#50022.100004300 "Tumor Site (Note A)"
* $CAPeCCCodeSystem#41947.100004300 "Tumor Laterality"
* $CAPeCCCodeSystem#23444.100004300 "Tumor Size"
* $CAPeCCCodeSystem#23448.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#23447.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#866269.100004300 "Histologic Type (Note B)"
* $CAPeCCCodeSystem#556700.100004300 "Architectural Type"
* $CAPeCCCodeSystem#866284.100004300 "Malignant Component Histologic Type(s)"
* $CAPeCCCodeSystem#378958.100004300 "Percentage of Solid Component for Adenoid Cystic Carcinoma"
* $CAPeCCCodeSystem#866295.100004300 "Percentage of Papillary Component for Polymorphous Adenocarcinoma"
* $CAPeCCCodeSystem#866299.100004300 "Percentage of Cribriform Component for Polymorphous Adenocarcinoma"
* $CAPeCCCodeSystem#866319.100004300 "Type of Combined Histology#"
* $CAPeCCCodeSystem#39597.100004300 "Histologic Type Comment"
* $CAPeCCCodeSystem#57015.100004300 "?Histologic Grade# (Note C)"
* $CAPeCCCodeSystem#866433.100004300 "?Grade / Intrinsic Biologic Potential#"
* $CAPeCCCodeSystem#42700.100004300 "Tumor Extent (specify)"
* $CAPeCCCodeSystem#23651.100004300 "Lymphatic and / or Vascular Invasion"
* $CAPeCCCodeSystem#23655.100004300 "Perineural Invasion (Note D)"
* $CAPeCCCodeSystem#866452.100004300 "Extent / Type of Perineural Invasion#"
* $CAPeCCCodeSystem#866524.100004300 "Specify Diameter of Involved Nerve in Millimeters (mm)"
* $CAPeCCCodeSystem#379543.100004300 "Tumor Comment"
* $CAPeCCCodeSystem#46793.100004300 "Margin Status for Invasive Tumor"
* $CAPeCCCodeSystem#364491.100004300 "Distance from Invasive Tumor to Closest Margin"
* $CAPeCCCodeSystem#30430.100004300 "Closest Margin(s) to Invasive Tumor (use orientation when provided)"
* $CAPeCCCodeSystem#364500.100004300 "Other Close Margin(s) to Invasive Tumor"
* $CAPeCCCodeSystem#23730.100004300 "Margin(s) Involved by Invasive Tumor (use orientation when provided)"
* $CAPeCCCodeSystem#59777.100004300 "?Margin Status for Noninvasive Tumor (High-grade Dysplasia)"
* $CAPeCCCodeSystem#364505.100004300 "Distance from Noninvasive Tumor to Closest Margin"
* $CAPeCCCodeSystem#30431.100004300 "Closest Margin(s) to Noninvasive Tumor (use orientation when provided)"
* $CAPeCCCodeSystem#23769.100004300 "Margin(s) Involved by Noninvasive Tumor (use orientation when provided)"
* $CAPeCCCodeSystem#364501.100004300 "Margin Comment"
* $CAPeCCCodeSystem#364859.100004300 "Regional Lymph Node Status"
* $CAPeCCCodeSystem#364866.100004300 "Number of Lymph Nodes with Tumor"
* $CAPeCCCodeSystem#44011.100004300 "?Laterality of Lymph Node(s) with Tumor (not applicable for mucosal melanoma)"
* $CAPeCCCodeSystem#866457.100004300 "Nodal Site(s) with Tumor"
* $CAPeCCCodeSystem#364880.100004300 "?Size of Largest Nodal Metastatic Deposit (not applicable for mucosal melanoma)"
* $CAPeCCCodeSystem#29875.100004300 "?Extranodal Extension (ENE) (not applicable for mucosal melanoma)"
* $CAPeCCCodeSystem#365015.100004300 "Distance of ENE from Lymph Node Capsule"
* $CAPeCCCodeSystem#364871.100004300 "Number of Lymph Nodes Examined"
* $CAPeCCCodeSystem#364887.100004300 "Regional Lymph Node Comment"
* $CAPeCCCodeSystem#364353.100004300 "?Distant Site(s) Involved, if applicable"
* $CAPeCCCodeSystem#866591.100004300 "?Modified Classification (required only if applicable)"
* $CAPeCCCodeSystem#24038.100004300 "pTNM Classification"
* $CAPeCCCodeSystem#327651.100004300 "pT Category"
* $CAPeCCCodeSystem#866466.100004300 "?T Suffix (required only if applicable)"
* $CAPeCCCodeSystem#327662.100004300 "pN Category# (Note F)"
* $CAPeCCCodeSystem#23634.100004300 "?pM Category (required only if confirmed pathologically)"
* $CAPeCCCodeSystem#39283.100004300 "pT Category"
* $CAPeCCCodeSystem#866469.100004300 "?T Suffix (required only if applicable)"
* $CAPeCCCodeSystem#327665.100004300 "pN Category"
* $CAPeCCCodeSystem#24692.100004300 "?pM Category (required only if confirmed pathologically)"
* $CAPeCCCodeSystem#59237.100004300 "Additional Findings"
* $CAPeCCCodeSystem#23665.100004300 "?Comment(s)"
* $CAPeCCCodeSystem#52352.100004300 "Procedure"
* $CAPeCCCodeSystem#41068.100004300 "Tumor Focality"
* $CAPeCCCodeSystem#378924.100004300 "?Multiple Primary Sites (e.g., lower gingiva and floor of mouth)"
* $CAPeCCCodeSystem#56534.100004300 "Tumor Site (Note B)"
* $CAPeCCCodeSystem#866536.100004300 "Tumor Subsite"
* $CAPeCCCodeSystem#44589.100004300 "Tumor Laterality"
* $CAPeCCCodeSystem#23202.100004300 "Tumor Size (Note E)"
* $CAPeCCCodeSystem#23205.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#23206.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#866324.100004300 "Histologic Type (Note C)"
* $CAPeCCCodeSystem#563562.100004300 "Architectural Type"
* $CAPeCCCodeSystem#866328.100004300 "Malignant Component Histologic Type(s)"
* $CAPeCCCodeSystem#378918.100004300 "Percentage of Solid Component for Adenoid Cystic Carcinoma"
* $CAPeCCCodeSystem#866339.100004300 "Percentage of Papillary Component for Polymorphous Adenocarcinoma"
* $CAPeCCCodeSystem#866343.100004300 "Percentage of Cribriform Component for Polymorphous Adenocarcinoma"
* $CAPeCCCodeSystem#866363.100004300 "Type of Combined Histology#"
* $CAPeCCCodeSystem#35757.100004300 "Histologic Type Comment"
* $CAPeCCCodeSystem#23274.100004300 "?Histologic Grade# (Note D)"
* $CAPeCCCodeSystem#866472.100004300 "?Grade / Intrinsic Biologic Potential#"
* $CAPeCCCodeSystem#58426.100004300 "?Tumor Depth of Invasion (DOI)"
* $CAPeCCCodeSystem#50517.100004300 "Tumor Extent (specify other structures involved)"
* $CAPeCCCodeSystem#23409.100004300 "Lymphatic and / or Vascular Invasion"
* $CAPeCCCodeSystem#23413.100004300 "Perineural Invasion (Note F)"
* $CAPeCCCodeSystem#866487.100004300 "Extent / Type of Perineural Invasion#"
* $CAPeCCCodeSystem#866491.100004300 "Specify Diameter of Involved Nerve in Millimeters (mm)"
* $CAPeCCCodeSystem#49664.100004300 "Worst Pattern of Invasion (WPOI) (Note G)"
* $CAPeCCCodeSystem#379541.100004300 "Tumor Comment"
* $CAPeCCCodeSystem#364423.100004300 "Specimen Margin Status for Invasive Tumor"
* $CAPeCCCodeSystem#364424.100004300 "Distance from Invasive Tumor to Closest Specimen Margin"
* $CAPeCCCodeSystem#364425.100004300 "Closest Specimen Margin(s) to Invasive Tumor"
* $CAPeCCCodeSystem#364426.100004300 "Other Close Specimen Margin(s) to Invasive Tumor"
* $CAPeCCCodeSystem#364427.100004300 "Specimen Margin(s) Involved by Invasive Tumor (per orientation)"
* $CAPeCCCodeSystem#364389.100004300 "?Specimen Margin Status for Noninvasive Tumor (High-grade Dysplasia)"
* $CAPeCCCodeSystem#364445.100004300 "Distance from Noninvasive Tumor to Closest Specimen Margin"
* $CAPeCCCodeSystem#364408.100004300 "Closest Specimen Margin(s) to Noninvasive Tumor (use orientation when provided)"
* $CAPeCCCodeSystem#364394.100004300 "Specimen Margin(s) Involved by Noninvasive Tumor (per orientation)"
* $CAPeCCCodeSystem#364414.100004300 "?Tumor Bed Margin Status (separately submitted)"
* $CAPeCCCodeSystem#364416.100004300 "Tumor Bed Margin Orientation"
* $CAPeCCCodeSystem#364419.100004300 "Tumor Bed Margin Status for Invasive Tumor"
* $CAPeCCCodeSystem#364390.100004300 "Distance from Invasive Tumor to True Margin Surface (if oriented and sectioned perpendicularly)"
* $CAPeCCCodeSystem#364411.100004300 "Tumor Bed Margin(s) Involved by Invasive Tumor (per part labeling)"
* $CAPeCCCodeSystem#364405.100004300 "?Tumor Bed Margin Status for Noninvasive Tumor"
* $CAPeCCCodeSystem#364459.100004300 "Distance from Noninvasive Tumor to True Margin Surface (if oriented and sectioned perpendicularly)"
* $CAPeCCCodeSystem#364403.100004300 "Tumor Bed Margin(s) Involved by Noninvasive Tumor (per orientation)"
* $CAPeCCCodeSystem#364511.100004300 "Margin Comment"
* $CAPeCCCodeSystem#364905.100004300 "Regional Lymph Node Status"
* $CAPeCCCodeSystem#364912.100004300 "Number of Lymph Nodes with Tumor"
* $CAPeCCCodeSystem#58632.100004300 "?Laterality of Lymph Node(s) with Tumor (not applicable for mucosal melanoma)"
* $CAPeCCCodeSystem#866497.100004300 "Nodal Site(s) with Tumor"
* $CAPeCCCodeSystem#364923.100004300 "?Size of Largest Nodal Metastatic Deposit (not applicable for mucosal melanoma)"
* $CAPeCCCodeSystem#57848.100004300 "?Extranodal Extension (ENE) (not applicable for mucosal melanoma) (Note I)"
* $CAPeCCCodeSystem#365001.100004300 "Distance of ENE from Lymph Node Capsule"
* $CAPeCCCodeSystem#364917.100004300 "Number of Lymph Nodes Examined"
* $CAPeCCCodeSystem#364931.100004300 "Regional Lymph Node Comment"
* $CAPeCCCodeSystem#364362.100004300 "?Distant Site(s) Involved, if applicable"
* $CAPeCCCodeSystem#866514.100004300 "?Modified Classification (required only if applicable)"
* $CAPeCCCodeSystem#23281.100004300 "pTNM Classification"
* $CAPeCCCodeSystem#515679.100004300 "pT Category"
* $CAPeCCCodeSystem#866515.100004300 "?T Suffix (required only if applicable)"
* $CAPeCCCodeSystem#327862.100004300 "pN Category# (Note I)"
* $CAPeCCCodeSystem#2286.100004300 "?pM Category (required only if confirmed pathologically)"
* $CAPeCCCodeSystem#54786.100004300 "pT Category"
* $CAPeCCCodeSystem#866518.100004300 "?T Suffix (required only if applicable)"
* $CAPeCCCodeSystem#327865.100004300 "pN Category"
* $CAPeCCCodeSystem#23392.100004300 "?pM Category (required only if confirmed pathologically)"
* $CAPeCCCodeSystem#866526.100004300 "Additional Findings"
* $CAPeCCCodeSystem#374366.100004300 "Specify Test and Result"
* $CAPeCCCodeSystem#23423.100004300 "?Comment(s)"
* $CAPeCCCodeSystem#39041.100004300 "Procedure"
* $CAPeCCCodeSystem#24741.100004300 "Tumor Focality"
* $CAPeCCCodeSystem#378975.100004300 "?Multiple Primary Sites (e.g., oropharynx and nasopharynx)"
* $CAPeCCCodeSystem#17202.100004300 "Tumor Site (Note A)"
* $CAPeCCCodeSystem#379137.100004300 "Tumor Subsite"
* $CAPeCCCodeSystem#379139.100004300 "Tumor Subsite"
* $CAPeCCCodeSystem#17248.100004300 "Tumor Subsite"
* $CAPeCCCodeSystem#24739.100004300 "Tumor Laterality"
* $CAPeCCCodeSystem#23686.100004300 "Tumor Size"
* $CAPeCCCodeSystem#23690.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#23689.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#866377.100004300 "Histologic Type (Note B)"
* $CAPeCCCodeSystem#557465.100004300 "Architectural Type"
* $CAPeCCCodeSystem#866383.100004300 "Malignant Component Histologic Type(s)"
* $CAPeCCCodeSystem#378985.100004300 "Percentage of Solid Component for Adenoid Cystic Carcinoma"
* $CAPeCCCodeSystem#866394.100004300 "Percentage of Papillary Component for Polymorphous Adenocarcinoma"
* $CAPeCCCodeSystem#866398.100004300 "Percentage of Cribriform Component for Polymorphous Adenocarcinoma"
* $CAPeCCCodeSystem#866417.100004300 "Type of Combined Histology#"
* $CAPeCCCodeSystem#891740.100004300 "?Squamous Cell Carcinoma Subtypes (required only for carcinomas of the oropharynx and hypopharynx)"
* $CAPeCCCodeSystem#53082.100004300 "Histologic Type Comment"
* $CAPeCCCodeSystem#51456.100004300 "?Histologic Grade# (Note C)"
* $CAPeCCCodeSystem#866593.100004300 "?Grade / Intrinsic Biologic Potential#"
* $CAPeCCCodeSystem#38048.100004300 "Tumor Extent (specify)"
* $CAPeCCCodeSystem#23893.100004300 "Lymphatic and / or Vascular Invasion"
* $CAPeCCCodeSystem#23897.100004300 "Perineural Invasion (Note D)"
* $CAPeCCCodeSystem#866600.100004300 "Extent / Type of Perineural Invasion#"
* $CAPeCCCodeSystem#866605.100004300 "Specify Diameter of Involved Nerve in Millimeters (mm)"
* $CAPeCCCodeSystem#379544.100004300 "Tumor Comment"
* $CAPeCCCodeSystem#44887.100004300 "Margin Status for Invasive Tumor"
* $CAPeCCCodeSystem#364519.100004300 "Distance from Invasive Tumor to Closest Margin"
* $CAPeCCCodeSystem#30436.100004300 "Closest Margin(s) to Invasive Tumor (use orientation when provided)"
* $CAPeCCCodeSystem#364527.100004300 "Other Close Margin(s) to Invasive Tumor"
* $CAPeCCCodeSystem#364529.100004300 "Margin(s) Involved by Invasive Tumor (use orientation when provided)"
* $CAPeCCCodeSystem#46693.100004300 "?Margin Status for Noninvasive Tumor (High-grade Dysplasia)"
* $CAPeCCCodeSystem#364532.100004300 "Distance from Noninvasive Tumor to Closest Margin"
* $CAPeCCCodeSystem#30438.100004300 "Closest Margin(s) to Noninvasive Tumor (use orientation when provided)"
* $CAPeCCCodeSystem#23796.100004300 "Margin(s) Involved by Noninvasive Tumor (use orientation when provided)"
* $CAPeCCCodeSystem#364503.100004300 "Margin Comment"
* $CAPeCCCodeSystem#364951.100004300 "Regional Lymph Node Status"
* $CAPeCCCodeSystem#364958.100004300 "Number of Lymph Nodes with Tumor"
* $CAPeCCCodeSystem#42837.100004300 "?Laterality of Lymph Node(s) with Tumor (not applicable for mucosal melanoma)"
* $CAPeCCCodeSystem#866606.100004300 "Nodal Site(s) with Tumor"
* $CAPeCCCodeSystem#364969.100004300 "?Size of Largest Nodal Metastatic Deposit (not applicable for mucosal melanoma)"
* $CAPeCCCodeSystem#45482.100004300 "?Extranodal Extension (ENE)"
* $CAPeCCCodeSystem#365008.100004300 "Distance of ENE from Lymph Node Capsule"
* $CAPeCCCodeSystem#364963.100004300 "Number of Lymph Nodes Examined"
* $CAPeCCCodeSystem#364976.100004300 "Regional Lymph Node Comment"
* $CAPeCCCodeSystem#364380.100004300 "?Distant Site(s) Involved, if applicable"
* $CAPeCCCodeSystem#866615.100004300 "?Modified Classification (required only if applicable)"
* $CAPeCCCodeSystem#53494.100004300 "pTNM Classification (Note H)"
* $CAPeCCCodeSystem#49767.100004300 "pT Category and pN Category"
* $CAPeCCCodeSystem#40510.100004300 "pT Category"
* $CAPeCCCodeSystem#866616.100004300 "?T Suffix (required only if applicable)"
* $CAPeCCCodeSystem#327904.100004300 "pN Category"
* $CAPeCCCodeSystem#327907.100004300 "pT Category"
* $CAPeCCCodeSystem#866619.100004300 "?T Suffix (required only if applicable)"
* $CAPeCCCodeSystem#327908.100004300 "pN Category#"
* $CAPeCCCodeSystem#327912.100004300 "pT Category"
* $CAPeCCCodeSystem#866622.100004300 "?T Suffix (required only if applicable)"
* $CAPeCCCodeSystem#327913.100004300 "pN Category"
* $CAPeCCCodeSystem#327917.100004300 "pT Category"
* $CAPeCCCodeSystem#866625.100004300 "?T Suffix (required only if applicable)"
* $CAPeCCCodeSystem#327918.100004300 "pN Category"
* $CAPeCCCodeSystem#23876.100004300 "?pM Category (required only if confirmed pathologically)"
* $CAPeCCCodeSystem#53269.100004300 "pT Category"
* $CAPeCCCodeSystem#866679.100004300 "?T Suffix (required only if applicable)"
* $CAPeCCCodeSystem#327922.100004300 "pN Category"
* $CAPeCCCodeSystem#24823.100004300 "?pM Category (required only if confirmed pathologically)"
* $CAPeCCCodeSystem#23900.100004300 "Additional Findings"
* $CAPeCCCodeSystem#866651.100004300 "?Ancillary Studies Performed#"
* $CAPeCCCodeSystem#866647.100004300 "p16 IHC as a Surrogate for Transcriptionally Active High-Risk HPV"
* $CAPeCCCodeSystem#866633.100004300 "HPV E6 / E7 mRNA ISH"
* $CAPeCCCodeSystem#866663.100004300 "Specify Subtypes (if available)"
* $CAPeCCCodeSystem#866668.100004300 "HPV-DNA ISH"
* $CAPeCCCodeSystem#866665.100004300 "Specify Subtypes (if available)"
* $CAPeCCCodeSystem#891582.100004300 "HPV-DNA PCR"
* $CAPeCCCodeSystem#866671.100004300 "Specify Subtypes (if available)"
* $CAPeCCCodeSystem#891587.100004300 "HPV E6 / E7 mRNA RT-PCR"
* $CAPeCCCodeSystem#866643.100004300 "Specify Subtypes (if available)"
* $CAPeCCCodeSystem#866652.100004300 "EBV Early mRNA (EBER) ISH"
* $CAPeCCCodeSystem#23907.100004300 "?Comment(s)"
* $CAPeCCCodeSystem#744720.100004300 "Procedure"
* $CAPeCCCodeSystem#744740.100004300 "Tumor Focality"
* $CAPeCCCodeSystem#744744.100004300 "Multiple Primary Sites"
* $CAPeCCCodeSystem#744748.100004300 "Tumor Site"
* $CAPeCCCodeSystem#744751.100004300 "Tumor Laterality"
* $CAPeCCCodeSystem#744756.100004300 "Tumor Size"
* $CAPeCCCodeSystem#744758.100004300 "Additional Dimensions in Centimeters"
* $CAPeCCCodeSystem#744759.100004300 "Additional Dimensions in Centimeters"
* $CAPeCCCodeSystem#744761.100004300 "Histologic Type (Note B)"
* $CAPeCCCodeSystem#744774.100004300 "Histologic Grade (Note C)"
* $CAPeCCCodeSystem#744782.100004300 "Tumor Depth of Invasion (DOI) (Note D)"
* $CAPeCCCodeSystem#744787.100004300 "Anatomic Level"
* $CAPeCCCodeSystem#744794.100004300 "Tumor Extent (specify other structures involved)"
* $CAPeCCCodeSystem#744795.100004300 "Lymphovascular Invasion"
* $CAPeCCCodeSystem#744848.100004300 "Perineural Invasion (Note E)"
* $CAPeCCCodeSystem#744800.100004300 "Margin Status for Invasive Tumor"
* $CAPeCCCodeSystem#744802.100004300 "Distance from Invasive Tumor to Closest Margin"
* $CAPeCCCodeSystem#744809.100004300 "Closest Margin(s) to Invasive Tumor"
* $CAPeCCCodeSystem#744812.100004300 "Other Close Margin(s) to Invasive Tumor"
* $CAPeCCCodeSystem#759326.100004300 "Margin(s) Involved by Invasive Tumor"
* $CAPeCCCodeSystem#744816.100004300 "Margin Status for Noninvasive Tumor"
* $CAPeCCCodeSystem#744825.100004300 "Distance from Noninvasive Tumor to Closest Margin"
* $CAPeCCCodeSystem#744832.100004300 "Closest Margin(s) to Noninvasive Tumor"
* $CAPeCCCodeSystem#759331.100004300 "Margin(s) Involved by Noninvasive Tumor"
* $CAPeCCCodeSystem#744867.100004300 "Regional Lymph Node Status"
* $CAPeCCCodeSystem#744874.100004300 "Number of Lymph Nodes with Tumor"
* $CAPeCCCodeSystem#744864.100004300 "Laterality of Lymph Node(s) with Tumor"
* $CAPeCCCodeSystem#744885.100004300 "Size of Largest Nodal Metastatic Deposit"
* $CAPeCCCodeSystem#744865.100004300 "Extranodal Extension (ENE) (Note G)"
* $CAPeCCCodeSystem#744879.100004300 "Number of Lymph Nodes Examined"
* $CAPeCCCodeSystem#744904.100004300 "Regional Lymph Node Comment"
* $CAPeCCCodeSystem#744905.100004300 "?Distant Site(s) Involved, if applicable"
* $CAPeCCCodeSystem#745257.100004300 "?TNM Descriptors"
* $CAPeCCCodeSystem#745271.100004300 "pT Category"
* $CAPeCCCodeSystem#745276.100004300 "pN Category#"
* $CAPeCCCodeSystem#745309.100004300 "?pM Category (required only if confirmed pathologically)"
* $CAPeCCCodeSystem#745319.100004300 "High-risk Factors"
* $CAPeCCCodeSystem#745332.100004300 "BWH Tumor Classification"
* $CAPeCCCodeSystem#744984.100004300 "Additional Findings"
* $CAPeCCCodeSystem#744979.100004300 "Specify Test and Result"
* $CAPeCCCodeSystem#744982.100004300 "?Comment(s)"
* $CAPeCCCodeSystem#327451.100004300 "Case Identifier"
* $CAPeCCCodeSystem#327450.100004300 "Block Designation"
* $CAPeCCCodeSystem#352959.100004300 "Anatomic Site"
* $CAPeCCCodeSystem#352960.100004300 "Diagnosis"
* $CAPeCCCodeSystem#352852.100004300 "Biomarker(s) Assessed"
* $CAPeCCCodeSystem#327591.100004300 "Interpretation"
* $CAPeCCCodeSystem#327587.100004300 "Percentage of Tumor Cells with Staining (TPS)"
* $CAPeCCCodeSystem#327588.100004300 "Combined Number of Tumor and Immune Cells with Staining per 100 Tumor Cells (CPS)"
* $CAPeCCCodeSystem#327605.100004300 "Specify Percentage of Tumor-associated Immune Cells with Staining"
* $CAPeCCCodeSystem#327633.100004300 "Specify Percentage of Tumor Area Occupied by Tumor-associated Immune Cells"
* $CAPeCCCodeSystem#352965.100004300 "Comments"
* $CAPeCCCodeSystem#327582.100004300 "Antibody"
* $CAPeCCCodeSystem#327599.100004300 "Controls"
* $CAPeCCCodeSystem#327596.100004300 "Assay Information"
* $CAPeCCCodeSystem#353367.100004300 "Specify Quantitative Imaging Analytics Performed"
* $CAPeCCCodeSystem#327562.100004300 "Interpretation"
* $CAPeCCCodeSystem#352966.100004300 "Comments"
* $CAPeCCCodeSystem#327555.100004300 "Nuclear MLH1 staining"
* $CAPeCCCodeSystem#327610.100004300 "Nuclear PMS2 staining"
* $CAPeCCCodeSystem#327618.100004300 "Nuclear MSH2 staining"
* $CAPeCCCodeSystem#327614.100004300 "Nuclear MSH6 staining"
* $CAPeCCCodeSystem#327570.100004300 "Controls"
* $CAPeCCCodeSystem#327567.100004300 "Assay Information"
* $CAPeCCCodeSystem#353369.100004300 "Specify Quantitative Imaging Analytics Performed"
* $CAPeCCCodeSystem#327501.100004300 "Interpretation"
* $CAPeCCCodeSystem#327494.100004300 "Scoring System"
* $CAPeCCCodeSystem#327495.100004300 "Score"
* $CAPeCCCodeSystem#327545.100004300 "Specify Percentage of Cells with Uniform Intense Complete Membrane Staining"
* $CAPeCCCodeSystem#352964.100004300 "Comments"
* $CAPeCCCodeSystem#327489.100004300 "Antibody"
* $CAPeCCCodeSystem#541970.100004300 "Controls"
* $CAPeCCCodeSystem#327506.100004300 "Assay Information"
* $CAPeCCCodeSystem#353365.100004300 "Specify Quantitative Imaging Analytics Performed"
* $CAPeCCCodeSystem#327478.100004300 "Interpretation"
* $CAPeCCCodeSystem#330484.100004300 "Specify Tumor Cell Percent Positive"
* $CAPeCCCodeSystem#327472.100004300 "Tumor Cell Staining Intensity"
* $CAPeCCCodeSystem#352961.100004300 "Comments"
* $CAPeCCCodeSystem#327466.100004300 "Antibody"
* $CAPeCCCodeSystem#327535.100004300 "Controls"
* $CAPeCCCodeSystem#327483.100004300 "Assay Information"
* $CAPeCCCodeSystem#353359.100004300 "Specify Quantitative Imaging Analytics Performed"
* $CAPeCCCodeSystem#327453.100004300 "Interpretation"
* $CAPeCCCodeSystem#327157.100004300 "Specify Tumor Cell Percent Positive"
* $CAPeCCCodeSystem#327160.100004300 "Tumor Cell Staining Intensity"
* $CAPeCCCodeSystem#352962.100004300 "Comments"
* $CAPeCCCodeSystem#327147.100004300 "Antibody"
* $CAPeCCCodeSystem#327540.100004300 "Controls"
* $CAPeCCCodeSystem#327460.100004300 "Assay Information"
* $CAPeCCCodeSystem#353361.100004300 "Specify Quantitative Imaging Analytics Performed"
* $CAPeCCCodeSystem#327518.100004300 "Specify Tumor Cell Percent Positive"
* $CAPeCCCodeSystem#352963.100004300 "Comments"
* $CAPeCCCodeSystem#327513.100004300 "Antibody"
* $CAPeCCCodeSystem#541914.100004300 "Controls"
* $CAPeCCCodeSystem#327530.100004300 "Assay Information (e.g., Laboratory-developed Test)"
* $CAPeCCCodeSystem#353363.100004300 "Specify Quantitative Imaging Analytics Performed"
* $CAPeCCCodeSystem#541969.100004300 "Specify Biomarker"
* $CAPeCCCodeSystem#541949.100004300 "Interpretation"
* $CAPeCCCodeSystem#541966.100004300 "Tumor Cell Staining Intensity"
* $CAPeCCCodeSystem#541963.100004300 "Comments"
* $CAPeCCCodeSystem#541948.100004300 "Specify Antibody"
* $CAPeCCCodeSystem#541955.100004300 "Controls"
* $CAPeCCCodeSystem#541952.100004300 "Assay Information"
* $CAPeCCCodeSystem#541965.100004300 "Specify Quantitative Imaging Analytics Performed"
* $CAPeCCCodeSystem#403924.100004300 "?Comment(s)"
* $CAPeCCCodeSystem#36986.100004300 "Procedure"
* $CAPeCCCodeSystem#40790.100004300 "Tumor Site (Notes A, B)"
* $CAPeCCCodeSystem#938265.100004300 "Histologic Type and Grade# (Notes C, D)"
* $CAPeCCCodeSystem#379354.100004300 "?Mitotic Rate (required only when Ki-67 labeling index is not reported)#"
* $CAPeCCCodeSystem#379355.100004300 "?Ki-67 Labeling Index (required only when mitotic rate is not reported)"
* $CAPeCCCodeSystem#56465.100004300 "Tumor Size (Note E)"
* $CAPeCCCodeSystem#58251.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#52028.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#44829.100004300 "Tumor Focality"
* $CAPeCCCodeSystem#379360.100004300 "Number of Tumors"
* $CAPeCCCodeSystem#43143.100004300 "Tumor Extent"
* $CAPeCCCodeSystem#47683.100004300 "Lymphatic and / or Vascular Invasion"
* $CAPeCCCodeSystem#45997.100004300 "Perineural Invasion"
* $CAPeCCCodeSystem#42602.100004300 "Large Mesenteric Masses (greater than 2 cm) (Note G)"
* $CAPeCCCodeSystem#379368.100004300 "Number of Large Mesenteric Masses"
* $CAPeCCCodeSystem#379364.100004300 "Tumor Comment"
* $CAPeCCCodeSystem#366233.100004300 "Margin Status"
* $CAPeCCCodeSystem#938247.100004300 "Closest Margin(s) to Tumor"
* $CAPeCCCodeSystem#366244.100004300 "Distance from Tumor to Closest Margin"
* $CAPeCCCodeSystem#938250.100004300 "Margin(s) Involved by Tumor"
* $CAPeCCCodeSystem#366249.100004300 "Margin Comment"
* $CAPeCCCodeSystem#374372.100004300 "Regional Lymph Node Status"
* $CAPeCCCodeSystem#39960.100004300 "Number of Lymph Nodes with Tumor"
* $CAPeCCCodeSystem#58480.100004300 "Number of Lymph Nodes Examined"
* $CAPeCCCodeSystem#358488.100004300 "Regional Lymph Node Comment"
* $CAPeCCCodeSystem#359058.100004300 "?Distant Site(s) Involved, if applicable"
* $CAPeCCCodeSystem#937521.100004300 "?Modified Classification (required only if applicable)"
* $CAPeCCCodeSystem#937529.100004300 "pT Category#"
* $CAPeCCCodeSystem#937523.100004300 "?T Suffix (required only if applicable)"
* $CAPeCCCodeSystem#937536.100004300 "pN Category"
* $CAPeCCCodeSystem#937543.100004300 "?pM Category (required only if confirmed pathologically)"
* $CAPeCCCodeSystem#937548.100004300 "Additional Findings"
* $CAPeCCCodeSystem#46930.100004300 "?Comment(s)"
* $CAPeCCCodeSystem#4853.100004300 "Procedure"
* $CAPeCCCodeSystem#4858.100004300 "Specimen Laterality"
* $CAPeCCCodeSystem#380227.100004300 "Tumor Site"
* $CAPeCCCodeSystem#40359.100004300 "Histologic Type (Note A)"
* $CAPeCCCodeSystem#50838.100004300 "Histologic Type Comment"
* $CAPeCCCodeSystem#41930.100004300 "Histologic Grade (WHO / ISUP) (Note B)"
* $CAPeCCCodeSystem#21092.100004300 "Sarcomatoid Features (Note C)"
* $CAPeCCCodeSystem#380249.100004300 "Percentage of Sarcomatoid Element"
* $CAPeCCCodeSystem#53523.100004300 "Rhabdoid Features (Note C)"
* $CAPeCCCodeSystem#49255.100004300 "Necrosis (Note D)"
* $CAPeCCCodeSystem#53111.100004300 "Lymphovascular Invasion"
* $CAPeCCCodeSystem#379573.100004300 "Tumor Comment"
* $CAPeCCCodeSystem#4880.100004300 "Additional Findings"
* $CAPeCCCodeSystem#4886.100004300 "?Comment(s)"
* $CAPeCCCodeSystem#54885.100004300 "Procedure"
* $CAPeCCCodeSystem#4895.100004300 "Specimen Laterality"
* $CAPeCCCodeSystem#4905.100004300 "Tumor Focality"
* $CAPeCCCodeSystem#4899.100004300 "Tumor Site"
* $CAPeCCCodeSystem#4908.100004300 "Tumor Size"
* $CAPeCCCodeSystem#4911.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#4912.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#37943.100004300 "Histologic Type (Note B)"
* $CAPeCCCodeSystem#54902.100004300 "Histologic Type Comment"
* $CAPeCCCodeSystem#46120.100004300 "Histologic Grade (WHO / ISUP) (Note C)"
* $CAPeCCCodeSystem#380234.100004300 "Tumor Extent (Notes D, E)"
* $CAPeCCCodeSystem#21109.100004300 "Sarcomatoid Features (Note F)"
* $CAPeCCCodeSystem#379865.100004300 "Percentage of Sarcomatoid Element"
* $CAPeCCCodeSystem#45061.100004300 "Rhabdoid Features (Note F)"
* $CAPeCCCodeSystem#21100.100004300 "Tumor Necrosis (Note G)"
* $CAPeCCCodeSystem#379869.100004300 "Percentage of Tumor Necrosis"
* $CAPeCCCodeSystem#4979.100004300 "Lymphovascular Invasion (excluding renal vein and its segmental branches and inferior vena cava)"
* $CAPeCCCodeSystem#379572.100004300 "Tumor Comment"
* $CAPeCCCodeSystem#365458.100004300 "Margin Status"
* $CAPeCCCodeSystem#365490.100004300 "Margin(s) Involved by Invasive Carcinoma"
* $CAPeCCCodeSystem#365453.100004300 "Margin Comment"
* $CAPeCCCodeSystem#374374.100004300 "Regional Lymph Node Status"
* $CAPeCCCodeSystem#7543.100004300 "Number of Lymph Nodes with Tumor"
* $CAPeCCCodeSystem#41082.100004300 "Nodal Site(s) with Tumor"
* $CAPeCCCodeSystem#358186.100004300 "Size of Largest Nodal Metastatic Deposit"
* $CAPeCCCodeSystem#54235.100004300 "Nodal Site with Largest Metastatic Deposit (specify Site)"
* $CAPeCCCodeSystem#358190.100004300 "Size of Largest Lymph Node with Tumor"
* $CAPeCCCodeSystem#59628.100004300 "Largest Lymph Node with Tumor (specify site)"
* $CAPeCCCodeSystem#6893.100004300 "Number of Lymph Nodes Examined"
* $CAPeCCCodeSystem#358471.100004300 "Regional Lymph Node Comment"
* $CAPeCCCodeSystem#356501.100004300 "?Distant Site(s) Involved, if applicable"
* $CAPeCCCodeSystem#24237.100004300 "?TNM Descriptors"
* $CAPeCCCodeSystem#327848.100004300 "Primary Tumor (pT)"
* $CAPeCCCodeSystem#327850.100004300 "Regional Lymph Nodes (pN)"
* $CAPeCCCodeSystem#4958.100004300 "?Distant Metastasis (pM)"
* $CAPeCCCodeSystem#4988.100004300 "Additional Findings in Nonneoplastic Kidney"
* $CAPeCCCodeSystem#58246.100004300 "Additional Findings"
* $CAPeCCCodeSystem#4994.100004300 "?Comment(s)"
* $CAPeCCCodeSystem#702214.100004300 "Expert Consultation (Note A)"
* $CAPeCCCodeSystem#47899.100004300 "Procedure (Note B)"
* $CAPeCCCodeSystem#804637.100004300 "Specimen Laterality"
* $CAPeCCCodeSystem#820597.100004300 "Histologic Type (Note C)"
* $CAPeCCCodeSystem#379116.100004300 "Histologic Type Comment"
* $CAPeCCCodeSystem#802610.100004300 "Relevant Immunohistochemistry (Note C)"
* $CAPeCCCodeSystem#802614.100004300 "Ancillary Studies (Note D)"
* $CAPeCCCodeSystem#802628.100004300 "Additional Findings (specify) (Notes D, E)"
* $CAPeCCCodeSystem#49874.100004300 "?Comment(s)"
* $CAPeCCCodeSystem#702249.100004300 "Expert Consultation (Note A)"
* $CAPeCCCodeSystem#55187.100004300 "Procedure (Note B)"
* $CAPeCCCodeSystem#802542.100004300 "?Other Tissue Received (required only if applicable)"
* $CAPeCCCodeSystem#380078.100004300 "Nephrectomy Weight (Note B)"
* $CAPeCCCodeSystem#820608.100004300 "Specimen Laterality"
* $CAPeCCCodeSystem#802549.100004300 "Histologic Type (Note C)"
* $CAPeCCCodeSystem#379091.100004300 "Histologic Type Comment"
* $CAPeCCCodeSystem#19714.100004300 "Tumor Size"
* $CAPeCCCodeSystem#15223.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#15224.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#802493.100004300 "?Tumor Identifier"
* $CAPeCCCodeSystem#802492.100004300 "?Greatest Dimension of Additional Tumor in Centimeters (cm)"
* $CAPeCCCodeSystem#19709.100004300 "Tumor Focality"
* $CAPeCCCodeSystem#379092.100004300 "Number of Tumors in Specimen"
* $CAPeCCCodeSystem#379097.100004300 "Nephrogenic Rests (Note D)"
* $CAPeCCCodeSystem#802562.100004300 "Evidence of Tumor Disruption (pre-operative rupture or intra-operative spillage) (Note D)"
* $CAPeCCCodeSystem#802566.100004300 "Renal Sinus Involvement by Viable Tumor"
* $CAPeCCCodeSystem#15232.100004300 "Renal Vein Involvement by Viable Tumor"
* $CAPeCCCodeSystem#36735.100004300 "Extension Beyond Renal Capsule by Viable Tumor"
* $CAPeCCCodeSystem#15235.100004300 "Direct Extension into Adjacent Organs by Viable Tumor"
* $CAPeCCCodeSystem#379098.100004300 "Posttherapy Histologic Classification of Favorable Histology Wilms Tumor"
* $CAPeCCCodeSystem#379553.100004300 "Tumor Comment"
* $CAPeCCCodeSystem#804593.100004300 "Margin Status"
* $CAPeCCCodeSystem#359406.100004300 "Closest Margin(s) to Tumor"
* $CAPeCCCodeSystem#359410.100004300 "Distance from Tumor to Closest Margin"
* $CAPeCCCodeSystem#804596.100004300 "Margin(s) Involved by Viable or Non-Viable Tumor"
* $CAPeCCCodeSystem#379554.100004300 "Margin Comment"
* $CAPeCCCodeSystem#374376.100004300 "Regional Lymph Node Status"
* $CAPeCCCodeSystem#14467.100004300 "Number of Lymph Nodes with Tumor"
* $CAPeCCCodeSystem#379099.100004300 "?Nodal Site(s) with Tumor, if known"
* $CAPeCCCodeSystem#14464.100004300 "Number of Lymph Nodes Examined"
* $CAPeCCCodeSystem#379555.100004300 "Regional Lymph Node Comment"
* $CAPeCCCodeSystem#804611.100004300 "?Distant Site(s) Involved by Viable or Non-Viable Tumor, if applicable"
* $CAPeCCCodeSystem#15276.100004300 "Childrens Oncology Group Staging System for Pediatric Renal Tumors Other Than Renal Cell Carcinoma (Note F)"
* $CAPeCCCodeSystem#15304.100004300 "Right Kidney Stage"
* $CAPeCCCodeSystem#15309.100004300 "Left Kidney Stage"
* $CAPeCCCodeSystem#802571.100004300 "Relevant Immunohistochemistry (Note C)"
* $CAPeCCCodeSystem#802575.100004300 "Ancillary Studies (Note G)"
* $CAPeCCCodeSystem#15314.100004300 "Additional Findings (specify) (Notes G, H)"
* $CAPeCCCodeSystem#15315.100004300 "?Comment(s)"
* $CAPeCCCodeSystem#379509.100004300 "Procedure"
* $CAPeCCCodeSystem#760967.100004300 "Histologic Type (Note B)"
* $CAPeCCCodeSystem#51668.100004300 "Histologic Type Comment"
* $CAPeCCCodeSystem#5027.100004300 "Histologic Grade (Note C)"
* $CAPeCCCodeSystem#5009.100004300 "Tumor Focality"
* $CAPeCCCodeSystem#43019.100004300 "Tumor Identification"
* $CAPeCCCodeSystem#40138.100004300 "Tumor Site"
* $CAPeCCCodeSystem#35879.100004300 "Tumor Size"
* $CAPeCCCodeSystem#35873.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#35962.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#48880.100004300 "Greatest Dimension of Tumor on Gross Exam in Centimeters (cm)"
* $CAPeCCCodeSystem#53125.100004300 "Treatment Effect"
* $CAPeCCCodeSystem#379514.100004300 "Extent of Tumor Necrosis (%)"
* $CAPeCCCodeSystem#45823.100004300 "Satellitosis"
* $CAPeCCCodeSystem#50260.100004300 "Tumor Extent"
* $CAPeCCCodeSystem#379511.100004300 "Vascular Invasion (Note E)"
* $CAPeCCCodeSystem#18892.100004300 "Perineural Invasion"
* $CAPeCCCodeSystem#379513.100004300 "Tumor Comment"
* $CAPeCCCodeSystem#367033.100004300 "Margin Status"
* $CAPeCCCodeSystem#367039.100004300 "Closest Margin(s) to Invasive Carcinoma"
* $CAPeCCCodeSystem#367044.100004300 "Distance from Invasive Carcinoma to Closest Margin"
* $CAPeCCCodeSystem#367052.100004300 "Margin(s) Involved by Invasive Carcinoma"
* $CAPeCCCodeSystem#367049.100004300 "Margin Comment"
* $CAPeCCCodeSystem#374378.100004300 "Regional Lymph Node Status"
* $CAPeCCCodeSystem#57459.100004300 "Number of Lymph Nodes with Tumor"
* $CAPeCCCodeSystem#40410.100004300 "Number of Lymph Nodes Examined"
* $CAPeCCCodeSystem#358474.100004300 "Regional Lymph Node Comment"
* $CAPeCCCodeSystem#356496.100004300 "?Distant Site(s) Involved, if applicable"
* $CAPeCCCodeSystem#18899.100004300 "?TNM Descriptors"
* $CAPeCCCodeSystem#327833.100004300 "pT Category"
* $CAPeCCCodeSystem#327835.100004300 "pN Category"
* $CAPeCCCodeSystem#5049.100004300 "?pM Category (required only if confirmed pathologically)"
* $CAPeCCCodeSystem#46716.100004300 "Additional Findings"
* $CAPeCCCodeSystem#18905.100004300 "Ancillary Studies (specify)"
* $CAPeCCCodeSystem#5085.100004300 "?Comment(s)"
* $CAPeCCCodeSystem#702225.100004300 "Expert Consultation (Note A)"
* $CAPeCCCodeSystem#41135.100004300 "Procedure (Note B)"
* $CAPeCCCodeSystem#58138.100004300 "Tumor Focality (within liver)"
* $CAPeCCCodeSystem#42426.100004300 "Tumor Site"
* $CAPeCCCodeSystem#804022.100004300 "Histologic Type (Note C)"
* $CAPeCCCodeSystem#379156.100004300 "Histologic Type Comment"
* $CAPeCCCodeSystem#52210.100004300 "Additional Findings (Note D)"
* $CAPeCCCodeSystem#57992.100004300 "Serum Alpha-Fetoprotein (AFP) Level at Diagnosis (Note E)"
* $CAPeCCCodeSystem#804653.100004300 "Beta-catenin IHC"
* $CAPeCCCodeSystem#379166.100004300 "Glypican-3 IHC"
* $CAPeCCCodeSystem#46079.100004300 "Pattern of Glypican-3 IHC Staining"
* $CAPeCCCodeSystem#379169.100004300 "INI-1 IHC"
* $CAPeCCCodeSystem#379172.100004300 "Other Ancillary Studies (specify)"
* $CAPeCCCodeSystem#53438.100004300 "?Comment(s)"
* $CAPeCCCodeSystem#702254.100004300 "Expert Consultation (Note A)"
* $CAPeCCCodeSystem#36631.100004300 "Preoperative Treatment"
* $CAPeCCCodeSystem#59297.100004300 "Procedure (Note B)"
* $CAPeCCCodeSystem#4712.100004300 "Tumor Focality (within liver)"
* $CAPeCCCodeSystem#1769.100004300 "Tumor Site"
* $CAPeCCCodeSystem#4716.100004300 "Tumor Size (specify for each nodule)"
* $CAPeCCCodeSystem#4719.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#4720.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#802686.100004300 "Histologic Type (Note C)"
* $CAPeCCCodeSystem#802688.100004300 "?Post Treatment Histologic Type (required only if preoperative therapy was given) (Note D)"
* $CAPeCCCodeSystem#379177.100004300 "Histologic Type Comment"
* $CAPeCCCodeSystem#379178.100004300 "Macroscopic Extent of Tumor"
* $CAPeCCCodeSystem#804635.100004300 "Macroscopic Vascular Invasion (Note E)"
* $CAPeCCCodeSystem#36648.100004300 "Microscopic Lymphatic and / or Vascular Invasion (Note E)"
* $CAPeCCCodeSystem#36638.100004300 "Treatment Effect (Note D)"
* $CAPeCCCodeSystem#804636.100004300 "Percentage of Treatment Effect"
* $CAPeCCCodeSystem#379556.100004300 "Tumor Comment"
* $CAPeCCCodeSystem#358990.100004300 "Resection Margin Status"
* $CAPeCCCodeSystem#358999.100004300 "Closest Resection Margin(s) to Tumor"
* $CAPeCCCodeSystem#359001.100004300 "Distance from Tumor to Closest Resection Margin"
* $CAPeCCCodeSystem#359010.100004300 "Resection Margin(s) Involved by Tumor"
* $CAPeCCCodeSystem#359034.100004300 "Margin Comment"
* $CAPeCCCodeSystem#820606.100004300 "Capsular Surface Status"
* $CAPeCCCodeSystem#374380.100004300 "Regional Lymph Node Status"
* $CAPeCCCodeSystem#6869.100004300 "Number of Lymph Nodes with Tumor"
* $CAPeCCCodeSystem#359076.100004300 "?Nodal Site(s) with Tumor, if known"
* $CAPeCCCodeSystem#379187.100004300 "Histologic Type Present in Involved Node(s)"
* $CAPeCCCodeSystem#6866.100004300 "Number of Lymph Nodes Examined"
* $CAPeCCCodeSystem#365169.100004300 "Regional Lymph Node Comment"
* $CAPeCCCodeSystem#359082.100004300 "?Distant Site(s) Involved, if applicable"
* $CAPeCCCodeSystem#380115.100004300 "Histologic Type Present in Distant Metastasis"
* $CAPeCCCodeSystem#826965.100004300 "Additional Findings (Note H)"
* $CAPeCCCodeSystem#41645.100004300 "Serum Alpha-Fetoprotein (AFP) Level at Diagnosis (Note I)"
* $CAPeCCCodeSystem#804652.100004300 "Beta-catenin IHC"
* $CAPeCCCodeSystem#379217.100004300 "Glypican-3 IHC"
* $CAPeCCCodeSystem#58393.100004300 "Pattern of Glypican-3 IHC Staining"
* $CAPeCCCodeSystem#379218.100004300 "INI-1 IHC"
* $CAPeCCCodeSystem#379208.100004300 "Other Ancillary Studies (specify)"
* $CAPeCCCodeSystem#4798.100004300 "?Comment(s)"
* $CAPeCCCodeSystem#381632.100004300 "Adequacy of Sample for Testing"
* $CAPeCCCodeSystem#381630.100004300 "Specify Estimated Percent of Tumor Cellularity (area used for testing)"
* $CAPeCCCodeSystem#381624.100004300 "Specimen Type"
* $CAPeCCCodeSystem#381701.100004300 "Mutational Analysis"
* $CAPeCCCodeSystem#381659.100004300 "EGFR L858R by Immunohistochemistry (clone 43B2)"
* $CAPeCCCodeSystem#381636.100004300 "EGFR Exon 19 Deletion (E746_A750del) (clone 6B6)"
* $CAPeCCCodeSystem#381807.100004300 "Interpretation"
* $CAPeCCCodeSystem#381696.100004300 "Rearrangement by Molecular Methods"
* $CAPeCCCodeSystem#381652.100004300 "ALK Immunohistochemistry"
* $CAPeCCCodeSystem#381811.100004300 "Interpretation"
* $CAPeCCCodeSystem#381656.100004300 "Rearrangement by Molecular Methods"
* $CAPeCCCodeSystem#381643.100004300 "ROS1 by Immunohistochemistry"
* $CAPeCCCodeSystem#381816.100004300 "Interpretation"
* $CAPeCCCodeSystem#381645.100004300 "Rearrangement by Molecular Methods"
* $CAPeCCCodeSystem#540509.100004300 "Interpretation"
* $CAPeCCCodeSystem#381715.100004300 "Mutational Analysis"
* $CAPeCCCodeSystem#381821.100004300 "Interpretation"
* $CAPeCCCodeSystem#381682.100004300 "Mutational Analysis"
* $CAPeCCCodeSystem#540511.100004300 "Interpretation"
* $CAPeCCCodeSystem#381681.100004300 "Mutational Analysis"
* $CAPeCCCodeSystem#381826.100004300 "Copy Number Analysis"
* $CAPeCCCodeSystem#381827.100004300 "HER2 immunohistochemistry"
* $CAPeCCCodeSystem#381837.100004300 "Interpretation"
* $CAPeCCCodeSystem#381667.100004300 "Mutational Analysis"
* $CAPeCCCodeSystem#381671.100004300 "Copy Number Analysis"
* $CAPeCCCodeSystem#381841.100004300 "Interpretation"
* $CAPeCCCodeSystem#381738.100004300 "Rearrangement by Molecular Methods"
* $CAPeCCCodeSystem#381739.100004300 "NTRK by immunohistochemistry"
* $CAPeCCCodeSystem#381844.100004300 "Interpretation"
* $CAPeCCCodeSystem#381753.100004300 "Immunohistochemistry (IHC) Testing for Mismatch Repair (MMR) Proteins"
* $CAPeCCCodeSystem#381776.100004300 "MLH1 Result"
* $CAPeCCCodeSystem#381777.100004300 "MSH2 Result"
* $CAPeCCCodeSystem#381778.100004300 "MSH6 Result"
* $CAPeCCCodeSystem#381779.100004300 "PMS2 Result"
* $CAPeCCCodeSystem#381771.100004300 "Microsatellite Instability (MSI)"
* $CAPeCCCodeSystem#381848.100004300 "Interpretation"
* $CAPeCCCodeSystem#381747.100004300 "Specify Tumor Mutational Burden"
* $CAPeCCCodeSystem#381748.100004300 "Tumor Mutational Burden Level"
* $CAPeCCCodeSystem#381851.100004300 "Interpretation"
* $CAPeCCCodeSystem#381788.100004300 "PD-L1 IHC Interpretation"
* $CAPeCCCodeSystem#381786.100004300 "Specify Percentage of Tumor Cells with Staining (TPS)"
* $CAPeCCCodeSystem#381787.100004300 "Combined Number of Tumor and Immune Cells with Staining per 100 Tumor Cells (CPS)"
* $CAPeCCCodeSystem#381799.100004300 "Specify Percentage of Tumor-associated Immune Cells with Staining"
* $CAPeCCCodeSystem#381800.100004300 "Specify Percentage of Tumor Area Occupied by Tumor-associated Immune Cells"
* $CAPeCCCodeSystem#381803.100004300 "Comments"
* $CAPeCCCodeSystem#381781.100004300 "Antibody"
* $CAPeCCCodeSystem#381794.100004300 "Controls"
* $CAPeCCCodeSystem#381791.100004300 "Assay Information"
* $CAPeCCCodeSystem#381805.100004300 "Specify Quantitative Imaging Analytics Performed"
* $CAPeCCCodeSystem#381716.100004300 "Specify Other Marker and Results"
* $CAPeCCCodeSystem#29823.100004300 "?Comment(s)"
* $CAPeCCCodeSystem#43094.100004300 "?Synchronous Tumors (required if morphologically distinct unrelated multiple primary tumors are present)"
* $CAPeCCCodeSystem#41677.100004300 "Total Number of Primary Tumors"
* $CAPeCCCodeSystem#41680.100004300 "Specimen ID(s)"
* $CAPeCCCodeSystem#55856.100004300 "Procedure"
* $CAPeCCCodeSystem#1693.100004300 "Specimen Laterality"
* $CAPeCCCodeSystem#41711.100004300 "Tumor Focality (Note D)"
* $CAPeCCCodeSystem#41714.100004300 "Number of Intrapulmonary Metastases"
* $CAPeCCCodeSystem#41846.100004300 "Number of Intrapulmonary Metastases"
* $CAPeCCCodeSystem#43563.100004300 "Number of Distant Metastases"
* $CAPeCCCodeSystem#379976.100004300 "Number of Tumor Nodules"
* $CAPeCCCodeSystem#54193.100004300 "Tumor Site"
* $CAPeCCCodeSystem#43111.100004300 "Total Tumor Size (size of entire tumor)#"
* $CAPeCCCodeSystem#43122.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#43128.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#41688.100004300 "?Size of Invasive Component## (required only if invasive nonmucinous adenocarcinomas with lepidic component is present)"
* $CAPeCCCodeSystem#43145.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#43154.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#379873.100004300 "Percentage of Total Tumor Size (above)"
* $CAPeCCCodeSystem#372396.100004300 "Histologic Type (Note A)"
* $CAPeCCCodeSystem#759336.100004300 "Histologic Component(s) Present (may include percentages)"
* $CAPeCCCodeSystem#759343.100004300 "?Histologic Patterns Present (may include percentages in 5-10% increments totaling 100%)#"
* $CAPeCCCodeSystem#33392.100004300 "Histologic Type Comment"
* $CAPeCCCodeSystem#1731.100004300 "Histologic Grade (Note B)"
* $CAPeCCCodeSystem#35936.100004300 "Spread Through Air Spaces (STAS) (Note A)"
* $CAPeCCCodeSystem#15671.100004300 "Visceral Pleura Invasion (Note E)"
* $CAPeCCCodeSystem#379975.100004300 "Direct Invasion of Adjacent Structures (Note F)"
* $CAPeCCCodeSystem#379988.100004300 "Involved Adjacent Structures"
* $CAPeCCCodeSystem#372407.100004300 "Treatment Effect (Note G)"
* $CAPeCCCodeSystem#372409.100004300 "Percentage of Residual Viable Tumor"
* $CAPeCCCodeSystem#372412.100004300 "Percentage of Necrosis"
* $CAPeCCCodeSystem#372411.100004300 "Percentage of Stroma (includes fibrosis and inflammation)"
* $CAPeCCCodeSystem#545136.100004300 "Lymphovascular Invasion"
* $CAPeCCCodeSystem#379564.100004300 "Tumor Comment"
* $CAPeCCCodeSystem#356773.100004300 "Margin Status for Invasive Carcinoma"
* $CAPeCCCodeSystem#356784.100004300 "Closest Margin(s) to Invasive Carcinoma"
* $CAPeCCCodeSystem#356789.100004300 "Distance from Invasive Carcinoma to Closest Margin"
* $CAPeCCCodeSystem#356779.100004300 "Margin(s) Involved by Invasive Carcinoma"
* $CAPeCCCodeSystem#356799.100004300 "Margin Status for Non-Invasive Tumor"
* $CAPeCCCodeSystem#356823.100004300 "Margin Comment"
* $CAPeCCCodeSystem#374388.100004300 "Lymph Node(s) from Prior Procedures"
* $CAPeCCCodeSystem#374435.100004300 "Prior Lymph Node Procedure(s) Included (describe and specify case ID)"
* $CAPeCCCodeSystem#374382.100004300 "Regional Lymph Node Status"
* $CAPeCCCodeSystem#33448.100004300 "Number of Lymph Nodes with Tumor"
* $CAPeCCCodeSystem#33426.100004300 "Nodal Site(s) with Tumor"
* $CAPeCCCodeSystem#54482.100004300 "Extranodal Extension (Note J)"
* $CAPeCCCodeSystem#33444.100004300 "Number of Lymph Nodes Examined"
* $CAPeCCCodeSystem#33450.100004300 "Nodal Site(s) Examined"
* $CAPeCCCodeSystem#358329.100004300 "Regional Lymph Node Comment"
* $CAPeCCCodeSystem#357454.100004300 "?Distant Site(s) Involved, if applicable"
* $CAPeCCCodeSystem#15994.100004300 "?TNM Descriptors"
* $CAPeCCCodeSystem#327868.100004300 "pT Category"
* $CAPeCCCodeSystem#327870.100004300 "pN Category"
* $CAPeCCCodeSystem#47348.100004300 "?pM Category (required only if confirmed pathologically)"
* $CAPeCCCodeSystem#45910.100004300 "Additional Findings"
* $CAPeCCCodeSystem#1804.100004300 "?Comment(s)"
* $CAPeCCCodeSystem#702232.100004300 "Expert Consultation (Note A)"
* $CAPeCCCodeSystem#39930.100004300 "Patient Age"
* $CAPeCCCodeSystem#49187.100004300 "Procedure (Note B)"
* $CAPeCCCodeSystem#802649.100004300 "Tissue Allocation (Note B)"
* $CAPeCCCodeSystem#58576.100004300 "Tumor Site (Note C)"
* $CAPeCCCodeSystem#802654.100004300 "Histologic Type (Note D)"
* $CAPeCCCodeSystem#380126.100004300 "Number of Nodules"
* $CAPeCCCodeSystem#352630.100004300 "Nodular Subtype(s) (repeat for each nodule)"
* $CAPeCCCodeSystem#48861.100004300 "Histologic Type Comment"
* $CAPeCCCodeSystem#37408.100004300 "?Degree of Differentiation (neuroblastic component) (Note E)"
* $CAPeCCCodeSystem#53292.100004300 "Mitotic-Karyorrhectic Index (MKI) (Note F)"
* $CAPeCCCodeSystem#379560.100004300 "Tumor Comment"
* $CAPeCCCodeSystem#45609.100004300 "International Neuroblastoma Pathology Classification (INPC) (Note G)"
* $CAPeCCCodeSystem#47398.100004300 "Additional Findings (specify) (Notes H, I)"
* $CAPeCCCodeSystem#49170.100004300 "?MYCN Amplification Status (required for all tumors except ganglioneuroma) (Note K)"
* $CAPeCCCodeSystem#802659.100004300 "Molecular Genetic Studies (Note K)"
* $CAPeCCCodeSystem#802660.100004300 "Method for Molecular Genetic Studies"
* $CAPeCCCodeSystem#54540.100004300 "Other Ancillary Studies (specify) (Note K)"
* $CAPeCCCodeSystem#50518.100004300 "?Comment(s)"
* $CAPeCCCodeSystem#702259.100004300 "Expert Consultation (Note A)"
* $CAPeCCCodeSystem#19056.100004300 "Treatment History (Note B)"
* $CAPeCCCodeSystem#19066.100004300 "Patient Age"
* $CAPeCCCodeSystem#802630.100004300 "Tissue Allocation (Note B)"
* $CAPeCCCodeSystem#56910.100004300 "Procedure"
* $CAPeCCCodeSystem#50753.100004300 "Tumor Site (Note C)"
* $CAPeCCCodeSystem#5210.100004300 "Tumor Size"
* $CAPeCCCodeSystem#5213.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#5214.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#59887.100004300 "Histologic Type (Notes D, E)"
* $CAPeCCCodeSystem#380140.100004300 "Number of Nodules"
* $CAPeCCCodeSystem#352629.100004300 "Nodular Subtype(s) (repeat for each nodule)"
* $CAPeCCCodeSystem#379558.100004300 "Histologic Type Comment"
* $CAPeCCCodeSystem#19085.100004300 "?Degree of Differentiation (Note F)"
* $CAPeCCCodeSystem#19091.100004300 "?Mitotic-Karyorrhectic Index (MKI) (Note G)"
* $CAPeCCCodeSystem#36483.100004300 "Treatment Effect# (Note D)"
* $CAPeCCCodeSystem#804633.100004300 "Percentage of Treatment Effect"
* $CAPeCCCodeSystem#804634.100004300 "Percentage of Therapy-Induced Maturation / Cytodifferentiation"
* $CAPeCCCodeSystem#379559.100004300 "Tumor Comment"
* $CAPeCCCodeSystem#374384.100004300 "Regional Lymph Node Status"
* $CAPeCCCodeSystem#10259.100004300 "Number of Lymph Nodes with Tumor"
* $CAPeCCCodeSystem#359126.100004300 "?Nodal Site(s) with Tumor, if known"
* $CAPeCCCodeSystem#10256.100004300 "Number of Lymph Nodes Examined"
* $CAPeCCCodeSystem#365182.100004300 "Regional Lymph Node Comment"
* $CAPeCCCodeSystem#379681.100004300 "?Distant Site(s) Involved, if applicable"
* $CAPeCCCodeSystem#52568.100004300 "?International Neuroblastoma Pathology Classification (INPC) (report if not previously treated) (Note H)"
* $CAPeCCCodeSystem#2947.100004300 "Additional Findings (specify) (Notes I, J)"
* $CAPeCCCodeSystem#19055.100004300 "?MYCN Amplification Status (for all tumors except ganglioneuroma or post-therapy resection specimens) (Note L)"
* $CAPeCCCodeSystem#802636.100004300 "Molecular Genetic Studies (Note L)"
* $CAPeCCCodeSystem#802637.100004300 "Method for Molecular Genetic Studies"
* $CAPeCCCodeSystem#36723.100004300 "Other Ancillary Studies (specify) (Notes K, L)"
* $CAPeCCCodeSystem#5282.100004300 "?Comment(s)"
* $CAPeCCCodeSystem#38445.100004300 "Clinical History"
* $CAPeCCCodeSystem#38447.100004300 "Procedure"
* $CAPeCCCodeSystem#38489.100004300 "Hysterectomy Type"
* $CAPeCCCodeSystem#381606.100004300 "Specimen Integrity"
* $CAPeCCCodeSystem#38501.100004300 "Right Ovary Integrity"
* $CAPeCCCodeSystem#38469.100004300 "Left Ovary Integrity"
* $CAPeCCCodeSystem#379632.100004300 "Ovary Integrity"
* $CAPeCCCodeSystem#49518.100004300 "Right Fallopian Tube Integrity"
* $CAPeCCCodeSystem#45651.100004300 "Left Fallopian Tube Integrity"
* $CAPeCCCodeSystem#379640.100004300 "Fallopian Tube Integrity"
* $CAPeCCCodeSystem#379647.100004300 "Uterus Integrity"
* $CAPeCCCodeSystem#38526.100004300 "Tumor Site (Notes C, D, E)"
* $CAPeCCCodeSystem#56978.100004300 "Tumor Size"
* $CAPeCCCodeSystem#54296.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#51542.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#847313.100004300 "Histologic Type (Notes F, G)"
* $CAPeCCCodeSystem#38600.100004300 "Histologic Type Comment"
* $CAPeCCCodeSystem#348534.100004300 "?Histologic Grade (required for serous, endometrioid, mucinous, and seromucinous carcinomas, immature teratomas, and Sertoli-Leydig cell tumors)# (Note H)"
* $CAPeCCCodeSystem#379652.100004300 "?Ovarian Surface Involvement (required only if applicable)"
* $CAPeCCCodeSystem#379660.100004300 "?Fallopian Tube Surface Involvement (required only if applicable)"
* $CAPeCCCodeSystem#38685.100004300 "?Implants (required for advanced stage serous / seromucinous borderline tumors only)# (Note I)"
* $CAPeCCCodeSystem#53686.100004300 "Other Tissue / Organ Involvement"
* $CAPeCCCodeSystem#49733.100004300 "?Largest Extrapelvic Peritoneal Focus (required only if applicable)"
* $CAPeCCCodeSystem#348291.100004300 "Peritoneal / Ascitic Fluid Involvement (Note J)"
* $CAPeCCCodeSystem#379668.100004300 "?Chemotherapy Response Score (CRS) (required only if applicable) (Note K)"
* $CAPeCCCodeSystem#379532.100004300 "Tumor Comment"
* $CAPeCCCodeSystem#374386.100004300 "Regional Lymph Node Status#"
* $CAPeCCCodeSystem#39074.100004300 "Number of Nodes with Metastasis Greater than 10 mm"
* $CAPeCCCodeSystem#38721.100004300 "Number of Nodes with Metastasis 10 mm or Less (excluding isolated tumor cells)"
* $CAPeCCCodeSystem#42027.100004300 "?Number of Nodes with Isolated Tumor Cells (ITCs) (0.2 mm or less) (required only if applicable)#"
* $CAPeCCCodeSystem#39783.100004300 "Nodal Site(s) with Tumor"
* $CAPeCCCodeSystem#348528.100004300 "Size of Largest Nodal Metastatic Deposit"
* $CAPeCCCodeSystem#348318.100004300 "Location of Largest Nodal Metastatic Deposit"
* $CAPeCCCodeSystem#38730.100004300 "Number of Lymph Nodes Examined"
* $CAPeCCCodeSystem#52472.100004300 "Nodal Site(s) Examined"
* $CAPeCCCodeSystem#358321.100004300 "Regional Lymph Node Comment"
* $CAPeCCCodeSystem#348300.100004300 "?Distant Site(s) Involved, if applicable#"
* $CAPeCCCodeSystem#847238.100004300 "?Modified Classification (required only if applicable)"
* $CAPeCCCodeSystem#526323.100004300 "pT Category"
* $CAPeCCCodeSystem#847240.100004300 "?T Suffix (required only if applicable)"
* $CAPeCCCodeSystem#327695.100004300 "pN Category#"
* $CAPeCCCodeSystem#847243.100004300 "?N Suffix (required only if applicable)"
* $CAPeCCCodeSystem#58430.100004300 "?pM Category (required only if confirmed pathologically)"
* $CAPeCCCodeSystem#847239.100004300 "FIGO Stage (2018 FIGO Cancer Report)"
* $CAPeCCCodeSystem#38859.100004300 "Additional Findings"
* $CAPeCCCodeSystem#366664.100004300 "p53 Immunohistochemistry"
* $CAPeCCCodeSystem#38845.100004300 "?Comment(s)"
* $CAPeCCCodeSystem#19535.100004300 "Clinical History"
* $CAPeCCCodeSystem#379431.100004300 "Functional Type of Pancreatic Neuroendocrine Tumor (Note B)"
* $CAPeCCCodeSystem#51985.100004300 "Procedure"
* $CAPeCCCodeSystem#45743.100004300 "Tumor Site (Note D)"
* $CAPeCCCodeSystem#939948.100004300 "Histologic Type and Grade# (Notes E, F)"
* $CAPeCCCodeSystem#35633.100004300 "Histologic Type and Grade Comment"
* $CAPeCCCodeSystem#379413.100004300 "?Mitotic Rate (required only when Ki-67 labeling index is not reported)#"
* $CAPeCCCodeSystem#379414.100004300 "?Ki-67 Labeling Index (required only when mitotic rate is not reported)"
* $CAPeCCCodeSystem#5555.100004300 "Tumor Size (Note G)"
* $CAPeCCCodeSystem#5559.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#5558.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#5544.100004300 "Tumor Focality (Note H)"
* $CAPeCCCodeSystem#379419.100004300 "Number of Tumors"
* $CAPeCCCodeSystem#379405.100004300 "Site(s) Involved by Direct Tumor Extension"
* $CAPeCCCodeSystem#5609.100004300 "Lymphatic and / or Vascular Invasion (Note I)"
* $CAPeCCCodeSystem#5613.100004300 "Perineural Invasion (Note J)"
* $CAPeCCCodeSystem#19513.100004300 "Tumor Necrosis (Note K)"
* $CAPeCCCodeSystem#379389.100004300 "Tumor Comment"
* $CAPeCCCodeSystem#366266.100004300 "Margin Status"
* $CAPeCCCodeSystem#366272.100004300 "Closest Margin(s) to Tumor"
* $CAPeCCCodeSystem#366277.100004300 "Distance from Tumor to Closest Margin"
* $CAPeCCCodeSystem#366285.100004300 "Margin(s) Involved by Tumor"
* $CAPeCCCodeSystem#366282.100004300 "Margin Comment"
* $CAPeCCCodeSystem#374417.100004300 "Regional Lymph Node Status"
* $CAPeCCCodeSystem#33899.100004300 "Number of Lymph Nodes with Tumor"
* $CAPeCCCodeSystem#33903.100004300 "Number of Lymph Nodes Examined"
* $CAPeCCCodeSystem#358489.100004300 "Regional Lymph Node Comment"
* $CAPeCCCodeSystem#359145.100004300 "?Distant Site(s) Involved, if applicable"
* $CAPeCCCodeSystem#938177.100004300 "?Modified Classification (required only if applicable)"
* $CAPeCCCodeSystem#938159.100004300 "pT Category#"
* $CAPeCCCodeSystem#938179.100004300 "?T Suffix (required only if applicable)"
* $CAPeCCCodeSystem#938164.100004300 "pN Category"
* $CAPeCCCodeSystem#938172.100004300 "?pM Category (required only if confirmed pathologically)"
* $CAPeCCCodeSystem#48765.100004300 "Additional Findings"
* $CAPeCCCodeSystem#5627.100004300 "?Comment(s)"
* $CAPeCCCodeSystem#53655.100004300 "Procedure"
* $CAPeCCCodeSystem#37075.100004300 "Tumor Site (Note B)"
* $CAPeCCCodeSystem#49042.100004300 "Histologic Type (Note C)"
* $CAPeCCCodeSystem#35565.100004300 "Histologic Type Comment"
* $CAPeCCCodeSystem#44970.100004300 "?Histologic Grade (ductal carcinoma only) (Note D)"
* $CAPeCCCodeSystem#5646.100004300 "Tumor Size"
* $CAPeCCCodeSystem#5649.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#5650.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#379521.100004300 "Site(s) Involved by Direct Tumor Extension"
* $CAPeCCCodeSystem#34017.100004300 "Pancreatic Surface Involvement"
* $CAPeCCCodeSystem#379519.100004300 "Treatment Effect (Note E)"
* $CAPeCCCodeSystem#5720.100004300 "Lymphovascular Invasion (Note F)"
* $CAPeCCCodeSystem#5724.100004300 "Perineural Invasion (Note G)"
* $CAPeCCCodeSystem#379518.100004300 "Tumor Comment"
* $CAPeCCCodeSystem#366965.100004300 "Margin Status for Invasive Carcinoma"
* $CAPeCCCodeSystem#366971.100004300 "Closest Margin(s) to Invasive Carcinoma"
* $CAPeCCCodeSystem#366976.100004300 "Distance from Invasive Carcinoma to Closest Margin"
* $CAPeCCCodeSystem#366983.100004300 "Margin(s) Involved by Invasive Carcinoma"
* $CAPeCCCodeSystem#366993.100004300 "Margin Status for Dysplasia and Intraepithelial Neoplasia"
* $CAPeCCCodeSystem#366999.100004300 "Margin(s) Involved by Pancreatic High-Grade Intraepithelial Neoplasia"
* $CAPeCCCodeSystem#367016.100004300 "Margin(s) Involved by High-Grade Dysplasia"
* $CAPeCCCodeSystem#366981.100004300 "Margin Comment"
* $CAPeCCCodeSystem#374419.100004300 "Regional Lymph Node Status"
* $CAPeCCCodeSystem#34190.100004300 "Number of Lymph Nodes with Tumor"
* $CAPeCCCodeSystem#34189.100004300 "Number of Lymph Nodes Examined"
* $CAPeCCCodeSystem#358477.100004300 "Regional Lymph Node Comment"
* $CAPeCCCodeSystem#356486.100004300 "?Distant Site(s) Involved, if applicable"
* $CAPeCCCodeSystem#19289.100004300 "?TNM Descriptors"
* $CAPeCCCodeSystem#327704.100004300 "pT Category#"
* $CAPeCCCodeSystem#327705.100004300 "pN Category"
* $CAPeCCCodeSystem#5698.100004300 "?pM Category (required only if confirmed pathologically)"
* $CAPeCCCodeSystem#5727.100004300 "Additional Findings"
* $CAPeCCCodeSystem#19293.100004300 "Ancillary Studies (Note K) (specify)"
* $CAPeCCCodeSystem#5738.100004300 "?Comment(s)"
* $CAPeCCCodeSystem#891280.100004300 "Procedure (Notes A, B)"
* $CAPeCCCodeSystem#16129.100004300 "Foreskin (presence and type) (Note C)"
* $CAPeCCCodeSystem#42434.100004300 "Tumor Focality (Note D)"
* $CAPeCCCodeSystem#40793.100004300 "Tumor Site (Note E)"
* $CAPeCCCodeSystem#16268.100004300 "Tumor Macroscopic Features (Note F)"
* $CAPeCCCodeSystem#39648.100004300 "Tumor Size (Note G)"
* $CAPeCCCodeSystem#16193.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#16194.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#891292.100004300 "Histologic Type (Notes H, I)"
* $CAPeCCCodeSystem#50159.100004300 "Histologic Type Comment"
* $CAPeCCCodeSystem#16170.100004300 "Histologic Grade (Note J)"
* $CAPeCCCodeSystem#891568.100004300 "Tumor Depth of Invasion / Thickness (Note K)"
* $CAPeCCCodeSystem#891318.100004300 "Tumor Deep Borders (Notes L, M)"
* $CAPeCCCodeSystem#891324.100004300 "Tumor Extent (Note N)"
* $CAPeCCCodeSystem#16281.100004300 "Lymphatic and / or Vascular Invasion (Note O)"
* $CAPeCCCodeSystem#17017.100004300 "Perineural Invasion (Note P)"
* $CAPeCCCodeSystem#379574.100004300 "Tumor Comment"
* $CAPeCCCodeSystem#365501.100004300 "Margin Status for Invasive Carcinoma"
* $CAPeCCCodeSystem#365507.100004300 "Closest Margin(s) to Invasive Carcinoma"
* $CAPeCCCodeSystem#365512.100004300 "Distance from Invasive Carcinoma to Closest Margin"
* $CAPeCCCodeSystem#365537.100004300 "Margin(s) Involved by Invasive Carcinoma"
* $CAPeCCCodeSystem#365571.100004300 "Margin Status for Noninvasive Carcinoma / Carcinoma in Situ"
* $CAPeCCCodeSystem#365652.100004300 "Margin(s) Involved by Noninvasive Carcinoma / Carcinoma in Situ"
* $CAPeCCCodeSystem#365532.100004300 "Margin Comment"
* $CAPeCCCodeSystem#374421.100004300 "Regional Lymph Node Status"
* $CAPeCCCodeSystem#41749.100004300 "Number of Lymph Nodes with Tumor"
* $CAPeCCCodeSystem#46830.100004300 "Nodal Site(s) with Tumor"
* $CAPeCCCodeSystem#47033.100004300 "Number of Inguinal Lymph Nodes with Tumor"
* $CAPeCCCodeSystem#56981.100004300 "Laterality of Inguinal Lymph Node(s) with Tumor"
* $CAPeCCCodeSystem#365661.100004300 "Size of Largest Nodal Metastatic Deposit"
* $CAPeCCCodeSystem#45914.100004300 "Nodal Site with Largest Metastatic Deposit (specify site)"
* $CAPeCCCodeSystem#365655.100004300 "Size of Largest Lymph Node with Tumor"
* $CAPeCCCodeSystem#50385.100004300 "Largest Lymph Node with Tumor (specify site)"
* $CAPeCCCodeSystem#55211.100004300 "Extranodal Extension"
* $CAPeCCCodeSystem#48433.100004300 "Number of Lymph Nodes Examined"
* $CAPeCCCodeSystem#358472.100004300 "Regional Lymph Node Comment"
* $CAPeCCCodeSystem#891353.100004300 "?Distant Site(s) Involved, if applicable"
* $CAPeCCCodeSystem#891355.100004300 "?Modified Classification (required only if applicable)"
* $CAPeCCCodeSystem#327885.100004300 "pT Category"
* $CAPeCCCodeSystem#891356.100004300 "?T Suffix (required only if applicable)"
* $CAPeCCCodeSystem#327886.100004300 "pN Category"
* $CAPeCCCodeSystem#16377.100004300 "?pM Category (required only if confirmed pathologically)"
* $CAPeCCCodeSystem#891359.100004300 "Additional Findings"
* $CAPeCCCodeSystem#891365.100004300 "p16 Immunohistochemistry"
* $CAPeCCCodeSystem#891368.100004300 "HPV-ISH"
* $CAPeCCCodeSystem#16396.100004300 "Other Ancillary Studies"
* $CAPeCCCodeSystem#16484.100004300 "?Comment(s)"
* $CAPeCCCodeSystem#18593.100004300 "Clinical History"
* $CAPeCCCodeSystem#47595.100004300 "Procedure"
* $CAPeCCCodeSystem#17696.100004300 "Specimen Laterality"
* $CAPeCCCodeSystem#5839.100004300 "Tumor Focality (Note D)"
* $CAPeCCCodeSystem#5833.100004300 "Tumor Site"
* $CAPeCCCodeSystem#5844.100004300 "Tumor Size (for localized tumors only)"
* $CAPeCCCodeSystem#5847.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#5848.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#367529.100004300 "Histologic Type (Note B)"
* $CAPeCCCodeSystem#367536.100004300 "Architectural Pattern (may include percentages totaling 100%)"
* $CAPeCCCodeSystem#367543.100004300 "Cytological Features"
* $CAPeCCCodeSystem#367551.100004300 "Stromal Features"
* $CAPeCCCodeSystem#367554.100004300 "Cytological Features"
* $CAPeCCCodeSystem#367559.100004300 "Stromal Features"
* $CAPeCCCodeSystem#367564.100004300 "Percentage of Sarcomatoid Pattern"
* $CAPeCCCodeSystem#51777.100004300 "Histologic Type Comment"
* $CAPeCCCodeSystem#379040.100004300 "Nuclear Atypia Score"
* $CAPeCCCodeSystem#379041.100004300 "Mitotic Count Score"
* $CAPeCCCodeSystem#379042.100004300 "Nuclear Grade (sum of nuclear atypia and mitotic count scores)"
* $CAPeCCCodeSystem#379043.100004300 "Necrosis"
* $CAPeCCCodeSystem#379044.100004300 "Histologic Grade"
* $CAPeCCCodeSystem#50741.100004300 "Tumor Extent (Note E)"
* $CAPeCCCodeSystem#367566.100004300 "Treatment Effect (Note F)"
* $CAPeCCCodeSystem#367569.100004300 "Percentage of Residual Viable Tumor"
* $CAPeCCCodeSystem#379565.100004300 "Tumor Comment"
* $CAPeCCCodeSystem#5884.100004300 "Margin Status"
* $CAPeCCCodeSystem#358167.100004300 "Margin(s) Involved by Mesothelioma"
* $CAPeCCCodeSystem#358165.100004300 "Margin Comment"
* $CAPeCCCodeSystem#374423.100004300 "Regional Lymph Node Status"
* $CAPeCCCodeSystem#379905.100004300 "Nodal Site(s) with Tumor"
* $CAPeCCCodeSystem#46850.100004300 "Number of Lymph Nodes with Tumor"
* $CAPeCCCodeSystem#40541.100004300 "Number of Lymph Nodes Examined"
* $CAPeCCCodeSystem#358330.100004300 "Regional Lymph Node Comment"
* $CAPeCCCodeSystem#358179.100004300 "?Distant Site(s) Involved, if applicable"
* $CAPeCCCodeSystem#59960.100004300 "?TNM Descriptors"
* $CAPeCCCodeSystem#327895.100004300 "pT Category"
* $CAPeCCCodeSystem#327896.100004300 "pN Category"
* $CAPeCCCodeSystem#5876.100004300 "?pM Category (required only if confirmed pathologically)"
* $CAPeCCCodeSystem#5891.100004300 "Additional Findings"
* $CAPeCCCodeSystem#379913.100004300 "Immunohistochemistry (specify stains and results)"
* $CAPeCCCodeSystem#379914.100004300 "Histochemistry (specify stains and results)"
* $CAPeCCCodeSystem#379915.100004300 "Electron Microscopy (specify results)"
* $CAPeCCCodeSystem#379916.100004300 "Other Ancillary Studies (specify types and results)"
* $CAPeCCCodeSystem#5898.100004300 "?Comment(s)"
* $CAPeCCCodeSystem#22383.100004300 "Histologic Type"
* $CAPeCCCodeSystem#702239.100004300 "Expert Consultation (Note A)"
* $CAPeCCCodeSystem#24072.100004300 "Procedure (Note C)"
* $CAPeCCCodeSystem#15798.100004300 "Tumor Site"
* $CAPeCCCodeSystem#23922.100004300 "?Tumor Size (for excisional biopsy only)"
* $CAPeCCCodeSystem#23925.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#23926.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#23995.100004300 "Lymphovascular Invasion (Note D)"
* $CAPeCCCodeSystem#23988.100004300 "?Margin Status (for excisional biopsy only) (Note E)"
* $CAPeCCCodeSystem#353699.100004300 "Closest Margin(s) to Tumor"
* $CAPeCCCodeSystem#353704.100004300 "Distance from Tumor to Closest Margin"
* $CAPeCCCodeSystem#22991.100004300 "Margin(s) Involved by Tumor"
* $CAPeCCCodeSystem#358977.100004300 "Margin Comment"
* $CAPeCCCodeSystem#38001.100004300 "Immunohistochemistry (specify)"
* $CAPeCCCodeSystem#380152.100004300 "Cytogenetic Findings"
* $CAPeCCCodeSystem#36387.100004300 "?Method for Cytogenetic Studies"
* $CAPeCCCodeSystem#24094.100004300 "Additional Findings (specify)"
* $CAPeCCCodeSystem#24001.100004300 "?Comment(s)"
* $CAPeCCCodeSystem#22386.100004300 "Histologic Type"
* $CAPeCCCodeSystem#702266.100004300 "Expert Consultation (Note A)"
* $CAPeCCCodeSystem#22640.100004300 "Preresection Treatment"
* $CAPeCCCodeSystem#5902.100004300 "Procedure (Note C)"
* $CAPeCCCodeSystem#380265.100004300 "?Multiple Primary Sites"
* $CAPeCCCodeSystem#15796.100004300 "Tumor Site"
* $CAPeCCCodeSystem#5915.100004300 "Tumor Size (Note C)"
* $CAPeCCCodeSystem#5919.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#5918.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#371441.100004300 "Site(s) Involved by Direct Tumor Extension"
* $CAPeCCCodeSystem#5988.100004300 "Lymphovascular Invasion (Note D)"
* $CAPeCCCodeSystem#374329.100004300 "?Treatment Effect (Note E)"
* $CAPeCCCodeSystem#379877.100004300 "Percentage of Treatment Effect"
* $CAPeCCCodeSystem#379561.100004300 "Tumor Comment"
* $CAPeCCCodeSystem#5981.100004300 "Margin Status"
* $CAPeCCCodeSystem#353722.100004300 "Closest Margin(s) to Tumor"
* $CAPeCCCodeSystem#353725.100004300 "Distance from Tumor to Closest Margin"
* $CAPeCCCodeSystem#23022.100004300 "Margin(s) Involved by Tumor"
* $CAPeCCCodeSystem#358516.100004300 "Margin Comment"
* $CAPeCCCodeSystem#374335.100004300 "Regional Lymph Node Status"
* $CAPeCCCodeSystem#5821.100004300 "Number of Lymph Nodes with Tumor"
* $CAPeCCCodeSystem#5818.100004300 "Number of Lymph Nodes Examined"
* $CAPeCCCodeSystem#358517.100004300 "Regional Lymph Node Comment"
* $CAPeCCCodeSystem#353740.100004300 "?Distant Site(s) Involved, if applicable#"
* $CAPeCCCodeSystem#57497.100004300 "Immunohistochemistry (specify)"
* $CAPeCCCodeSystem#380169.100004300 "Cytogenetic Findings"
* $CAPeCCCodeSystem#36452.100004300 "?Method for Cytogenetic Studies"
* $CAPeCCCodeSystem#5993.100004300 "Additional Findings (specify)"
* $CAPeCCCodeSystem#5994.100004300 "?Comment(s)"
* $CAPeCCCodeSystem#381610.100004300 "Procedure (Note A)"
* $CAPeCCCodeSystem#330669.100004300 "Positive Specimen Location(s)"
* $CAPeCCCodeSystem#891078.100004300 "Histologic Type (Note B)"
* $CAPeCCCodeSystem#330701.100004300 "Histologic Type Comment"
* $CAPeCCCodeSystem#330703.100004300 "Highest Grade"
* $CAPeCCCodeSystem#330898.100004300 "Site(s) with Highest Gleason Score"
* $CAPeCCCodeSystem#378739.100004300 "?Systematic Biopsy Overall Grade (required only if there are 2 or more sites [containers] that contain cancer with different Gleason Scores)"
* $CAPeCCCodeSystem#378752.100004300 "Percentage of Pattern 4"
* $CAPeCCCodeSystem#378764.100004300 "Percentage of Pattern 4"
* $CAPeCCCodeSystem#381545.100004300 "Percentage of Pattern 4 (applicable for Overall Systematic Biopsy Gleason Score 8 and above)"
* $CAPeCCCodeSystem#378751.100004300 "Percentage of Pattern 5 (applicable for Overall Systematic Biopsy Gleason Score 8 and above)"
* $CAPeCCCodeSystem#381565.100004300 "Systematic Overall Grade Technique#"
* $CAPeCCCodeSystem#330928.100004300 "?Targeted Biopsy Grade (may be repeated according to the number of targeted biopsy sites)"
* $CAPeCCCodeSystem#378699.100004300 "Percentage of Pattern 4"
* $CAPeCCCodeSystem#378711.100004300 "Percentage of Pattern 4"
* $CAPeCCCodeSystem#381547.100004300 "Percentage of Pattern 4 (applicable for Targeted Biopsy Gleason Score 8 and above)"
* $CAPeCCCodeSystem#330943.100004300 "Percentage of Pattern 5 (applicable for Targeted Biopsy Gleason Score 8 and above)"
* $CAPeCCCodeSystem#381614.100004300 "Targeted Biopsy Identifier"
* $CAPeCCCodeSystem#381569.100004300 "Combined Systematic and Targeted Biopsy Grade"
* $CAPeCCCodeSystem#381582.100004300 "Percentage of Pattern 4"
* $CAPeCCCodeSystem#381589.100004300 "Percentage of Pattern 4"
* $CAPeCCCodeSystem#381595.100004300 "Percentage of Pattern 4 (applicable for Combined Systematic and Targeted Biopsy Gleason Score 8 and above)"
* $CAPeCCCodeSystem#381581.100004300 "Percentage of Pattern 5 (applicable for Combined Systematic and Targeted Biopsy Gleason Score 8 and above)"
* $CAPeCCCodeSystem#330720.100004300 "Intraductal Carcinoma (IDC) (Note D)"
* $CAPeCCCodeSystem#366689.100004300 "IDC Incorporated into Grade"
* $CAPeCCCodeSystem#330719.100004300 "?Cribriform Glands (applicable to Gleason Score 7 or 8 cancer only)"
* $CAPeCCCodeSystem#366693.100004300 "?Treatment Effect (required only if applicable)"
* $CAPeCCCodeSystem#366703.100004300 "Total Number of Cores"
* $CAPeCCCodeSystem#366706.100004300 "Number of Positive Cores"
* $CAPeCCCodeSystem#366709.100004300 "Tumor Measurement Technique"
* $CAPeCCCodeSystem#378723.100004300 "Greatest Percentage of Core Involvement by Cancer in Any Core"
* $CAPeCCCodeSystem#331031.100004300 "Specify Site(s)"
* $CAPeCCCodeSystem#331002.100004300 "Greatest Length of Core Involvement by Cancer in Any Core in Millimeters (mm)"
* $CAPeCCCodeSystem#331005.100004300 "Specify Site(s)"
* $CAPeCCCodeSystem#331004.100004300 "Percentage of Total Prostatic Tissue Involved by Tumor"
* $CAPeCCCodeSystem#366715.100004300 "Total Linear Millimeters (mm) of Carcinoma"
* $CAPeCCCodeSystem#331094.100004300 "Total Linear Millimeters (mm) of Needle Core Tissue"
* $CAPeCCCodeSystem#366716.100004300 "?Periprostatic Fat Invasion (report if identified in specimen) (Note F)"
* $CAPeCCCodeSystem#366719.100004300 "?Seminal Vesicle Invasion (report if seminal vesicle is submitted) (Note F)"
* $CAPeCCCodeSystem#366722.100004300 "Lymphatic and / or Vascular Invasion"
* $CAPeCCCodeSystem#366727.100004300 "Perineural Invasion (Note G)"
* $CAPeCCCodeSystem#366730.100004300 "Additional Findings"
* $CAPeCCCodeSystem#330897.100004300 "?Comment(s)"
* $CAPeCCCodeSystem#330591.100004300 "Treatment Effect"
* $CAPeCCCodeSystem#381607.100004300 "Treatment Effect Comment"
* $CAPeCCCodeSystem#330424.100004300 "Positive Specimen Location"
* $CAPeCCCodeSystem#891105.100004300 "Histologic Type (Note B)"
* $CAPeCCCodeSystem#330456.100004300 "Histologic Type Comment"
* $CAPeCCCodeSystem#330458.100004300 "Grade"
* $CAPeCCCodeSystem#365295.100004300 "Tumor Microfocus"
* $CAPeCCCodeSystem#378776.100004300 "?Percentage of Pattern 4 (not required if other specimen(s) have Gleason Scores of 8 or higher)"
* $CAPeCCCodeSystem#378788.100004300 "?Percentage of Pattern 4 (not required if other specimen(s) have Gleason Scores of 8 or higher)"
* $CAPeCCCodeSystem#381544.100004300 "Percentage of Pattern 4 (applicable for Gleason Score 8 and above)"
* $CAPeCCCodeSystem#365298.100004300 "Percentage of Pattern 5 (applicable for Gleason Score 8 and above)"
* $CAPeCCCodeSystem#330476.100004300 "Intraductal Carcinoma (IDC) (Note D)"
* $CAPeCCCodeSystem#365299.100004300 "IDC Incorporated into Grade"
* $CAPeCCCodeSystem#891419.100004300 "?Cribriform Glands (applicable to Gleason Score 7 or 8 cancer only)"
* $CAPeCCCodeSystem#330492.100004300 "Total Number of Cores"
* $CAPeCCCodeSystem#330489.100004300 "Number of Positive Cores"
* $CAPeCCCodeSystem#330495.100004300 "Tumor Measurement Technique"
* $CAPeCCCodeSystem#378826.100004300 "Percentage of Prostatic Tissue Involved by Tumor (repeat for multiple cores)"
* $CAPeCCCodeSystem#330508.100004300 "Length of Prostatic Tissue Involved by Tumor (repeat for multiple cores)"
* $CAPeCCCodeSystem#330511.100004300 "?Periprostatic Fat Invasion (report if identified in specimen) (Note F)"
* $CAPeCCCodeSystem#330515.100004300 "?Seminal Vesicle Invasion / Ejaculatory Duct Invasion (report if identified in specimen) (Note F)"
* $CAPeCCCodeSystem#330519.100004300 "Lymphatic and / or Vascular Invasion"
* $CAPeCCCodeSystem#330520.100004300 "Perineural Invasion (Note G)"
* $CAPeCCCodeSystem#381563.100004300 "Additional Findings"
* $CAPeCCCodeSystem#330659.100004300 "?Comment(s)"
* $CAPeCCCodeSystem#18225.100004300 "Procedure"
* $CAPeCCCodeSystem#18230.100004300 "Prostate Weight in Grams (g)"
* $CAPeCCCodeSystem#18233.100004300 "Prostate Size in Centimeters (cm)"
* $CAPeCCCodeSystem#18231.100004300 "Additional Prostate Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#18232.100004300 "Additional Prostate Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#891021.100004300 "Histologic Type (Note B)"
* $CAPeCCCodeSystem#35699.100004300 "Histologic Type Comment"
* $CAPeCCCodeSystem#59767.100004300 "Grade"
* $CAPeCCCodeSystem#365268.100004300 "?Minor Tertiary Pattern 5 (less than 5%) (required only if applicable)"
* $CAPeCCCodeSystem#378599.100004300 "Percentage of Pattern 4"
* $CAPeCCCodeSystem#365271.100004300 "?Minor Tertiary Pattern 5 (less than 5%) (required only if applicable)"
* $CAPeCCCodeSystem#378611.100004300 "Percentage of Pattern 4"
* $CAPeCCCodeSystem#38953.100004300 "If Gleason Score is Greater Than 7 Specify Percentage of Pattern 4"
* $CAPeCCCodeSystem#39050.100004300 "If Gleason Score is Greater Than 7 Specify Percentage of Pattern 5"
* $CAPeCCCodeSystem#38962.100004300 "Intraductal Carcinoma (IDC) (Note D)"
* $CAPeCCCodeSystem#365274.100004300 "IDC Incorporated into Grade"
* $CAPeCCCodeSystem#365277.100004300 "?Cribriform Glands (applicable to Gleason score 7 or 8 cancer only)"
* $CAPeCCCodeSystem#891422.100004300 "Treatment Effect"
* $CAPeCCCodeSystem#378635.100004300 "Tumor Quantitation"
* $CAPeCCCodeSystem#378623.100004300 "Estimated Percentage of Prostate Involved by Tumor"
* $CAPeCCCodeSystem#378639.100004300 "Greatest Dimension of Dominant Nodule in Millimeters (mm)"
* $CAPeCCCodeSystem#16837.100004300 "Additional Dimension of Dominant Nodule in Millimeters (mm)"
* $CAPeCCCodeSystem#16838.100004300 "Additional Dimension of Dominant Nodule in Millimeters (mm)"
* $CAPeCCCodeSystem#54333.100004300 "Location of Dominant Nodule"
* $CAPeCCCodeSystem#16839.100004300 "Extraprostatic Extension (EPE) (Note F)"
* $CAPeCCCodeSystem#56219.100004300 "Location of Extraprostatic Extension"
* $CAPeCCCodeSystem#38965.100004300 "Urinary Bladder Neck Invasion (Note G)"
* $CAPeCCCodeSystem#381597.100004300 "Seminal Vesicle Invasion (Note H)"
* $CAPeCCCodeSystem#16899.100004300 "Lymphatic and / or Vascular Invasion (Note I)"
* $CAPeCCCodeSystem#16892.100004300 "Perineural Invasion (Note J)"
* $CAPeCCCodeSystem#16877.100004300 "Margin Status"
* $CAPeCCCodeSystem#350639.100004300 "Linear Length of Margin(s) Involved by Carcinoma"
* $CAPeCCCodeSystem#39102.100004300 "Focality of Margin Involvement"
* $CAPeCCCodeSystem#3851.100004300 "Margin(s) Involved by Invasive Carcinoma"
* $CAPeCCCodeSystem#38995.100004300 "Margin Involvement by Invasive Carcinoma in Area of Extraprostatic Extension (EPE)"
* $CAPeCCCodeSystem#38996.100004300 "Margin(s) Involved by Invasive Carcinoma in Area of EPE"
* $CAPeCCCodeSystem#39052.100004300 "Gleason Pattern at Margin(s) Involved by Carcinoma (Note K)"
* $CAPeCCCodeSystem#379567.100004300 "Margin Comment"
* $CAPeCCCodeSystem#374425.100004300 "Regional Lymph Node Status"
* $CAPeCCCodeSystem#47414.100004300 "Number of Lymph Nodes with Tumor"
* $CAPeCCCodeSystem#40062.100004300 "Nodal Site(s) with Tumor"
* $CAPeCCCodeSystem#42802.100004300 "Laterality"
* $CAPeCCCodeSystem#42888.100004300 "Laterality"
* $CAPeCCCodeSystem#51292.100004300 "Laterality"
* $CAPeCCCodeSystem#51438.100004300 "Laterality"
* $CAPeCCCodeSystem#51464.100004300 "Laterality"
* $CAPeCCCodeSystem#51481.100004300 "Laterality"
* $CAPeCCCodeSystem#51369.100004300 "Laterality"
* $CAPeCCCodeSystem#51395.100004300 "Laterality"
* $CAPeCCCodeSystem#51758.100004300 "Laterality"
* $CAPeCCCodeSystem#51506.100004300 "Laterality"
* $CAPeCCCodeSystem#358213.100004300 "Size of Largest Nodal Metastatic Deposit"
* $CAPeCCCodeSystem#50403.100004300 "Nodal Site with Largest Metastatic Deposit (specify site)"
* $CAPeCCCodeSystem#358215.100004300 "Size of Largest Lymph Node with Tumor"
* $CAPeCCCodeSystem#41148.100004300 "Largest Lymph Node with Tumor (specify site)"
* $CAPeCCCodeSystem#39717.100004300 "Extranodal Extension"
* $CAPeCCCodeSystem#49907.100004300 "Number of Lymph Nodes Examined"
* $CAPeCCCodeSystem#358491.100004300 "Regional Lymph Node Comment"
* $CAPeCCCodeSystem#358218.100004300 "?Distant Site(s) Involved, if applicable"
* $CAPeCCCodeSystem#891067.100004300 "?Modified Classification"
* $CAPeCCCodeSystem#52957.100004300 "pT Category#"
* $CAPeCCCodeSystem#891068.100004300 "?T Suffix (required only if applicable)"
* $CAPeCCCodeSystem#327901.100004300 "pN Category"
* $CAPeCCCodeSystem#47484.100004300 "?pM Category (required only if confirmed pathologically)#"
* $CAPeCCCodeSystem#381558.100004300 "Additional Findings"
* $CAPeCCCodeSystem#18236.100004300 "Ancillary Studies"
* $CAPeCCCodeSystem#45895.100004300 "Testing Performed on Block Number(s)"
* $CAPeCCCodeSystem#16910.100004300 "?Comment(s)"
* $CAPeCCCodeSystem#16916.100004300 "Procedure (Note A)"
* $CAPeCCCodeSystem#891047.100004300 "Histologic Type (Note B)"
* $CAPeCCCodeSystem#42517.100004300 "Histologic Type Comment"
* $CAPeCCCodeSystem#58768.100004300 "Grade"
* $CAPeCCCodeSystem#378653.100004300 "Percentage of Pattern 4"
* $CAPeCCCodeSystem#378665.100004300 "Percentage of Pattern 4"
* $CAPeCCCodeSystem#59374.100004300 "If Gleason Score is Greater Than 7 Specify Percentage of Pattern 4"
* $CAPeCCCodeSystem#38790.100004300 "If Gleason Score is Greater Than 7 Specify Percentage of Pattern 5"
* $CAPeCCCodeSystem#59082.100004300 "Intraductal Carcinoma (IDC) (Note D)"
* $CAPeCCCodeSystem#365287.100004300 "IDC Incorporated into Grade"
* $CAPeCCCodeSystem#365290.100004300 "?Cribriform Glands (applicable to Gleason score 7 or 8 cancer only)"
* $CAPeCCCodeSystem#50925.100004300 "Treatment Effect"
* $CAPeCCCodeSystem#22091.100004300 "Tumor Quantitation"
* $CAPeCCCodeSystem#378679.100004300 "Estimated Percentage of Prostate Involved by Tumor"
* $CAPeCCCodeSystem#16952.100004300 "Number of Positive Chips"
* $CAPeCCCodeSystem#16953.100004300 "Total Number of Chips"
* $CAPeCCCodeSystem#46473.100004300 "?Greatest Dimension of Dominant Nodule in Millimeters (mm) (if present)"
* $CAPeCCCodeSystem#52722.100004300 "Additional Dimension of Dominant Nodule in Millimeters (mm)"
* $CAPeCCCodeSystem#50578.100004300 "Additional Dimension of Dominant Nodule in Millimeters (mm)"
* $CAPeCCCodeSystem#42656.100004300 "Specify Estimated Percentage of Prostatic Tissue Involved by Tumor"
* $CAPeCCCodeSystem#380173.100004300 "?Periprostatic Fat Invasion (report if identified in specimen)"
* $CAPeCCCodeSystem#380176.100004300 "?Seminal Vesicle Invasion (report if identified in specimen)"
* $CAPeCCCodeSystem#16969.100004300 "Lymphatic and / or Vascular Invasion"
* $CAPeCCCodeSystem#16966.100004300 "Perineural Invasion (Note F)"
* $CAPeCCCodeSystem#381561.100004300 "Additional Findings"
* $CAPeCCCodeSystem#16980.100004300 "?Comment(s)"
* $CAPeCCCodeSystem#355472.100004300 "Treatment History"
* $CAPeCCCodeSystem#362537.100004300 "Procedure"
* $CAPeCCCodeSystem#356292.100004300 "Total Length of Optic Nerve"
* $CAPeCCCodeSystem#355473.100004300 "Tumor Sampling for Molecular Studies"
* $CAPeCCCodeSystem#36771.100004300 "Specimen Laterality (Note D)"
* $CAPeCCCodeSystem#355486.100004300 "Tumor Site (macroscopic examination / transillumination) (Notes D, E)"
* $CAPeCCCodeSystem#355487.100004300 "Tumor Site after Sectioning (Notes E, F, G)"
* $CAPeCCCodeSystem#380267.100004300 "Tumor Size after Sectioning (Notes E, F, G)"
* $CAPeCCCodeSystem#356238.100004300 "Greatest Basal Diameter of Tumor"
* $CAPeCCCodeSystem#356247.100004300 "Basal Diameter at Cut Edge of Tumor"
* $CAPeCCCodeSystem#356256.100004300 "Greatest Thickness of Tumor"
* $CAPeCCCodeSystem#356265.100004300 "Thickness at Cut Edge of Tumor"
* $CAPeCCCodeSystem#379820.100004300 "Percentage of Vitreous Cavity Occupied by Tumor"
* $CAPeCCCodeSystem#356283.100004300 "Distance from Anterior Edge of Tumor to Limbus at Cut Edge"
* $CAPeCCCodeSystem#356274.100004300 "Distance from Posterior Margin of Tumor Base to Edge of Optic Disc"
* $CAPeCCCodeSystem#6188.100004300 "Tumor Growth Pattern (Note H)"
* $CAPeCCCodeSystem#44560.100004300 "Histologic Grade"
* $CAPeCCCodeSystem#362691.100004300 "Histologic Grade Comment"
* $CAPeCCCodeSystem#33241.100004300 "Anaplasia Grade"
* $CAPeCCCodeSystem#51470.100004300 "Histopathologic Features Suggesting MYCN Amplification (Note I)"
* $CAPeCCCodeSystem#355491.100004300 "Other Ocular Structures Involved by Tumor (Note J)"
* $CAPeCCCodeSystem#362539.100004300 "Extent of Optic Nerve Invasion"
* $CAPeCCCodeSystem#379545.100004300 "Tumor Comment"
* $CAPeCCCodeSystem#6233.100004300 "Margin Status"
* $CAPeCCCodeSystem#356301.100004300 "Margin Comment"
* $CAPeCCCodeSystem#374427.100004300 "Regional Lymph Node Status"
* $CAPeCCCodeSystem#46773.100004300 "Number of Lymph Nodes with Tumor"
* $CAPeCCCodeSystem#48313.100004300 "Number of Lymph Nodes Examined"
* $CAPeCCCodeSystem#358513.100004300 "Regional Lymph Node Comment"
* $CAPeCCCodeSystem#355515.100004300 "?Distant Site(s) Involved, if applicable"
* $CAPeCCCodeSystem#17189.100004300 "?TNM Descriptors"
* $CAPeCCCodeSystem#355512.100004300 "pT Category"
* $CAPeCCCodeSystem#355513.100004300 "pN Category"
* $CAPeCCCodeSystem#57649.100004300 "?pM Category (required only if confirmed pathologically)"
* $CAPeCCCodeSystem#355524.100004300 "Heritable Trait (H) Status"
* $CAPeCCCodeSystem#355507.100004300 "Additional Findings"
* $CAPeCCCodeSystem#6252.100004300 "?Comment(s)"
* $CAPeCCCodeSystem#702244.100004300 "Expert Consultation (Note A)"
* $CAPeCCCodeSystem#47693.100004300 "Procedure (Note C)"
* $CAPeCCCodeSystem#48984.100004300 "Tumor Site"
* $CAPeCCCodeSystem#43654.100004300 "?Tumor Size (required only for excisional biopsy)"
* $CAPeCCCodeSystem#48277.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#52605.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#40783.100004300 "Histologic Type (Note D)"
* $CAPeCCCodeSystem#379144.100004300 "Histologic Type Comment"
* $CAPeCCCodeSystem#58639.100004300 "Anaplasia (Note E)"
* $CAPeCCCodeSystem#379563.100004300 "Tumor Comment"
* $CAPeCCCodeSystem#43425.100004300 "?Margin Status (required only for excisional biopsy)"
* $CAPeCCCodeSystem#364620.100004300 "Distance from Tumor to Closest Margin"
* $CAPeCCCodeSystem#364628.100004300 "Closest Margin to Tumor"
* $CAPeCCCodeSystem#364616.100004300 "Margin(s) Involved by Tumor"
* $CAPeCCCodeSystem#364632.100004300 "Margin Comment"
* $CAPeCCCodeSystem#39890.100004300 "Additional Findings (specify) (Note G)"
* $CAPeCCCodeSystem#52436.100004300 "Gene Fusion Studies (Note H)"
* $CAPeCCCodeSystem#364596.100004300 "?Method for Gene Fusion Studies"
* $CAPeCCCodeSystem#364597.100004300 "Molecular Genetic Studies (Note I)"
* $CAPeCCCodeSystem#364609.100004300 "Method for Molecular Genetic Studies"
* $CAPeCCCodeSystem#55662.100004300 "?Comment(s)"
* $CAPeCCCodeSystem#702271.100004300 "Expert Consultation (Note A)"
* $CAPeCCCodeSystem#34997.100004300 "Preoperative Treatment"
* $CAPeCCCodeSystem#58490.100004300 "Procedure (Note C)"
* $CAPeCCCodeSystem#6280.100004300 "Tumor Site"
* $CAPeCCCodeSystem#6272.100004300 "Tumor Size"
* $CAPeCCCodeSystem#6276.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#6275.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#37298.100004300 "Histologic Type (Note D)"
* $CAPeCCCodeSystem#379117.100004300 "Histologic Type Comment"
* $CAPeCCCodeSystem#6303.100004300 "Anaplasia (Note E)"
* $CAPeCCCodeSystem#36620.100004300 "Treatment Effect (Note F)"
* $CAPeCCCodeSystem#379118.100004300 "Percentage of Treatment Effect"
* $CAPeCCCodeSystem#379122.100004300 "Percentage of Therapy-Induced Cytodifferentiation"
* $CAPeCCCodeSystem#379562.100004300 "Tumor Comment"
* $CAPeCCCodeSystem#39512.100004300 "Margin Status (Note G)"
* $CAPeCCCodeSystem#359616.100004300 "Distance from Tumor to Closest Margin"
* $CAPeCCCodeSystem#359624.100004300 "Closest Margin(s) to Tumor"
* $CAPeCCCodeSystem#359612.100004300 "Margin(s) Involved by Tumor"
* $CAPeCCCodeSystem#364631.100004300 "Margin Comment"
* $CAPeCCCodeSystem#374327.100004300 "Regional Lymph Node Status"
* $CAPeCCCodeSystem#11076.100004300 "Number of Lymph Nodes with Tumor"
* $CAPeCCCodeSystem#11047.100004300 "Number of Lymph Nodes Examined"
* $CAPeCCCodeSystem#365222.100004300 "Regional Lymph Node Comment"
* $CAPeCCCodeSystem#379127.100004300 "?Distant Site(s) Involved, if applicable"
* $CAPeCCCodeSystem#6333.100004300 "The Intergroup Rhabdomyosarcoma Study Postsurgical Clinical Grouping System (Note H)"
* $CAPeCCCodeSystem#20733.100004300 "Modified Site, Size, Metastasis Staging for Rhabdomyosarcoma (for relevant stage) (Note H)"
* $CAPeCCCodeSystem#20720.100004300 "Stage III Findings"
* $CAPeCCCodeSystem#6349.100004300 "Additional Findings (specify) (Note I)"
* $CAPeCCCodeSystem#59292.100004300 "Gene Fusion Studies (Note J)"
* $CAPeCCCodeSystem#364566.100004300 "?Method for Gene Fusion Studies"
* $CAPeCCCodeSystem#364567.100004300 "Molecular Genetic Studies (Note K)"
* $CAPeCCCodeSystem#364580.100004300 "Method for Molecular Genetic Studies"
* $CAPeCCCodeSystem#6350.100004300 "?Comment(s)"
* $CAPeCCCodeSystem#937550.100004300 "Procedure (Note A)"
* $CAPeCCCodeSystem#937559.100004300 "Specimen Laterality"
* $CAPeCCCodeSystem#937929.100004300 "Tumor Site (Note B)"
* $CAPeCCCodeSystem#937954.100004300 "?Multiple Primary Sites (required only if applicable)"
* $CAPeCCCodeSystem#937950.100004300 "Histologic Type (Note C)"
* $CAPeCCCodeSystem#937904.100004300 "Histologic Type Comment"
* $CAPeCCCodeSystem#937903.100004300 "Maximum Tumor (Breslow) Thickness in Millimeters (mm) (Note D)"
* $CAPeCCCodeSystem#937907.100004300 "Tumor (Breslow) Thickness (explain)"
* $CAPeCCCodeSystem#937914.100004300 "Ulceration (Note E)"
* $CAPeCCCodeSystem#937958.100004300 "Extent of Ulceration in Millimeters (mm)"
* $CAPeCCCodeSystem#937909.100004300 "Anatomic (Clark) Level (Note D)"
* $CAPeCCCodeSystem#937953.100004300 "Anatomic (Clark) Level (explain)"
* $CAPeCCCodeSystem#937918.100004300 "Mitotic Rate (Note F)"
* $CAPeCCCodeSystem#937930.100004300 "Microsatellite(s) (Note G)"
* $CAPeCCCodeSystem#937934.100004300 "Lymphatic and / or Vascular Invasion (Note H)"
* $CAPeCCCodeSystem#937938.100004300 "Neurotropism (Note I)"
* $CAPeCCCodeSystem#937942.100004300 "Tumor-Infiltrating Lymphocytes (Note J)"
* $CAPeCCCodeSystem#937946.100004300 "Tumor Regression (Note K)"
* $CAPeCCCodeSystem#937712.100004300 "Margin Status for Invasive Melanoma"
* $CAPeCCCodeSystem#939844.100004300 "Closest Margin(s) to Invasive Melanoma"
* $CAPeCCCodeSystem#937714.100004300 "Distance from Invasive Melanoma to Peripheral Margin"
* $CAPeCCCodeSystem#937720.100004300 "Distance from Invasive Melanoma to Deep Margin"
* $CAPeCCCodeSystem#937704.100004300 "Margin(s) Involved by Invasive Melanoma"
* $CAPeCCCodeSystem#937733.100004300 "?Margin Status for Melanoma In Situ (required only if applicable)#"
* $CAPeCCCodeSystem#937736.100004300 "Distance from Melanoma In Situ to Closest Peripheral Margin"
* $CAPeCCCodeSystem#937726.100004300 "Margin(s) Involved by Melanoma In Situ"
* $CAPeCCCodeSystem#937711.100004300 "Margin Comment"
* $CAPeCCCodeSystem#938084.100004300 "?Modified Classification (required only if applicable)"
* $CAPeCCCodeSystem#938075.100004300 "pT Category"
* $CAPeCCCodeSystem#938086.100004300 "?T Suffix (required only if applicable)"
* $CAPeCCCodeSystem#938148.100004300 "Additional Findings"
* $CAPeCCCodeSystem#939849.100004300 "?Comment(s)"
* $CAPeCCCodeSystem#937063.100004300 "Procedure (Note A)"
* $CAPeCCCodeSystem#937072.100004300 "Specimen Laterality"
* $CAPeCCCodeSystem#937220.100004300 "Tumor Site (Note B)"
* $CAPeCCCodeSystem#937380.100004300 "?Multiple Primary Sites (required only if applicable)"
* $CAPeCCCodeSystem#937176.100004300 "Macroscopic Satellite Lesion(s)"
* $CAPeCCCodeSystem#937244.100004300 "Histologic Type (Note C)"
* $CAPeCCCodeSystem#937184.100004300 "Histologic Type Comment"
* $CAPeCCCodeSystem#937180.100004300 "Maximum Tumor (Breslow) Thickness in Millimeters (mm) (Note D)"
* $CAPeCCCodeSystem#937194.100004300 "Tumor (Breslow) Thickness (explain)"
* $CAPeCCCodeSystem#937201.100004300 "Ulceration (Note E)"
* $CAPeCCCodeSystem#937416.100004300 "Extent of Ulceration in Millimeters (mm)"
* $CAPeCCCodeSystem#937196.100004300 "Anatomic (Clark) Level (Note D)"
* $CAPeCCCodeSystem#937265.100004300 "Anatomic (Clark) Level (explain)"
* $CAPeCCCodeSystem#937205.100004300 "Mitotic Rate (Note F)"
* $CAPeCCCodeSystem#937222.100004300 "Microsatellite(s) (Note G)"
* $CAPeCCCodeSystem#937478.100004300 "Margin Involvement by Microsatellite(s)"
* $CAPeCCCodeSystem#937226.100004300 "Lymphatic and / or Vascular Invasion (Note H)"
* $CAPeCCCodeSystem#937230.100004300 "Neurotropism (Note I)"
* $CAPeCCCodeSystem#937234.100004300 "Tumor-Infiltrating Lymphocytes (Note J)"
* $CAPeCCCodeSystem#937238.100004300 "Tumor Regression (Note K)"
* $CAPeCCCodeSystem#937486.100004300 "Margin Involvement by Tumor Regression"
* $CAPeCCCodeSystem#937315.100004300 "Margin Status for Invasive Melanoma"
* $CAPeCCCodeSystem#939834.100004300 "Closest Margin(s) to Invasive Melanoma"
* $CAPeCCCodeSystem#937317.100004300 "Distance from Invasive Melanoma to Peripheral Margin"
* $CAPeCCCodeSystem#937323.100004300 "Distance from Invasive Melanoma to Deep Margin"
* $CAPeCCCodeSystem#937307.100004300 "Margin(s) Involved by Invasive Melanoma"
* $CAPeCCCodeSystem#937336.100004300 "?Margin Status for Melanoma In Situ (required only if applicable)#"
* $CAPeCCCodeSystem#937339.100004300 "Distance from Melanoma In Situ to Peripheral Margin"
* $CAPeCCCodeSystem#937329.100004300 "Margin(s) Involved by Melanoma In Situ"
* $CAPeCCCodeSystem#937314.100004300 "Margin Comment"
* $CAPeCCCodeSystem#937345.100004300 "Regional Lymph Node Status"
* $CAPeCCCodeSystem#937079.100004300 "Total Number of Lymph Nodes with Tumor"
* $CAPeCCCodeSystem#937078.100004300 "?Number of Sentinel Lymph Nodes with Tumor (required only if applicable)"
* $CAPeCCCodeSystem#937160.100004300 "Nodal Site(s) with Tumor"
* $CAPeCCCodeSystem#937496.100004300 "?Size of Largest Sentinel Node Metastatic Deposit (required only if applicable)"
* $CAPeCCCodeSystem#937354.100004300 "?Size of Largest Non-Sentinel Node Metastatic Deposit (required only if applicable)"
* $CAPeCCCodeSystem#937154.100004300 "Extranodal Extension"
* $CAPeCCCodeSystem#937158.100004300 "Matted Nodes"
* $CAPeCCCodeSystem#937356.100004300 "Total Number of Lymph Nodes Examined (sentinel and non-sentinel)"
* $CAPeCCCodeSystem#937361.100004300 "Number of Sentinel Nodes Examined"
* $CAPeCCCodeSystem#937376.100004300 "Regional Lymph Node Comment"
* $CAPeCCCodeSystem#937367.100004300 "?Distant Site(s) Involved, if applicable"
* $CAPeCCCodeSystem#937185.100004300 "Prior Procedure Classification"
* $CAPeCCCodeSystem#937513.100004300 "?Modified Classification (required only if applicable)"
* $CAPeCCCodeSystem#937278.100004300 "pT Category"
* $CAPeCCCodeSystem#937515.100004300 "?T Suffix (required only if applicable)"
* $CAPeCCCodeSystem#937280.100004300 "pN Category"
* $CAPeCCCodeSystem#937258.100004300 "?pM Category (required only if confirmed pathologically)"
* $CAPeCCCodeSystem#937431.100004300 "Additional Findings"
* $CAPeCCCodeSystem#937436.100004300 "?Comment(s)"
* $CAPeCCCodeSystem#72913.100004300 "BRAF Mutational Analysis (Note A)"
* $CAPeCCCodeSystem#72921.100004300 "NRAS Mutational Analysis (Note B)"
* $CAPeCCCodeSystem#72935.100004300 "KIT Mutational Analysis (Note C)"
* $CAPeCCCodeSystem#72944.100004300 "Specify Other Marker"
* $CAPeCCCodeSystem#72945.100004300 "Specify Results"
* $CAPeCCCodeSystem#72947.100004300 "BRAF Mutational Analysis Testing Method"
* $CAPeCCCodeSystem#72948.100004300 "BRAF Assay Sensitivity (specify)"
* $CAPeCCCodeSystem#72959.100004300 "NRAS Mutational Analysis Testing Method"
* $CAPeCCCodeSystem#72960.100004300 "NRAS Assay Sensitivity (specify)"
* $CAPeCCCodeSystem#72968.100004300 "KIT Mutational Analysis Testing Method"
* $CAPeCCCodeSystem#72969.100004300 "KIT Assay Sensitivity (specify)"
* $CAPeCCCodeSystem#72977.100004300 "Specify Other Marker"
* $CAPeCCCodeSystem#33165.100004300 "Specify Method"
* $CAPeCCCodeSystem#72978.100004300 "Comment(s)"
* $CAPeCCCodeSystem#51900.100004300 "Procedure"
* $CAPeCCCodeSystem#52632.100004300 "Specimen Laterality"
* $CAPeCCCodeSystem#48402.100004300 "Tumor Site"
* $CAPeCCCodeSystem#21584.100004300 "Tumor Size"
* $CAPeCCCodeSystem#21587.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#21588.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#21713.100004300 "Mitotic Rate (Note A)"
* $CAPeCCCodeSystem#48623.100004300 "Tumor Extent"
* $CAPeCCCodeSystem#21589.100004300 "Tumor Thickness in Millimeters (mm) (Note B)"
* $CAPeCCCodeSystem#20982.100004300 "Explain"
* $CAPeCCCodeSystem#21626.100004300 "Lymphovascular Invasion"
* $CAPeCCCodeSystem#21718.100004300 "Tumor-Infiltrating Lymphocytes (Note C)"
* $CAPeCCCodeSystem#21715.100004300 "Tumor Growth Pattern (Note D)"
* $CAPeCCCodeSystem#21724.100004300 "Second Malignancy (Note E)"
* $CAPeCCCodeSystem#381184.100004300 "Tumor Comment"
* $CAPeCCCodeSystem#355343.100004300 "Margin Status"
* $CAPeCCCodeSystem#355350.100004300 "Closest Peripheral Margin Location(s) to Carcinoma"
* $CAPeCCCodeSystem#355345.100004300 "Distance from Carcinoma to Closest Peripheral Margin"
* $CAPeCCCodeSystem#355379.100004300 "Closest Deep Margin Location(s) to Carcinoma"
* $CAPeCCCodeSystem#355363.100004300 "Distance from Carcinoma to Deep Margin"
* $CAPeCCCodeSystem#355352.100004300 "Margin(s) Involved by Carcinoma"
* $CAPeCCCodeSystem#355368.100004300 "Margin Comment"
* $CAPeCCCodeSystem#374430.100004300 "Regional Lymph Node Status"
* $CAPeCCCodeSystem#56520.100004300 "Number of Lymph Nodes with Tumor"
* $CAPeCCCodeSystem#355389.100004300 "Size of Largest Nodal Metastatic Deposit"
* $CAPeCCCodeSystem#52959.100004300 "Extranodal Extension"
* $CAPeCCCodeSystem#55232.100004300 "Total Number of Lymph Nodes Examined (sentinel and non-sentinel)"
* $CAPeCCCodeSystem#57104.100004300 "Number of Sentinel Nodes Examined"
* $CAPeCCCodeSystem#358512.100004300 "Regional Lymph Node Comment"
* $CAPeCCCodeSystem#355370.100004300 "?Distant Site(s) Involved, if applicable"
* $CAPeCCCodeSystem#21643.100004300 "?TNM Descriptors"
* $CAPeCCCodeSystem#327646.100004300 "pT Category"
* $CAPeCCCodeSystem#327648.100004300 "pN Category"
* $CAPeCCCodeSystem#52250.100004300 "?pM Category (required only if confirmed pathologically)"
* $CAPeCCCodeSystem#21684.100004300 "Additional Findings (specify)"
* $CAPeCCCodeSystem#21685.100004300 "?Comment(s)"
* $CAPeCCCodeSystem#44294.100004300 "Procedure"
* $CAPeCCCodeSystem#39763.100004300 "Tumor Site (Note A)"
* $CAPeCCCodeSystem#48836.100004300 "Histologic Type (Note B)"
* $CAPeCCCodeSystem#54470.100004300 "Histologic Type Comment"
* $CAPeCCCodeSystem#6552.100004300 "Histologic Grade (Note C)"
* $CAPeCCCodeSystem#6531.100004300 "Tumor Size"
* $CAPeCCCodeSystem#6534.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#6535.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#41271.100004300 "Tumor Extent"
* $CAPeCCCodeSystem#20227.100004300 "Macroscopic Tumor Perforation"
* $CAPeCCCodeSystem#6637.100004300 "Lymphovascular Invasion"
* $CAPeCCCodeSystem#379523.100004300 "Tumor Comment"
* $CAPeCCCodeSystem#366875.100004300 "Margin Status for Invasive Carcinoma"
* $CAPeCCCodeSystem#366881.100004300 "Closest Margin(s) to Invasive Carcinoma"
* $CAPeCCCodeSystem#366886.100004300 "Distance from Invasive Carcinoma to Closest Margin"
* $CAPeCCCodeSystem#366894.100004300 "Margin(s) Involved by Invasive Carcinoma"
* $CAPeCCCodeSystem#366905.100004300 "Margin Status for Dysplasia"
* $CAPeCCCodeSystem#366911.100004300 "Margin(s) Involved by Carcinoma in Situ"
* $CAPeCCCodeSystem#366918.100004300 "Margin(s) Involved by Adenoma"
* $CAPeCCCodeSystem#366891.100004300 "Margin Comment"
* $CAPeCCCodeSystem#374432.100004300 "Regional Lymph Node Status"
* $CAPeCCCodeSystem#42571.100004300 "Number of Lymph Nodes with Tumor"
* $CAPeCCCodeSystem#54181.100004300 "Number of Lymph Nodes Examined"
* $CAPeCCCodeSystem#358481.100004300 "Regional Lymph Node Comment"
* $CAPeCCCodeSystem#356476.100004300 "?Distant Site(s) Involved, if applicable"
* $CAPeCCCodeSystem#19310.100004300 "?TNM Descriptors"
* $CAPeCCCodeSystem#327652.100004300 "pT Category"
* $CAPeCCCodeSystem#327654.100004300 "pN Category"
* $CAPeCCCodeSystem#6575.100004300 "?pM Category (required only if confirmed pathologically)"
* $CAPeCCCodeSystem#6645.100004300 "Additional Findings"
* $CAPeCCCodeSystem#6653.100004300 "?Comment(s)"
* $CAPeCCCodeSystem#6657.100004300 "Prebiopsy Treatment"
* $CAPeCCCodeSystem#6666.100004300 "Procedure"
* $CAPeCCCodeSystem#45239.100004300 "Tumor Site (Note B)"
* $CAPeCCCodeSystem#352426.100004300 "Histologic Type (World Health Organization [WHO] Classification of Soft Tissue Tumors) (Note C)"
* $CAPeCCCodeSystem#380025.100004300 "Percentage of Hypercellular Areas (formerly known as round cells)"
* $CAPeCCCodeSystem#45036.100004300 "Histologic Type Comment"
* $CAPeCCCodeSystem#6711.100004300 "Histologic Grade (French Federation of Cancer Centers Sarcoma Group [FNCLCC]) (Note D)"
* $CAPeCCCodeSystem#366686.100004300 "Mitotic Rate (Note D)"
* $CAPeCCCodeSystem#6706.100004300 "Necrosis (Note D)"
* $CAPeCCCodeSystem#374405.100004300 "Extent of Necrosis"
* $CAPeCCCodeSystem#18933.100004300 "Treatment Effect (Note E)"
* $CAPeCCCodeSystem#374449.100004300 "Percentage of Viable Tumor (compared with pretreatment biopsy, if available)"
* $CAPeCCCodeSystem#6736.100004300 "Lymphovascular Invasion (Note F)"
* $CAPeCCCodeSystem#379549.100004300 "Tumor Comment"
* $CAPeCCCodeSystem#367473.100004300 "?Margin Status"
* $CAPeCCCodeSystem#367479.100004300 "Closest Margin(s) to Tumor"
* $CAPeCCCodeSystem#367482.100004300 "Distance from Tumor to Closest Margin"
* $CAPeCCCodeSystem#367492.100004300 "Other Close Margin(s) to Tumor (less than 2 cm)"
* $CAPeCCCodeSystem#367486.100004300 "Margin(s) Involved by Tumor"
* $CAPeCCCodeSystem#367485.100004300 "Margin Comment"
* $CAPeCCCodeSystem#6740.100004300 "Additional Findings (specify)"
* $CAPeCCCodeSystem#18929.100004300 "?Immunohistochemistry"
* $CAPeCCCodeSystem#18932.100004300 "?Cytogenetics"
* $CAPeCCCodeSystem#18931.100004300 "?Molecular Pathology"
* $CAPeCCCodeSystem#6741.100004300 "?Comment(s)"
* $CAPeCCCodeSystem#6744.100004300 "Preresection Treatment"
* $CAPeCCCodeSystem#6753.100004300 "Procedure"
* $CAPeCCCodeSystem#352286.100004300 "Tumor Focality"
* $CAPeCCCodeSystem#381312.100004300 "Number of Tumors"
* $CAPeCCCodeSystem#42680.100004300 "Tumor Site (Note B)"
* $CAPeCCCodeSystem#6780.100004300 "Tumor Size (Note C)"
* $CAPeCCCodeSystem#6783.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#6784.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#347258.100004300 "Histologic Type (World Health Organization [WHO] Classification of Soft Tissue Tumors) (Note D)"
* $CAPeCCCodeSystem#380015.100004300 "Percentage of Hypercellular Areas (formerly known as round cells)"
* $CAPeCCCodeSystem#58432.100004300 "Histologic Type Comment"
* $CAPeCCCodeSystem#17140.100004300 "Histologic Grade (French Federation of Cancer Centers Sarcoma Group [FNCLCC]) (Note E)"
* $CAPeCCCodeSystem#366682.100004300 "Mitotic Rate (Note E)"
* $CAPeCCCodeSystem#6794.100004300 "Necrosis (macroscopic or microscopic) (Note E)"
* $CAPeCCCodeSystem#374396.100004300 "Extent of Necrosis"
* $CAPeCCCodeSystem#18416.100004300 "Treatment Effect (Note F)"
* $CAPeCCCodeSystem#374414.100004300 "Percentage of Viable Tumor (compared with pretreatment biopsy, if available)"
* $CAPeCCCodeSystem#6831.100004300 "Lymphovascular Invasion (Note G)"
* $CAPeCCCodeSystem#379550.100004300 "Tumor Comment"
* $CAPeCCCodeSystem#367500.100004300 "Margin Status"
* $CAPeCCCodeSystem#367506.100004300 "Closest Margin(s) to Tumor"
* $CAPeCCCodeSystem#367509.100004300 "Distance from Tumor to Closest Margin"
* $CAPeCCCodeSystem#367519.100004300 "Other Close Margin(s) to Tumor (less than 2 cm)"
* $CAPeCCCodeSystem#367513.100004300 "Margin(s) Involved by Tumor"
* $CAPeCCCodeSystem#367512.100004300 "Margin Comment"
* $CAPeCCCodeSystem#374437.100004300 "Regional Lymph Node Status"
* $CAPeCCCodeSystem#53345.100004300 "Number of Lymph Nodes with Tumor"
* $CAPeCCCodeSystem#41706.100004300 "Number of Lymph Nodes Examined"
* $CAPeCCCodeSystem#358328.100004300 "Regional Lymph Node Comment"
* $CAPeCCCodeSystem#352597.100004300 "?Distant Site(s) Involved, if applicable"
* $CAPeCCCodeSystem#380258.100004300 "?Pathologic Stage Classification"
* $CAPeCCCodeSystem#17054.100004300 "?TNM Descriptors"
* $CAPeCCCodeSystem#40813.100004300 "pT Category"
* $CAPeCCCodeSystem#327657.100004300 "pT Category"
* $CAPeCCCodeSystem#327659.100004300 "pT Category"
* $CAPeCCCodeSystem#327661.100004300 "pT Category"
* $CAPeCCCodeSystem#327670.100004300 "pT Category"
* $CAPeCCCodeSystem#327672.100004300 "pT Category"
* $CAPeCCCodeSystem#50555.100004300 "pN Category"
* $CAPeCCCodeSystem#6819.100004300 "?pM Category (required only if confirmed pathologically)"
* $CAPeCCCodeSystem#6835.100004300 "Additional Findings (specify)"
* $CAPeCCCodeSystem#17146.100004300 "?Immunohistochemistry"
* $CAPeCCCodeSystem#17161.100004300 "?Cytogenetics"
* $CAPeCCCodeSystem#17164.100004300 "?Molecular Pathology"
* $CAPeCCCodeSystem#6836.100004300 "?Comment(s)"
* $CAPeCCCodeSystem#31955.100004300 "KIT (CD117)"
* $CAPeCCCodeSystem#31958.100004300 "DOG1 (ANO1)"
* $CAPeCCCodeSystem#31991.100004300 "SDHA"
* $CAPeCCCodeSystem#31961.100004300 "SDHB"
* $CAPeCCCodeSystem#31964.100004300 "Test Name (repeat this question as needed)"
* $CAPeCCCodeSystem#31975.100004300 "KIT Mutational Analysis (Note D)"
* $CAPeCCCodeSystem#32008.100004300 "KIT Exons Assessed (Note D)"
* $CAPeCCCodeSystem#820601.100004300 "PDGFRA Mutational Analysis (Note E)"
* $CAPeCCCodeSystem#32016.100004300 "PDGFRA Exons Assessed (Note E)"
* $CAPeCCCodeSystem#31981.100004300 "SDH A / B / C / D Mutational Analysis (Note G)"
* $CAPeCCCodeSystem#31982.100004300 "NF1 Mutational Analysis (Note H)"
* $CAPeCCCodeSystem#820590.100004300 "BRAF Mutational Analysis (Note F)"
* $CAPeCCCodeSystem#820545.100004300 "BRAF Fusion Gene Analysis (Note I)"
* $CAPeCCCodeSystem#820544.100004300 "FGFR1 Fusion Gene Analysis (Note I)"
* $CAPeCCCodeSystem#820537.100004300 "Mutation Name (repeat this question as needed)"
* $CAPeCCCodeSystem#820531.100004300 "Fusion Name (repeat this question as needed)"
* $CAPeCCCodeSystem#32029.100004300 "?Comment(s)"
* $CAPeCCCodeSystem#820499.100004300 "Associated Syndrome"
* $CAPeCCCodeSystem#24159.100004300 "Prebiopsy Treatment"
* $CAPeCCCodeSystem#820507.100004300 "Procedure"
* $CAPeCCCodeSystem#820509.100004300 "Tumor Site (Note A)"
* $CAPeCCCodeSystem#24181.100004300 "Histologic Type"
* $CAPeCCCodeSystem#379495.100004300 "Histologic Type Comment"
* $CAPeCCCodeSystem#820514.100004300 "Tumor Size (based on clinicoradiologic estimate)"
* $CAPeCCCodeSystem#820517.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#820518.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#823276.100004300 "Mitotic Rate (Note B)"
* $CAPeCCCodeSystem#51133.100004300 "Histologic Grade (Note B)"
* $CAPeCCCodeSystem#24198.100004300 "Necrosis"
* $CAPeCCCodeSystem#379496.100004300 "Extent of Necrosis"
* $CAPeCCCodeSystem#49212.100004300 "Treatment Effect (Note C)"
* $CAPeCCCodeSystem#379500.100004300 "Percentage of Viable Tumor"
* $CAPeCCCodeSystem#24223.100004300 "Risk Assessment (Note D)"
* $CAPeCCCodeSystem#379504.100004300 "Tumor Comment"
* $CAPeCCCodeSystem#24222.100004300 "Additional Findings (specify)"
* $CAPeCCCodeSystem#820519.100004300 "Immunohistochemical Studies"
* $CAPeCCCodeSystem#24207.100004300 "KIT (CD117)"
* $CAPeCCCodeSystem#32036.100004300 "DOG1 (ANO1)"
* $CAPeCCCodeSystem#43054.100004300 "SDHA"
* $CAPeCCCodeSystem#43036.100004300 "SDHB"
* $CAPeCCCodeSystem#820520.100004300 "BRAF"
* $CAPeCCCodeSystem#38747.100004300 "Molecular Genetic Studies (eg., KIT, PDGFRA, SDHA  / B / C / D, RAS or NF1 mutational analysis or BRAF or FGFR1 fusion gene analysis)"
* $CAPeCCCodeSystem#24231.100004300 "?Comment(s)"
* $CAPeCCCodeSystem#820399.100004300 "Associated Syndrome"
* $CAPeCCCodeSystem#19392.100004300 "Preresection Treatment"
* $CAPeCCCodeSystem#56640.100004300 "Procedure"
* $CAPeCCCodeSystem#19345.100004300 "Tumor Focality"
* $CAPeCCCodeSystem#379492.100004300 "Number of Tumors"
* $CAPeCCCodeSystem#19348.100004300 "Sizes of Tumors"
* $CAPeCCCodeSystem#380273.100004300 "?Multiple Primary Sites (eg., stomach and small intestine)"
* $CAPeCCCodeSystem#820492.100004300 "Tumor Site (Note A)"
* $CAPeCCCodeSystem#18815.100004300 "Histologic Type"
* $CAPeCCCodeSystem#379494.100004300 "Histologic Type Comment"
* $CAPeCCCodeSystem#4552.100004300 "Tumor Size (based on clinicoradiologic estimate)"
* $CAPeCCCodeSystem#4555.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#4556.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#19353.100004300 "Mitotic Rate (Note B)"
* $CAPeCCCodeSystem#50428.100004300 "Histologic Grade (Note B)"
* $CAPeCCCodeSystem#19355.100004300 "Necrosis"
* $CAPeCCCodeSystem#379482.100004300 "Extent of Necrosis"
* $CAPeCCCodeSystem#41850.100004300 "Treatment Effect (Note C)"
* $CAPeCCCodeSystem#379486.100004300 "Percentage of Viable Tumor"
* $CAPeCCCodeSystem#19364.100004300 "Risk Assessment (Note D)"
* $CAPeCCCodeSystem#379481.100004300 "Tumor Comment"
* $CAPeCCCodeSystem#366820.100004300 "Margin Status"
* $CAPeCCCodeSystem#366826.100004300 "Closest Margin(s) to GIST"
* $CAPeCCCodeSystem#366831.100004300 "Distance from GIST to Closest Margin"
* $CAPeCCCodeSystem#366839.100004300 "Margin(s) Involved by GIST"
* $CAPeCCCodeSystem#366836.100004300 "Margin Comment"
* $CAPeCCCodeSystem#374434.100004300 "Regional Lymph Node Status"
* $CAPeCCCodeSystem#53901.100004300 "Number of Lymph Nodes with Tumor"
* $CAPeCCCodeSystem#51986.100004300 "Number of Lymph Nodes Examined"
* $CAPeCCCodeSystem#358476.100004300 "Regional Lymph Node Comment"
* $CAPeCCCodeSystem#352583.100004300 "?Distant Site(s) Involved, if applicable"
* $CAPeCCCodeSystem#820556.100004300 "?Modified Classification (required only if applicable)"
* $CAPeCCCodeSystem#327831.100004300 "pT Category"
* $CAPeCCCodeSystem#820559.100004300 "?T Suffix (required only if applicable)"
* $CAPeCCCodeSystem#348260.100004300 "pN Category (Notes E, F)"
* $CAPeCCCodeSystem#19384.100004300 "?pM Category (required only if confirmed pathologically) (Notes E, F)"
* $CAPeCCCodeSystem#4632.100004300 "Additional Findings (specify)"
* $CAPeCCCodeSystem#820471.100004300 "Immunohistochemical Studies"
* $CAPeCCCodeSystem#18920.100004300 "KIT (CD117)"
* $CAPeCCCodeSystem#32046.100004300 "DOG1 (ANO1)"
* $CAPeCCCodeSystem#42650.100004300 "SDHA"
* $CAPeCCCodeSystem#42633.100004300 "SDHB"
* $CAPeCCCodeSystem#820486.100004300 "BRAF"
* $CAPeCCCodeSystem#43564.100004300 "Molecular Genetic Studies (eg., KIT, PDGFRA, SDHA / B / C / D, RAS, or NF1 mutational analysis or BRAF or FGFR1 fusion gene analysis)"
* $CAPeCCCodeSystem#4638.100004300 "?Comment(s)"
* $CAPeCCCodeSystem#50200.100004300 "Test(s) Performed"
* $CAPeCCCodeSystem#30158.100004300 "Results"
* $CAPeCCCodeSystem#31389.100004300 "HER2 (protein expression by immunohistochemistry)"
* $CAPeCCCodeSystem#31392.100004300 "Primary Antibody"
* $CAPeCCCodeSystem#31401.100004300 "Results"
* $CAPeCCCodeSystem#31407.100004300 "Number of Invasive Cancer Cells Counted"
* $CAPeCCCodeSystem#31408.100004300 "Method"
* $CAPeCCCodeSystem#31412.100004300 "HER2 (ERBB2):CEP17 Ratio"
* $CAPeCCCodeSystem#31410.100004300 "Average Number of HER2 (ERBB2) Signals per Cancer Cell"
* $CAPeCCCodeSystem#31411.100004300 "Average Number of CEP17 Signals per Cancer Cell"
* $CAPeCCCodeSystem#59053.100004300 "Range of Number of HER2 (ERBB2) Signals per Cancer Cell"
* $CAPeCCCodeSystem#31414.100004300 "Average Number of HER2 (ERBB2) Signals per Cancer Cell"
* $CAPeCCCodeSystem#42943.100004300 "Range of Number of HER2 (ERBB2) Signals per Cancer Cell"
* $CAPeCCCodeSystem#31418.100004300 "HER2 (ERBB2) (gene amplification by in situ hybridization)"
* $CAPeCCCodeSystem#47477.100004300 "Results"
* $CAPeCCCodeSystem#53311.100004300 "HER2 (ERBB2) (genomic test for amplification or mutation)"
* $CAPeCCCodeSystem#31499.100004300 "?Comment(s)"
* $CAPeCCCodeSystem#22079.100004300 "Procedure"
* $CAPeCCCodeSystem#938184.100004300 "Tumor Site (Note B)"
* $CAPeCCCodeSystem#939950.100004300 "Histologic Type and Grade# (Notes C, D)"
* $CAPeCCCodeSystem#53941.100004300 "Histologic Type and Grade Comment"
* $CAPeCCCodeSystem#379381.100004300 "?Mitotic Rate (required only when Ki-67 labeling index is not reported)#"
* $CAPeCCCodeSystem#379382.100004300 "?Ki-67 Labeling Index (required only when mitotic rate is not reported)"
* $CAPeCCCodeSystem#22127.100004300 "Tumor Size (Note E)"
* $CAPeCCCodeSystem#22130.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#22915.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#22405.100004300 "Tumor Focality"
* $CAPeCCCodeSystem#379374.100004300 "Number of Tumors"
* $CAPeCCCodeSystem#56837.100004300 "Tumor Extent"
* $CAPeCCCodeSystem#22186.100004300 "Lymphatic and / or Vascular Invasion"
* $CAPeCCCodeSystem#22190.100004300 "Perineural Invasion"
* $CAPeCCCodeSystem#379372.100004300 "Tumor Comment"
* $CAPeCCCodeSystem#366306.100004300 "Margin Status"
* $CAPeCCCodeSystem#366312.100004300 "Closest Margin(s) to Tumor"
* $CAPeCCCodeSystem#366317.100004300 "Distance from Tumor to Closest Margin"
* $CAPeCCCodeSystem#366325.100004300 "Margin(s) Involved by Tumor"
* $CAPeCCCodeSystem#366322.100004300 "Margin Comment"
* $CAPeCCCodeSystem#374439.100004300 "Regional Lymph Node Status"
* $CAPeCCCodeSystem#46658.100004300 "Number of Lymph Nodes with Tumor"
* $CAPeCCCodeSystem#58168.100004300 "Number of Lymph Nodes Examined"
* $CAPeCCCodeSystem#358490.100004300 "Regional Lymph Node Comment"
* $CAPeCCCodeSystem#356657.100004300 "?Distant Site(s) Involved, if applicable"
* $CAPeCCCodeSystem#938191.100004300 "?Modified Classification (required only if applicable)"
* $CAPeCCCodeSystem#938199.100004300 "pT Category#"
* $CAPeCCCodeSystem#938193.100004300 "?T Suffix (required only if applicable)"
* $CAPeCCCodeSystem#938206.100004300 "pN Category"
* $CAPeCCCodeSystem#938213.100004300 "?pM Category (required only if confirmed pathologically)"
* $CAPeCCCodeSystem#938218.100004300 "Additional Findings"
* $CAPeCCCodeSystem#22245.100004300 "?Comment(s)"
* $CAPeCCCodeSystem#6897.100004300 "Procedure"
* $CAPeCCCodeSystem#45513.100004300 "Tumor Site (Note B)"
* $CAPeCCCodeSystem#37852.100004300 "Histologic Type (Note C)"
* $CAPeCCCodeSystem#46209.100004300 "Adenocarcinoma Classification (based on WHO)"
* $CAPeCCCodeSystem#26707.100004300 "Lauren Classification of Adenocarcinoma"
* $CAPeCCCodeSystem#51565.100004300 "Histologic Type Comment"
* $CAPeCCCodeSystem#51413.100004300 "Histologic Grade (Note D)"
* $CAPeCCCodeSystem#6932.100004300 "Tumor Size"
* $CAPeCCCodeSystem#6935.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#6936.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#46959.100004300 "Tumor Extent"
* $CAPeCCCodeSystem#379525.100004300 "Treatment Effect (Note E)"
* $CAPeCCCodeSystem#7010.100004300 "Lymphatic and / or Vascular Invasion (Note F)"
* $CAPeCCCodeSystem#7018.100004300 "Perineural Invasion (Note G)"
* $CAPeCCCodeSystem#379528.100004300 "Tumor Comment"
* $CAPeCCCodeSystem#366741.100004300 "Margin Status for Invasive Carcinoma"
* $CAPeCCCodeSystem#366747.100004300 "Closest Margin(s) to Invasive Carcinoma"
* $CAPeCCCodeSystem#366752.100004300 "Distance from Invasive Carcinoma to Closest Margin"
* $CAPeCCCodeSystem#366760.100004300 "Margin(s) Involved by Invasive Carcinoma"
* $CAPeCCCodeSystem#366774.100004300 "Margin Status for Dysplasia"
* $CAPeCCCodeSystem#366792.100004300 "Margin(s) Involved by Carcinoma in Situ"
* $CAPeCCCodeSystem#366804.100004300 "Margin(s) Involved by Low-Grade Dysplasia"
* $CAPeCCCodeSystem#366757.100004300 "Margin Comment"
* $CAPeCCCodeSystem#374441.100004300 "Regional Lymph Node Status"
* $CAPeCCCodeSystem#40902.100004300 "Number of Lymph Nodes with Tumor"
* $CAPeCCCodeSystem#39574.100004300 "Number of Lymph Nodes Examined"
* $CAPeCCCodeSystem#358482.100004300 "Regional Lymph Node Comment"
* $CAPeCCCodeSystem#356458.100004300 "?Distant Site(s) Involved, if applicable"
* $CAPeCCCodeSystem#820573.100004300 "?Modified Classification (required only if applicable)"
* $CAPeCCCodeSystem#327678.100004300 "pT Category"
* $CAPeCCCodeSystem#820574.100004300 "?T Suffix (required only if applicable)"
* $CAPeCCCodeSystem#327707.100004300 "pN Category#"
* $CAPeCCCodeSystem#495867.100004300 "?pM Category (required only if confirmed pathologically)"
* $CAPeCCCodeSystem#410435.100004300 "Additional Findings"
* $CAPeCCCodeSystem#7028.100004300 "?Comment(s)"
* $CAPeCCCodeSystem#7031.100004300 "Pre-Orchiectomy Serum Tumor Marker(s) (Note A)"
* $CAPeCCCodeSystem#27277.100004300 "Post-Orchiectomy Serum Tumor Marker(s) (Note A)"
* $CAPeCCCodeSystem#7104.100004300 "Serum Tumor Markers (S) (applies to post-orchiectomy values) (Note A)"
* $CAPeCCCodeSystem#7041.100004300 "Specimen Laterality"
* $CAPeCCCodeSystem#7046.100004300 "Tumor Focality"
* $CAPeCCCodeSystem#7049.100004300 "Tumor Size"
* $CAPeCCCodeSystem#7053.100004300 "Additional Dimension of Main Tumor Mass in Centimeters (cm)"
* $CAPeCCCodeSystem#7052.100004300 "Additional Dimension of Main Tumor Mass in Centimeters (cm)"
* $CAPeCCCodeSystem#7054.100004300 "?Greatest Dimension of Additional Tumor Nodule in Centimeters (cm)"
* $CAPeCCCodeSystem#868283.100004300 "Histologic Type (Notes B, C, D)"
* $CAPeCCCodeSystem#57619.100004300 "Histologic Type Comment"
* $CAPeCCCodeSystem#40187.100004300 "Tumor Extent (Note E)"
* $CAPeCCCodeSystem#7129.100004300 "Lymphatic and / or Vascular Invasion (Note F)"
* $CAPeCCCodeSystem#379575.100004300 "Tumor Comment"
* $CAPeCCCodeSystem#365796.100004300 "Margin Status"
* $CAPeCCCodeSystem#365822.100004300 "Margin(s) Involved by Tumor"
* $CAPeCCCodeSystem#365830.100004300 "Margin Comment"
* $CAPeCCCodeSystem#374443.100004300 "Regional Lymph Node Status"
* $CAPeCCCodeSystem#358396.100004300 "Number of Lymph Nodes with Tumor"
* $CAPeCCCodeSystem#42247.100004300 "?Nodal Site(s) with Tumor (required only if applicable)"
* $CAPeCCCodeSystem#365772.100004300 "Size of Largest Nodal Metastatic Deposit"
* $CAPeCCCodeSystem#381321.100004300 "Nodal Site with Largest Metastatic Deposit"
* $CAPeCCCodeSystem#365771.100004300 "Size of Largest Lymph Node or Nodal Mass with Tumor"
* $CAPeCCCodeSystem#358406.100004300 "Largest Lymph Node with Tumor (specify site)"
* $CAPeCCCodeSystem#56485.100004300 "Extranodal Extension"
* $CAPeCCCodeSystem#868293.100004300 "?Histologic Subtype of Germ Cell Tumor in Involved Lymph Node(s) (required only if applicable)"
* $CAPeCCCodeSystem#57192.100004300 "Number of Lymph Nodes Examined"
* $CAPeCCCodeSystem#358473.100004300 "Regional Lymph Node Comment"
* $CAPeCCCodeSystem#358981.100004300 "?Distant Site(s) Involved, if applicable"
* $CAPeCCCodeSystem#868279.100004300 "?Modified Classification (required only if applicable)"
* $CAPeCCCodeSystem#327725.100004300 "pT Category"
* $CAPeCCCodeSystem#868280.100004300 "?T Suffix (required only if applicable)"
* $CAPeCCCodeSystem#327727.100004300 "pN Category"
* $CAPeCCCodeSystem#35957.100004300 "?pM Category (required only if confirmed pathologically)"
* $CAPeCCCodeSystem#41950.100004300 "Additional Findings"
* $CAPeCCCodeSystem#7139.100004300 "?Comment(s)"
* $CAPeCCCodeSystem#359171.100004300 "Prelymphadenectomy Treatment"
* $CAPeCCCodeSystem#7153.100004300 "Regional Nodal Site(s) Examined (specify)"
* $CAPeCCCodeSystem#7155.100004300 "Number of Regional Nodal Groups Examined"
* $CAPeCCCodeSystem#359174.100004300 "Nonregional Nodal Site(s) Examined (specify)"
* $CAPeCCCodeSystem#359175.100004300 "Number of Nonregional Nodal Groups Examined"
* $CAPeCCCodeSystem#868324.100004300 "Histologic Type of Metastatic Tumor (Note A)"
* $CAPeCCCodeSystem#48808.100004300 "Histologic Type Comment"
* $CAPeCCCodeSystem#30288.100004300 "?Histologic Viability of Tumor (if applicable)"
* $CAPeCCCodeSystem#55821.100004300 "Number of Regional Lymph Nodes with Tumor"
* $CAPeCCCodeSystem#56379.100004300 "Regional Nodal Site(s) with Tumor"
* $CAPeCCCodeSystem#359192.100004300 "Size of Largest Nodal Metastatic Deposit"
* $CAPeCCCodeSystem#891566.100004300 "Site of Largest Nodal Metastatic Deposit"
* $CAPeCCCodeSystem#359183.100004300 "Size of Largest Lymph Node or Nodal Mass"
* $CAPeCCCodeSystem#56827.100004300 "?Histologic Subtype of Tumor in Largest Involved Lymph Node (if applicable)"
* $CAPeCCCodeSystem#48387.100004300 "Extranodal Extension (ENE)"
* $CAPeCCCodeSystem#48825.100004300 "Number of Regional Lymph Nodes Examined"
* $CAPeCCCodeSystem#359207.100004300 "Nonregional Lymph Node Status (Note B)"
* $CAPeCCCodeSystem#54327.100004300 "Number of Nonregional Lymph Nodes with Tumor"
* $CAPeCCCodeSystem#54467.100004300 "Nonregional Nodal Site(s) with Tumor"
* $CAPeCCCodeSystem#51851.100004300 "Number of Nonregional Lymph Nodes Examined"
* $CAPeCCCodeSystem#43665.100004300 "?Modified Classification (required only if applicable)"
* $CAPeCCCodeSystem#327730.100004300 "pN Category"
* $CAPeCCCodeSystem#868349.100004300 "?pM Category (required only if confirmed pathologically)"
* $CAPeCCCodeSystem#7540.100004300 "?Comment(s)"
* $CAPeCCCodeSystem#7960.100004300 "Procedure"
* $CAPeCCCodeSystem#379887.100004300 "Tumor Site"
* $CAPeCCCodeSystem#367289.100004300 "Histologic Type (Note A)"
* $CAPeCCCodeSystem#379891.100004300 "Histological Patterns Present (may include percentages totaling 100%)"
* $CAPeCCCodeSystem#40373.100004300 "Histologic Type Comment"
* $CAPeCCCodeSystem#8130.100004300 "Tumor Size"
* $CAPeCCCodeSystem#8133.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#8134.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#8516.100004300 "Lymphovascular Invasion"
* $CAPeCCCodeSystem#19593.100004300 "Treatment Effect"
* $CAPeCCCodeSystem#379898.100004300 "Percentage of Residual Viable Tumor"
* $CAPeCCCodeSystem#358185.100004300 "Site(s) Involved by Direct Tumor Invasion"
* $CAPeCCCodeSystem#379566.100004300 "Tumor Comment"
* $CAPeCCCodeSystem#8469.100004300 "Margin Status"
* $CAPeCCCodeSystem#358123.100004300 "Distance from Tumor to Closest Margin"
* $CAPeCCCodeSystem#358135.100004300 "Margin(s) Involved by Tumor"
* $CAPeCCCodeSystem#358164.100004300 "Margin Comment"
* $CAPeCCCodeSystem#374445.100004300 "Regional Lymph Node Status"
* $CAPeCCCodeSystem#56666.100004300 "Number of Lymph Nodes with Tumor"
* $CAPeCCCodeSystem#41440.100004300 "Nodal Site(s) with Tumor"
* $CAPeCCCodeSystem#57627.100004300 "Number of Lymph Nodes Examined"
* $CAPeCCCodeSystem#358331.100004300 "Regional Lymph Node Comment"
* $CAPeCCCodeSystem#358149.100004300 "?Distant Site(s) Involved, if applicable"
* $CAPeCCCodeSystem#17060.100004300 "?TNM Descriptors"
* $CAPeCCCodeSystem#327732.100004300 "pT Category"
* $CAPeCCCodeSystem#327734.100004300 "pN Category"
* $CAPeCCCodeSystem#41759.100004300 "?pM Category (required only if confirmed pathologically)"
* $CAPeCCCodeSystem#378531.100004300 "Modified Masaoka Stage (applies only to thymomas in addition to TNM categories)"
* $CAPeCCCodeSystem#378535.100004300 "Great Vessel Involvement"
* $CAPeCCCodeSystem#44145.100004300 "Additional Findings"
* $CAPeCCCodeSystem#25322.100004300 "Immunohistochemistry (specify stains and results)"
* $CAPeCCCodeSystem#8580.100004300 "?Comment(s)"
* $CAPeCCCodeSystem#35911.100004300 "Adequacy Assessment of Thyroid Fine-Needle Aspirates (Note A)"
* $CAPeCCCodeSystem#35901.100004300 "Adequacy of Resected Specimens or Cell Blocks for Testing (Note A)"
* $CAPeCCCodeSystem#35905.100004300 "Estimated Percentage of Tumor Cellularity (area used for testing)"
* $CAPeCCCodeSystem#33181.100004300 "BRAF Mutational Analysis (Note B)"
* $CAPeCCCodeSystem#33189.100004300 "Specify Mutation"
* $CAPeCCCodeSystem#33190.100004300 "Indicate Mutant Allele Frequency"
* $CAPeCCCodeSystem#35342.100004300 "TERT Mutational Analysis (Note B)"
* $CAPeCCCodeSystem#36042.100004300 "NRAS Mutational Analysis (Note C)"
* $CAPeCCCodeSystem#36148.100004300 "NRAS Codons Assessed"
* $CAPeCCCodeSystem#36052.100004300 "HRAS Mutational Analysis (Note C)"
* $CAPeCCCodeSystem#36159.100004300 "HRAS Codons Assessed"
* $CAPeCCCodeSystem#36062.100004300 "KRAS Mutational Analysis (Note C)"
* $CAPeCCCodeSystem#36079.100004300 "KRAS Codons Assessed"
* $CAPeCCCodeSystem#36072.100004300 "AKT1 Mutational Analysis (Note D)"
* $CAPeCCCodeSystem#36092.100004300 "TP53 Mutational Analysis (Note D)"
* $CAPeCCCodeSystem#36102.100004300 "PIK3CA Mutational Analysis (Note D)"
* $CAPeCCCodeSystem#36112.100004300 "CTNNB1 (beta-catenin) Mutational Analysis (Note E)"
* $CAPeCCCodeSystem#36082.100004300 "RET Mutational Analysis"
* $CAPeCCCodeSystem#35774.100004300 "Mutation Type"
* $CAPeCCCodeSystem#36123.100004300 "RET Rearrangement"
* $CAPeCCCodeSystem#36059.100004300 "ALK Rearrangement (Note G)"
* $CAPeCCCodeSystem#36131.100004300 "NTRK1 Rearrangement (Note H)"
* $CAPeCCCodeSystem#36100.100004300 "NTRK3 Rearrangement (Note H)"
* $CAPeCCCodeSystem#36139.100004300 "PPAR gamma Rearrangement (Note I)"
* $CAPeCCCodeSystem#36152.100004300 "Specify Other Marker"
* $CAPeCCCodeSystem#36153.100004300 "Specify Results"
* $CAPeCCCodeSystem#36154.100004300 "Specify Testing Method(s)"
* $CAPeCCCodeSystem#36174.100004300 "Sequencing Type"
* $CAPeCCCodeSystem#36178.100004300 "Dissection Method(s)"
* $CAPeCCCodeSystem#36191.100004300 "BRAF Mutational Analysis Testing Method(s)"
* $CAPeCCCodeSystem#36200.100004300 "TERT Mutational Analysis Testing Method(s)"
* $CAPeCCCodeSystem#36204.100004300 "NRAS Mutational Analysis Testing Method(s)"
* $CAPeCCCodeSystem#36146.100004300 "HRAS Mutational Analysis Testing Method(s)"
* $CAPeCCCodeSystem#36172.100004300 "KRAS Mutational Analysis Testing Method(s)"
* $CAPeCCCodeSystem#36470.100004300 "AKT1 Mutational Analysis Testing Method(s)"
* $CAPeCCCodeSystem#36478.100004300 "TP53 Mutational Analysis Testing Method(s)"
* $CAPeCCCodeSystem#36486.100004300 "PIK3CA Mutational Analysis Testing Method(s)"
* $CAPeCCCodeSystem#36216.100004300 "ALK Rearrangement Testing Method(s)"
* $CAPeCCCodeSystem#36209.100004300 "PPAR gamma Rearrangement Testing Method(s)"
* $CAPeCCCodeSystem#36230.100004300 "RET/PTC1 Rearrangement Testing Method(s)"
* $CAPeCCCodeSystem#36494.100004300 "RET/PTC3 Rearrangement Testing Method(s)"
* $CAPeCCCodeSystem#36502.100004300 "NTRK1 Rearrangement Testing Method(s)"
* $CAPeCCCodeSystem#36510.100004300 "NTRK3 Rearrangement Testing Method(s)"
* $CAPeCCCodeSystem#36239.100004300 "CTNNB1 Mutational Analysis Testing Method(s)"
* $CAPeCCCodeSystem#36228.100004300 "Sensitivity / Limit of Mutation Detection (Note A)"
* $CAPeCCCodeSystem#36245.100004300 "Comment(s)"
* $CAPeCCCodeSystem#379223.100004300 "Predisposing Condition(s)"
* $CAPeCCCodeSystem#846589.100004300 "Preoperative Biopsy Diagnosis (specify type[s] and result[s])"
* $CAPeCCCodeSystem#379227.100004300 "Preoperative Serum Marker Findings (specify type[s] and result[s])"
* $CAPeCCCodeSystem#379226.100004300 "Postoperative Serum Marker Findings (specify type[s] and result[s])"
* $CAPeCCCodeSystem#379225.100004300 "Clinical History (specify)"
* $CAPeCCCodeSystem#51121.100004300 "Procedure"
* $CAPeCCCodeSystem#8722.100004300 "Tumor Focality (Note C)"
* $CAPeCCCodeSystem#43022.100004300 "?Tumor Identifier (required only for cases with multiple tumors)"
* $CAPeCCCodeSystem#48385.100004300 "Tumor Site (Note C)"
* $CAPeCCCodeSystem#20791.100004300 "Tumor Size (Note I)"
* $CAPeCCCodeSystem#20795.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#20794.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#847080.100004300 "Histologic Tumor Types and Subtypes (Notes D, E, F, G, H)"
* $CAPeCCCodeSystem#35700.100004300 "Histology Comment"
* $CAPeCCCodeSystem#846590.100004300 "Mitotic Rate"
* $CAPeCCCodeSystem#846597.100004300 "Specify Mitoses per 2 mm2"
* $CAPeCCCodeSystem#846598.100004300 "Specify Mitoses per 2 mm2"
* $CAPeCCCodeSystem#846593.100004300 "Specify Mitoses per 2 mm2"
* $CAPeCCCodeSystem#846600.100004300 "?Ki-67 Labeling Index (required only if applicable)"
* $CAPeCCCodeSystem#846604.100004300 "Methodology"
* $CAPeCCCodeSystem#354220.100004300 "Tumor Necrosis"
* $CAPeCCCodeSystem#846613.100004300 "Angioinvasion (vascular invasion) (Note K)"
* $CAPeCCCodeSystem#31474.100004300 "Lymphatic Invasion (Note K)"
* $CAPeCCCodeSystem#24291.100004300 "Perineural Invasion"
* $CAPeCCCodeSystem#847058.100004300 "Extrathyroidal Extension (Note J)"
* $CAPeCCCodeSystem#379220.100004300 "Tumor Comment"
* $CAPeCCCodeSystem#9431.100004300 "Margin Status (Note L)"
* $CAPeCCCodeSystem#354138.100004300 "Distance from Invasive Carcinoma to Closest Margin"
* $CAPeCCCodeSystem#23322.100004300 "Margin(s) Involved by Carcinoma"
* $CAPeCCCodeSystem#354137.100004300 "Margin Comment"
* $CAPeCCCodeSystem#374447.100004300 "Regional Lymph Node Status"
* $CAPeCCCodeSystem#38976.100004300 "Number of Lymph Nodes with Tumor"
* $CAPeCCCodeSystem#43806.100004300 "Nodal Level(s) Involved"
* $CAPeCCCodeSystem#46095.100004300 "Size of Largest Metastatic Deposit"
* $CAPeCCCodeSystem#24301.100004300 "Extranodal Extension (ENE)"
* $CAPeCCCodeSystem#33889.100004300 "Number of Lymph Nodes Examined"
* $CAPeCCCodeSystem#43847.100004300 "Nodal Level(s) Examined"
* $CAPeCCCodeSystem#358412.100004300 "Regional Lymph Node Comment"
* $CAPeCCCodeSystem#354167.100004300 "?Distant Site(s) Involved, if applicable"
* $CAPeCCCodeSystem#847067.100004300 "?Modified Classification (required only if applicable)"
* $CAPeCCCodeSystem#847062.100004300 "pT Category"
* $CAPeCCCodeSystem#327750.100004300 "pT Category"
* $CAPeCCCodeSystem#847069.100004300 "?T Suffix (required only if applicable)"
* $CAPeCCCodeSystem#327752.100004300 "pT Category"
* $CAPeCCCodeSystem#847072.100004300 "?T Suffix (required only if applicable)"
* $CAPeCCCodeSystem#327755.100004300 "pN Category#"
* $CAPeCCCodeSystem#9411.100004300 "?pM Category (required only if confirmed pathologically)"
* $CAPeCCCodeSystem#847075.100004300 "Additional Findings"
* $CAPeCCCodeSystem#31667.100004300 "Number of Parathyroid Glands"
* $CAPeCCCodeSystem#31668.100004300 "Location of Parathyroid Gland(s)"
* $CAPeCCCodeSystem#24532.100004300 "Parathyroid Gland Findings"
* $CAPeCCCodeSystem#9567.100004300 "?Comment(s)"
* $CAPeCCCodeSystem#38689.100004300 "Procedure"
* $CAPeCCCodeSystem#37513.100004300 "Hysterectomy Type"
* $CAPeCCCodeSystem#38509.100004300 "Specimen Integrity"
* $CAPeCCCodeSystem#50434.100004300 "Tumor Site"
* $CAPeCCCodeSystem#9680.100004300 "Tumor Size"
* $CAPeCCCodeSystem#9683.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#9696.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#48015.100004300 "Histologic Type (Note A)"
* $CAPeCCCodeSystem#35701.100004300 "Histologic Type Comment"
* $CAPeCCCodeSystem#379768.100004300 "Other Tissue / Organ Involvement"
* $CAPeCCCodeSystem#352197.100004300 "Lymphovascular Invasion"
* $CAPeCCCodeSystem#379533.100004300 "Tumor Comment"
* $CAPeCCCodeSystem#52744.100004300 "Margin Status"
* $CAPeCCCodeSystem#352206.100004300 "Distance from Tumor to Closest Margin"
* $CAPeCCCodeSystem#379770.100004300 "Closest Margin(s) to Tumor"
* $CAPeCCCodeSystem#379773.100004300 "Margin(s) Involved by Tumor"
* $CAPeCCCodeSystem#352217.100004300 "Margin Comment"
* $CAPeCCCodeSystem#41752.100004300 "?Distant Site(s) Involved, if applicable#"
* $CAPeCCCodeSystem#55678.100004300 "Number of Distant Metastases"
* $CAPeCCCodeSystem#36981.100004300 "?TNM Descriptors"
* $CAPeCCCodeSystem#327758.100004300 "pT Category"
* $CAPeCCCodeSystem#53212.100004300 "?pM Category (required only if confirmed pathologically)"
* $CAPeCCCodeSystem#33221.100004300 "FIGO Stage (2018 FIGO Cancer Report)"
* $CAPeCCCodeSystem#9929.100004300 "Additional Findings"
* $CAPeCCCodeSystem#19410.100004300 "Ancillary Studies (specify)"
* $CAPeCCCodeSystem#10003.100004300 "?Comment(s)"
* $CAPeCCCodeSystem#37259.100004300 "Treatment History"
* $CAPeCCCodeSystem#37267.100004300 "Specimen Site (specify)"
* $CAPeCCCodeSystem#37268.100004300 "Specimen Laterality"
* $CAPeCCCodeSystem#37272.100004300 "Procedure"
* $CAPeCCCodeSystem#37273.100004300 "Specimen Adequacy"
* $CAPeCCCodeSystem#37277.100004300 "Histologic Type (specify)"
* $CAPeCCCodeSystem#37278.100004300 "Histologic Grade (specify)"
* $CAPeCCCodeSystem#37282.100004300 "Lymphovascular Invasion"
* $CAPeCCCodeSystem#381223.100004300 "Tumor Comment"
* $CAPeCCCodeSystem#37285.100004300 "Biomarker Tested"
* $CAPeCCCodeSystem#37286.100004300 "Results"
* $CAPeCCCodeSystem#37287.100004300 "Testing Method"
* $CAPeCCCodeSystem#37288.100004300 "?Comment(s)"
* $CAPeCCCodeSystem#49575.100004300 "Procedure"
* $CAPeCCCodeSystem#43163.100004300 "Specimen Laterality"
* $CAPeCCCodeSystem#42190.100004300 "Lymph Node Sampling"
* $CAPeCCCodeSystem#45453.100004300 "Lymph Nodes Sampled"
* $CAPeCCCodeSystem#49137.100004300 "Tumor Site(s)"
* $CAPeCCCodeSystem#53073.100004300 "Histologic Type"
* $CAPeCCCodeSystem#58483.100004300 "Histologic Grade"
* $CAPeCCCodeSystem#48244.100004300 "Tumor Size"
* $CAPeCCCodeSystem#39980.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#48636.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#51132.100004300 "Tumor Extent (specify structures or organs involved by tumor)"
* $CAPeCCCodeSystem#58271.100004300 "Mitotic Rate"
* $CAPeCCCodeSystem#45436.100004300 "Tumor Necrosis"
* $CAPeCCCodeSystem#380029.100004300 "Percentage of Tumor Necrosis"
* $CAPeCCCodeSystem#47162.100004300 "Lymphovascular Invasion"
* $CAPeCCCodeSystem#47036.100004300 "Treatment Effect"
* $CAPeCCCodeSystem#53856.100004300 "Preoperative Therapy Given (specify)"
* $CAPeCCCodeSystem#379529.100004300 "Tumor Comment"
* $CAPeCCCodeSystem#42223.100004300 "Margin Status"
* $CAPeCCCodeSystem#358364.100004300 "Distance from Tumor to Closest Margin"
* $CAPeCCCodeSystem#43606.100004300 "Closest Margin(s) to Tumor"
* $CAPeCCCodeSystem#42232.100004300 "Margin(s) Involved by Tumor"
* $CAPeCCCodeSystem#358369.100004300 "Margin Comment"
* $CAPeCCCodeSystem#378491.100004300 "Regional Lymph Node Status"
* $CAPeCCCodeSystem#48510.100004300 "Number of Lymph Nodes with Tumor"
* $CAPeCCCodeSystem#49658.100004300 "Extranodal Extension"
* $CAPeCCCodeSystem#39854.100004300 "Number of Lymph Nodes Examined"
* $CAPeCCCodeSystem#358362.100004300 "Regional Lymph Node Comment"
* $CAPeCCCodeSystem#45018.100004300 "Stage or Classification System (specify)"
* $CAPeCCCodeSystem#46518.100004300 "Additional Findings (specify)"
* $CAPeCCCodeSystem#55191.100004300 "Biomarker Tested"
* $CAPeCCCodeSystem#57527.100004300 "Results"
* $CAPeCCCodeSystem#40355.100004300 "Testing Method"
* $CAPeCCCodeSystem#54155.100004300 "?Comment(s)"
* $CAPeCCCodeSystem#21054.100004300 "Specimen (Note A)"
* $CAPeCCCodeSystem#12922.100004300 "Specimen Laterality"
* $CAPeCCCodeSystem#868467.100004300 "Histologic Type (Note B)"
* $CAPeCCCodeSystem#868470.100004300 "Specify Percentages of Histologic Subtypes and Divergent Differentiations Present (totaling 100%)#"
* $CAPeCCCodeSystem#56623.100004300 "Histologic Type Comment"
* $CAPeCCCodeSystem#41349.100004300 "Histologic Grade (Note C)"
* $CAPeCCCodeSystem#53506.100004300 "Tumor Extent (Note D)"
* $CAPeCCCodeSystem#381339.100004300 "Lymphatic and / or Vascular Invasion"
* $CAPeCCCodeSystem#13268.100004300 "Tumor Configuration"
* $CAPeCCCodeSystem#40316.100004300 "Muscularis (for determining T category) (Note D)"
* $CAPeCCCodeSystem#379577.100004300 "Tumor Comment"
* $CAPeCCCodeSystem#868493.100004300 "Associated Epithelial Lesions (Note C)"
* $CAPeCCCodeSystem#868494.100004300 "Additional Findings"
* $CAPeCCCodeSystem#13490.100004300 "?Comment(s)"
* $CAPeCCCodeSystem#45404.100004300 "Procedure"
* $CAPeCCCodeSystem#45181.100004300 "Specimen Laterality"
* $CAPeCCCodeSystem#45407.100004300 "Tumor Site"
* $CAPeCCCodeSystem#53548.100004300 "Tumor Size"
* $CAPeCCCodeSystem#58941.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#37796.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#868452.100004300 "Histologic Type (Note B)"
* $CAPeCCCodeSystem#868429.100004300 "Specify Percentages of Histologic Subtypes and Divergent Differentiations Present (totaling 100%)#"
* $CAPeCCCodeSystem#44434.100004300 "Histologic Type Comment"
* $CAPeCCCodeSystem#56714.100004300 "Histologic Grade (Note C)"
* $CAPeCCCodeSystem#891427.100004300 "Tumor Extent (Note D)"
* $CAPeCCCodeSystem#39920.100004300 "Lymphatic and / or Vascular Invasion (Note E)"
* $CAPeCCCodeSystem#42539.100004300 "Tumor Configuration"
* $CAPeCCCodeSystem#379576.100004300 "Tumor Comment"
* $CAPeCCCodeSystem#366615.100004300 "Margin Status for Invasive Carcinoma"
* $CAPeCCCodeSystem#366621.100004300 "Closest Margin(s) to Invasive Carcinoma"
* $CAPeCCCodeSystem#366625.100004300 "Distance from Invasive Carcinoma to Closest Margin"
* $CAPeCCCodeSystem#868454.100004300 "Margin(s) Involved by Invasive Carcinoma"
* $CAPeCCCodeSystem#378514.100004300 "Margin Status for Carcinoma in Situ / Noninvasive Papillary Urothelial Carcinoma"
* $CAPeCCCodeSystem#378650.100004300 "Margin(s) Involved by Low-grade Papillary Urothelial Carcinoma"
* $CAPeCCCodeSystem#378644.100004300 "Margin(s) Involved by Carcinoma in Situ / Noninvasive Papillary Urothelial Carcinoma"
* $CAPeCCCodeSystem#366663.100004300 "Margin Comment"
* $CAPeCCCodeSystem#378493.100004300 "Regional Lymph Node Status"
* $CAPeCCCodeSystem#46223.100004300 "Number of Lymph Nodes with Tumor"
* $CAPeCCCodeSystem#359222.100004300 "Size of Largest Nodal Metastatic Deposit"
* $CAPeCCCodeSystem#48762.100004300 "Nodal Site with Largest Metastatic Deposit (specify site)"
* $CAPeCCCodeSystem#359230.100004300 "Size of Largest Lymph Node with Tumor"
* $CAPeCCCodeSystem#56883.100004300 "Largest Lymph Node with Tumor (specify site)"
* $CAPeCCCodeSystem#44603.100004300 "Extranodal Extension (ENE)"
* $CAPeCCCodeSystem#46561.100004300 "Number of Lymph Nodes Examined"
* $CAPeCCCodeSystem#364933.100004300 "Regional Lymph Node Comment"
* $CAPeCCCodeSystem#381332.100004300 "?Distant Site(s) Involved, if applicable"
* $CAPeCCCodeSystem#868456.100004300 "?Modified Classification (required only if applicable)"
* $CAPeCCCodeSystem#327760.100004300 "pT Category"
* $CAPeCCCodeSystem#868457.100004300 "?T Suffix (required only if applicable)"
* $CAPeCCCodeSystem#327762.100004300 "pN Category"
* $CAPeCCCodeSystem#40166.100004300 "?pM Category (required only if confirmed pathologically)"
* $CAPeCCCodeSystem#868463.100004300 "Associated Epithelial Lesions (Note C)"
* $CAPeCCCodeSystem#868464.100004300 "Additional Findings"
* $CAPeCCCodeSystem#45831.100004300 "Pathologic Findings in Ipsilateral Nonneoplastic Renal Tissue (Note I)"
* $CAPeCCCodeSystem#43959.100004300 "?Comment(s)"
* $CAPeCCCodeSystem#22671.100004300 "Specimen"
* $CAPeCCCodeSystem#53907.100004300 "Tumor Site"
* $CAPeCCCodeSystem#891239.100004300 "Histologic Type (Note B)"
* $CAPeCCCodeSystem#891240.100004300 "Specify Percentages of Histologic Subtypes and Divergent Differentiations Present (totaling 100%)#"
* $CAPeCCCodeSystem#47200.100004300 "Histologic Type Comment"
* $CAPeCCCodeSystem#59752.100004300 "Histologic Grade (Note C)"
* $CAPeCCCodeSystem#55747.100004300 "Tumor Extent (Note D)"
* $CAPeCCCodeSystem#381449.100004300 "Lymphatic and / or Vascular Invasion"
* $CAPeCCCodeSystem#22789.100004300 "Tumor Configuration"
* $CAPeCCCodeSystem#379579.100004300 "Tumor Comment"
* $CAPeCCCodeSystem#891405.100004300 "Associated Epithelial Lesions (Note C)"
* $CAPeCCCodeSystem#54256.100004300 "Additional Findings"
* $CAPeCCCodeSystem#22855.100004300 "?Comment(s)"
* $CAPeCCCodeSystem#22447.100004300 "Procedure"
* $CAPeCCCodeSystem#49184.100004300 "Tumor Site"
* $CAPeCCCodeSystem#891162.100004300 "Histologic Type (Note A)"
* $CAPeCCCodeSystem#891163.100004300 "Specify Percentages of Histologic Subtypes and Divergent Differentiations Present (totaling 100%)#"
* $CAPeCCCodeSystem#50431.100004300 "Histologic Type Comment"
* $CAPeCCCodeSystem#42574.100004300 "Histologic Grade (Note B)"
* $CAPeCCCodeSystem#22495.100004300 "Tumor Size"
* $CAPeCCCodeSystem#22499.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#22498.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#52449.100004300 "Tumor Extent (Note C)"
* $CAPeCCCodeSystem#22550.100004300 "Lymphatic and / or Vascular Invasion (Note D)"
* $CAPeCCCodeSystem#22543.100004300 "Tumor Configuration"
* $CAPeCCCodeSystem#379578.100004300 "Tumor Comment"
* $CAPeCCCodeSystem#365386.100004300 "Margin Status for Invasive Carcinoma"
* $CAPeCCCodeSystem#365392.100004300 "Closest Margin(s) to Invasive Carcinoma"
* $CAPeCCCodeSystem#365397.100004300 "Distance from Invasive Carcinoma to Closest Margin"
* $CAPeCCCodeSystem#365408.100004300 "Margin(s) Involved by Invasive Carcinoma"
* $CAPeCCCodeSystem#365416.100004300 "Margin Status for Carcinoma in Situ / Noninvasive Urothelial Carcinoma"
* $CAPeCCCodeSystem#365422.100004300 "Closest Margin(s) to Carcinoma in Situ / Noninvasive Urothelial Carcinoma"
* $CAPeCCCodeSystem#365427.100004300 "Distance from Carcinoma in Situ / Noninvasive Urothelial Carcinoma to Closest Margin"
* $CAPeCCCodeSystem#365437.100004300 "Margin(s) Involved by Carcinoma in Situ / Noninvasive Urothelial Carcinoma"
* $CAPeCCCodeSystem#365447.100004300 "Margin Comment"
* $CAPeCCCodeSystem#378495.100004300 "Regional Lymph Node Status"
* $CAPeCCCodeSystem#40395.100004300 "Number of Lymph Nodes with Tumor"
* $CAPeCCCodeSystem#359273.100004300 "Size of Largest Nodal Metastatic Deposit"
* $CAPeCCCodeSystem#53173.100004300 "Nodal Site with Largest Metastatic Deposit (specify site)"
* $CAPeCCCodeSystem#359278.100004300 "Size of Largest Lymph Node with Tumor"
* $CAPeCCCodeSystem#59797.100004300 "Largest Lymph Node with Tumor (specify site)"
* $CAPeCCCodeSystem#40630.100004300 "Extranodal Extension (ENE)"
* $CAPeCCCodeSystem#59127.100004300 "Number of Lymph Nodes Examined"
* $CAPeCCCodeSystem#364934.100004300 "Regional Lymph Node Comment"
* $CAPeCCCodeSystem#365449.100004300 "?Distant Site(s) Involved, if applicable"
* $CAPeCCCodeSystem#891196.100004300 "?Modified Classification (required only if applicable)"
* $CAPeCCCodeSystem#37996.100004300 "pT Category"
* $CAPeCCCodeSystem#327765.100004300 "pT Category"
* $CAPeCCCodeSystem#327767.100004300 "pT Category"
* $CAPeCCCodeSystem#891197.100004300 "?T Suffix (required only if applicable)"
* $CAPeCCCodeSystem#327769.100004300 "pN Category"
* $CAPeCCCodeSystem#22583.100004300 "?pM Category (required only if confirmed pathologically)"
* $CAPeCCCodeSystem#891403.100004300 "Associated Epithelial Lesions (Note B)"
* $CAPeCCCodeSystem#891387.100004300 "Additional Findings"
* $CAPeCCCodeSystem#22597.100004300 "?Comment(s)"
* $CAPeCCCodeSystem#20714.100004300 "Clinical History (Note A)"
* $CAPeCCCodeSystem#51756.100004300 "Procedure"
* $CAPeCCCodeSystem#44354.100004300 "Hysterectomy Type"
* $CAPeCCCodeSystem#53010.100004300 "Specimen Integrity"
* $CAPeCCCodeSystem#51991.100004300 "Tumor Site"
* $CAPeCCCodeSystem#1589.100004300 "Tumor Size"
* $CAPeCCCodeSystem#1592.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#1593.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#347078.100004300 "Histologic Type (Note C)"
* $CAPeCCCodeSystem#35612.100004300 "Histologic Type Comment"
* $CAPeCCCodeSystem#40384.100004300 "?Histologic Grade# (Note D)"
* $CAPeCCCodeSystem#938224.100004300 "Two-Tier Grading System (for endometrioid and mucinous carcinomas only) (Note D)"
* $CAPeCCCodeSystem#379685.100004300 "?Myometrial Invasion (required only if applicable) (Note E)"
* $CAPeCCCodeSystem#379688.100004300 "Depth of Myometrial Invasion"
* $CAPeCCCodeSystem#379695.100004300 "Myometrial Thickness"
* $CAPeCCCodeSystem#379699.100004300 "Percentage of Myometrial Invasion"
* $CAPeCCCodeSystem#52383.100004300 "Adenomyosis"
* $CAPeCCCodeSystem#42688.100004300 "Uterine Serosa Involvement"
* $CAPeCCCodeSystem#37538.100004300 "Lower Uterine Segment Involvement (Note F)"
* $CAPeCCCodeSystem#38081.100004300 "?Cervical Stroma Involvement (required only if applicable) (Note G)"
* $CAPeCCCodeSystem#379703.100004300 "Depth of Cervical Stroma Invasion"
* $CAPeCCCodeSystem#379707.100004300 "Cervical Stroma Thickness"
* $CAPeCCCodeSystem#380253.100004300 "Other Tissue / Organ Involvement# (Note G)"
* $CAPeCCCodeSystem#937061.100004300 "Peritoneal / Ascitic Fluid (Note H)"
* $CAPeCCCodeSystem#937062.100004300 "The International System for Reporting Serous Fluid Cytopathology"
* $CAPeCCCodeSystem#347087.100004300 "Lymphatic and / or Vascular Invasion# (Note I)"
* $CAPeCCCodeSystem#379534.100004300 "Tumor Comment"
* $CAPeCCCodeSystem#347108.100004300 "?Margin Status"
* $CAPeCCCodeSystem#347114.100004300 "Closest Margin(s) to Invasive Carcinoma"
* $CAPeCCCodeSystem#347121.100004300 "Distance from Invasive Carcinoma to Closest Margin"
* $CAPeCCCodeSystem#347126.100004300 "Margin(s) Involved by Invasive Carcinoma"
* $CAPeCCCodeSystem#347137.100004300 "Margin Comment"
* $CAPeCCCodeSystem#347175.100004300 "Regional Lymph Node Status#"
* $CAPeCCCodeSystem#347147.100004300 "Total Number of Pelvic Nodes with Macrometastasis (greater than 2 mm) (sentinel and non-sentinel)"
* $CAPeCCCodeSystem#347212.100004300 "Number of Pelvic Sentinel Nodes with Macrometastasis"
* $CAPeCCCodeSystem#347178.100004300 "Total Number of Pelvic Nodes with Micrometastasis (greater than 0.2 mm up to 2 mm and / or greater than 200 cells) (sentinel and non-sentinel)"
* $CAPeCCCodeSystem#347217.100004300 "Number of Pelvic Sentinel Nodes with Micrometastasis"
* $CAPeCCCodeSystem#347158.100004300 "?Total Number of Pelvic Nodes with Isolated Tumor Cells (0.2 mm or less and not more than 200 cells) (reported only if applicable)#"
* $CAPeCCCodeSystem#347223.100004300 "Number of Pelvic Sentinel Nodes with ITCs"
* $CAPeCCCodeSystem#347176.100004300 "?Laterality of Pelvic Node(s) with Tumor (reported only if applicable)"
* $CAPeCCCodeSystem#350648.100004300 "Size of Largest Pelvic Nodal Metastatic Deposit"
* $CAPeCCCodeSystem#347180.100004300 "?Total Number of Para-aortic Nodes with Macrometastasis (greater than 2 mm) (sentinel and non-sentinel) (reported only if applicable)"
* $CAPeCCCodeSystem#347238.100004300 "Number of Para-aortic Sentinel Nodes with Macrometastasis"
* $CAPeCCCodeSystem#347190.100004300 "?Total Number of Para-aortic Nodes with Micrometastasis (greater than 0.2 mm up to 2 mm and / or greater than 200 cells) (sentinel and non-sentinel) (reported only if applicable)"
* $CAPeCCCodeSystem#347243.100004300 "Number of Para-aortic Sentinel Nodes with Micrometastasis"
* $CAPeCCCodeSystem#347183.100004300 "?Total Number of Para-aortic Nodes with Isolated Tumor Cells# (0.2 mm or less and not more than 200 cells) (required only if applicable)"
* $CAPeCCCodeSystem#347248.100004300 "Number of Para-aortic Sentinel Nodes with ITCs"
* $CAPeCCCodeSystem#347160.100004300 "?Laterality of Para-aortic Node(s) with Tumor (required only if applicable)"
* $CAPeCCCodeSystem#350654.100004300 "Size of Largest Para-aortic Nodal Metastatic Deposit"
* $CAPeCCCodeSystem#347205.100004300 "Total Number of Pelvic Nodes Examined (sentinel and non-sentinel)"
* $CAPeCCCodeSystem#347204.100004300 "?Number of Pelvic Sentinel Nodes Examined (required only if applicable)"
* $CAPeCCCodeSystem#347189.100004300 "Total Number of Para-aortic Nodes Examined (sentinel and non-sentinel)"
* $CAPeCCCodeSystem#347194.100004300 "?Number of Para-aortic Sentinel Nodes Examined (required only if applicable)"
* $CAPeCCCodeSystem#358322.100004300 "Regional Lymph Node Comment"
* $CAPeCCCodeSystem#347096.100004300 "?Distant Site(s) Involved, if applicable# (Note L)"
* $CAPeCCCodeSystem#820577.100004300 "?Modified Classification (required only if applicable)"
* $CAPeCCCodeSystem#327816.100004300 "pT Category"
* $CAPeCCCodeSystem#820578.100004300 "?T Suffix (required only if applicable)"
* $CAPeCCCodeSystem#327818.100004300 "pN Category"
* $CAPeCCCodeSystem#43921.100004300 "?N Suffix (required only if applicable)"
* $CAPeCCCodeSystem#52054.100004300 "?pM Category (required only if confirmed pathologically)"
* $CAPeCCCodeSystem#937439.100004300 "FIGO Stage (2023 staging for cancer of the endometrium) (Note M)"
* $CAPeCCCodeSystem#937471.100004300 "FIGO Modified Classification"
* $CAPeCCCodeSystem#38100.100004300 "Additional Findings"
* $CAPeCCCodeSystem#1681.100004300 "?Comment(s)"
* $CAPeCCCodeSystem#49644.100004300 "Procedure"
* $CAPeCCCodeSystem#42019.100004300 "Hysterectomy Type"
* $CAPeCCCodeSystem#51144.100004300 "Specimen Integrity"
* $CAPeCCCodeSystem#379741.100004300 "Tumor Site"
* $CAPeCCCodeSystem#31023.100004300 "Tumor Size"
* $CAPeCCCodeSystem#31026.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#31027.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#350660.100004300 "Histologic Type (Note A)"
* $CAPeCCCodeSystem#35704.100004300 "Histologic Type Comment"
* $CAPeCCCodeSystem#352626.100004300 "?Histologic Grade (Note A)"
* $CAPeCCCodeSystem#379721.100004300 "?Myometrial Invasion (Note A)"
* $CAPeCCCodeSystem#379723.100004300 "Depth of Myometrial Invasion"
* $CAPeCCCodeSystem#379727.100004300 "Myometrial Thickness"
* $CAPeCCCodeSystem#379733.100004300 "Percentage of Myometrial Invasion"
* $CAPeCCCodeSystem#379714.100004300 "Other Tissue / Organ Involvement#"
* $CAPeCCCodeSystem#367133.100004300 "Lymphovascular Invasion (Note B)"
* $CAPeCCCodeSystem#350664.100004300 "Peritoneal / Ascitic Fluid Involvement"
* $CAPeCCCodeSystem#379535.100004300 "Tumor Comment"
* $CAPeCCCodeSystem#33132.100004300 "Margins Status"
* $CAPeCCCodeSystem#350670.100004300 "Distance from Sarcoma to Closest Margin"
* $CAPeCCCodeSystem#379744.100004300 "Closest Margin(s) to Sarcoma"
* $CAPeCCCodeSystem#379747.100004300 "Margin(s) Involved by Sarcoma"
* $CAPeCCCodeSystem#358323.100004300 "Margin Comment"
* $CAPeCCCodeSystem#378501.100004300 "Regional Lymph Node Status#"
* $CAPeCCCodeSystem#45889.100004300 "Number of Lymph Nodes with Tumor"
* $CAPeCCCodeSystem#705967.100004300 "?Number of Lymph Nodes with Isolated Tumor Cells# (0.2 mm or less)"
* $CAPeCCCodeSystem#44818.100004300 "Nodal Site(s) with Tumor"
* $CAPeCCCodeSystem#51047.100004300 "Number of Lymph Nodes Examined"
* $CAPeCCCodeSystem#52641.100004300 "Nodal Site(s) Examined"
* $CAPeCCCodeSystem#358324.100004300 "Regional Lymph Node Comment"
* $CAPeCCCodeSystem#350783.100004300 "?Distant Site(s) Involved, if applicable"
* $CAPeCCCodeSystem#40370.100004300 "?TNM Descriptors"
* $CAPeCCCodeSystem#31185.100004300 "pT Category"
* $CAPeCCCodeSystem#327796.100004300 "pT Category"
* $CAPeCCCodeSystem#327777.100004300 "pT Category"
* $CAPeCCCodeSystem#327798.100004300 "pN Category"
* $CAPeCCCodeSystem#31315.100004300 "?pM Category (required only if confirmed pathologically)"
* $CAPeCCCodeSystem#49913.100004300 "FIGO Stage (2018 FIGO Cancer Report) for All Sarcomas Except Adenosarcoma#"
* $CAPeCCCodeSystem#45396.100004300 "FIGO Stage (2018 FIGO Cancer Report) for Adenosarcoma"
* $CAPeCCCodeSystem#31328.100004300 "Ancillary Studies"
* $CAPeCCCodeSystem#31173.100004300 "?Comment(s)"
* $CAPeCCCodeSystem#355424.100004300 "Treatment History"
* $CAPeCCCodeSystem#362541.100004300 "Procedure"
* $CAPeCCCodeSystem#355392.100004300 "Tumor Sampling for Molecular Studies"
* $CAPeCCCodeSystem#14777.100004300 "Specimen Laterality"
* $CAPeCCCodeSystem#355396.100004300 "Tumor Site (macroscopic examination / transillumination) (Note B)"
* $CAPeCCCodeSystem#355401.100004300 "Tumor Site after Sectioning (Note C)"
* $CAPeCCCodeSystem#356166.100004300 "Distance from Anterior Edge of Tumor to Limbus at Cut Edge"
* $CAPeCCCodeSystem#356175.100004300 "Distance from Posterior Margin of Tumor Base to Edge of Optic Disc"
* $CAPeCCCodeSystem#380275.100004300 "Tumor Size after Sectioning (Note D)"
* $CAPeCCCodeSystem#356184.100004300 "Greatest Basal Diameter of Tumor"
* $CAPeCCCodeSystem#356193.100004300 "Basal Diameter at Cut Edge of Tumor"
* $CAPeCCCodeSystem#356202.100004300 "Greatest Thickness of Tumor"
* $CAPeCCCodeSystem#356211.100004300 "Thickness at Cut Edge of Tumor"
* $CAPeCCCodeSystem#362542.100004300 "Tumor Growth Pattern"
* $CAPeCCCodeSystem#380277.100004300 "Tumor Size in Microscopic Sections (Note D)"
* $CAPeCCCodeSystem#356220.100004300 "Greatest Basal Diameter of Tumor (microscopic)"
* $CAPeCCCodeSystem#356229.100004300 "Greatest Thickness of Tumor (microscopic)"
* $CAPeCCCodeSystem#19690.100004300 "Histologic Type (Note E)"
* $CAPeCCCodeSystem#35706.100004300 "Histologic Type Comment"
* $CAPeCCCodeSystem#355413.100004300 "Other Ocular Structures Involved by Tumor"
* $CAPeCCCodeSystem#362544.100004300 "Tumor Location"
* $CAPeCCCodeSystem#355416.100004300 "Scleral Involvement"
* $CAPeCCCodeSystem#379546.100004300 "Tumor Comment"
* $CAPeCCCodeSystem#14910.100004300 "Margin Status"
* $CAPeCCCodeSystem#355419.100004300 "Margin Comment"
* $CAPeCCCodeSystem#378503.100004300 "Regional Lymph Node Status"
* $CAPeCCCodeSystem#379859.100004300 "Discrete Tumor Deposits in Orbit"
* $CAPeCCCodeSystem#44758.100004300 "Number of Lymph Nodes with Tumor"
* $CAPeCCCodeSystem#40281.100004300 "Number of Lymph Nodes Examined"
* $CAPeCCCodeSystem#358514.100004300 "Regional Lymph Node Comment"
* $CAPeCCCodeSystem#355437.100004300 "?Distant Site(s) Involved, if applicable"
* $CAPeCCCodeSystem#379843.100004300 "Largest Diameter of Largest Distant Metastasis"
* $CAPeCCCodeSystem#17074.100004300 "?TNM Descriptions"
* $CAPeCCCodeSystem#327925.100004300 "pT Category"
* $CAPeCCCodeSystem#327927.100004300 "pN Category"
* $CAPeCCCodeSystem#59309.100004300 "?pM Category (required only if confirmed pathologically)"
* $CAPeCCCodeSystem#355443.100004300 "Additional Findings"
* $CAPeCCCodeSystem#355448.100004300 "Gene Expression Profile (GEP)"
* $CAPeCCCodeSystem#355449.100004300 "TCGA Classification"
* $CAPeCCCodeSystem#355450.100004300 "BAP1 Result by Immunohistochemistry"
* $CAPeCCCodeSystem#355451.100004300 "BAP1 Mutational Analysis"
* $CAPeCCCodeSystem#355452.100004300 "PRAME Expression Status"
* $CAPeCCCodeSystem#14931.100004300 "?Comment(s)"
* $CAPeCCCodeSystem#14935.100004300 "Procedure (Note A)"
* $CAPeCCCodeSystem#14939.100004300 "Tumor Site"
* $CAPeCCCodeSystem#353330.100004300 "Histologic Type (Note B)"
* $CAPeCCCodeSystem#35707.100004300 "Histologic Type Comment"
* $CAPeCCCodeSystem#381856.100004300 "Histologic Grade (Note C)"
* $CAPeCCCodeSystem#14963.100004300 "Tumor Extent"
* $CAPeCCCodeSystem#379538.100004300 "Tumor Comment"
* $CAPeCCCodeSystem#14967.100004300 "Margin Status"
* $CAPeCCCodeSystem#379808.100004300 "Margin(s) Involved by Tumor"
* $CAPeCCCodeSystem#379537.100004300 "Margin Comment"
* $CAPeCCCodeSystem#353349.100004300 "Additional Findings (Note D)"
* $CAPeCCCodeSystem#353357.100004300 "Ancillary Studies (specify)"
* $CAPeCCCodeSystem#353353.100004300 "p16 Immunohistochemistry"
* $CAPeCCCodeSystem#14979.100004300 "?Comment(s)"
* $CAPeCCCodeSystem#353122.100004300 "Procedure"
* $CAPeCCCodeSystem#14989.100004300 "Tumor Site"
* $CAPeCCCodeSystem#15012.100004300 "Tumor Size"
* $CAPeCCCodeSystem#15016.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#15015.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#353124.100004300 "Histologic Type (Note B)"
* $CAPeCCCodeSystem#35708.100004300 "Histologic Type Comment"
* $CAPeCCCodeSystem#381855.100004300 "Histologic Grade (Note C)"
* $CAPeCCCodeSystem#30397.100004300 "Site(s) Involved by Direct Tumor Extension"
* $CAPeCCCodeSystem#15068.100004300 "Lymphovascular Invasion"
* $CAPeCCCodeSystem#379536.100004300 "Tumor Comment"
* $CAPeCCCodeSystem#353140.100004300 "Margin Status for Invasive Carcinoma"
* $CAPeCCCodeSystem#353147.100004300 "Closest Margin(s) to Invasive Carcinoma"
* $CAPeCCCodeSystem#353152.100004300 "Distance from Invasive Carcinoma to Closest Margin"
* $CAPeCCCodeSystem#353161.100004300 "Margin(s) Involved by Invasive Carcinoma"
* $CAPeCCCodeSystem#353166.100004300 "Margin Status for HSIL (VaIN 2-3) or AIS"
* $CAPeCCCodeSystem#353176.100004300 "Margin(s) Involved by HSIL"
* $CAPeCCCodeSystem#353172.100004300 "Margin(s) Involved by AIS"
* $CAPeCCCodeSystem#353182.100004300 "Margin Comment"
* $CAPeCCCodeSystem#378499.100004300 "Regional Lymph Node Status"
* $CAPeCCCodeSystem#58644.100004300 "Number of Nodes with Tumor (excluding isolated tumor cells)"
* $CAPeCCCodeSystem#43307.100004300 "?Number of Nodes with Isolated Tumor Cells (0.2 mm or less)#"
* $CAPeCCCodeSystem#353200.100004300 "Nodal Site(s) with Tumor"
* $CAPeCCCodeSystem#52690.100004300 "?Additional Lymph Node Findings"
* $CAPeCCCodeSystem#52149.100004300 "Number of Lymph Nodes Examined"
* $CAPeCCCodeSystem#353235.100004300 "Nodal Site(s) Examined"
* $CAPeCCCodeSystem#358325.100004300 "Regional Lymph Node Comment"
* $CAPeCCCodeSystem#379777.100004300 "?Distant Site(s) Involved, if applicable"
* $CAPeCCCodeSystem#17228.100004300 "?TNM Descriptors"
* $CAPeCCCodeSystem#327930.100004300 "pT Category"
* $CAPeCCCodeSystem#327932.100004300 "pN Category"
* $CAPeCCCodeSystem#15053.100004300 "?pM Category (required only if confirmed pathologically)"
* $CAPeCCCodeSystem#30399.100004300 "FIGO Stage (2018 FIGO Cancer Report)"
* $CAPeCCCodeSystem#353254.100004300 "Additional Findings"
* $CAPeCCCodeSystem#353262.100004300 "Ancillary Studies (specify)"
* $CAPeCCCodeSystem#353258.100004300 "p16 Immunohistochemistry"
* $CAPeCCCodeSystem#15078.100004300 "?Comment(s)"
* $CAPeCCCodeSystem#15082.100004300 "Procedure"
* $CAPeCCCodeSystem#936836.100004300 "Tumor Focality"
* $CAPeCCCodeSystem#936838.100004300 "Tumor Site"
* $CAPeCCCodeSystem#15108.100004300 "Tumor Size (Note B)"
* $CAPeCCCodeSystem#15111.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#15112.100004300 "Additional Dimension in Centimeters (cm)"
* $CAPeCCCodeSystem#936839.100004300 "Histologic Type (Notes C, D)"
* $CAPeCCCodeSystem#35709.100004300 "Histologic Type Comment"
* $CAPeCCCodeSystem#350698.100004300 "Histologic Grade (Note E)"
* $CAPeCCCodeSystem#936852.100004300 "Depth of Invasion in Millimeters (mm) (FIGO 2021 method) (Note F)"
* $CAPeCCCodeSystem#936856.100004300 "Depth of Invasion in Millimeters (mm) (conventional method) (Note F)"
* $CAPeCCCodeSystem#936861.100004300 "Tumor Growth Pattern (Note G)"
* $CAPeCCCodeSystem#48848.100004300 "Other Tissue / Organ Involvement#"
* $CAPeCCCodeSystem#350756.100004300 "Lymphatic and / or Vascular Invasion (Note H)"
* $CAPeCCCodeSystem#379539.100004300 "Tumor Comment"
* $CAPeCCCodeSystem#350699.100004300 "Margin Status for Invasive Carcinoma"
* $CAPeCCCodeSystem#350707.100004300 "Closest Margin(s) to Invasive Carcinoma"
* $CAPeCCCodeSystem#350714.100004300 "Distance from Invasive Carcinoma to Closest Margin"
* $CAPeCCCodeSystem#350723.100004300 "Margin(s) Involved by Invasive Carcinoma"
* $CAPeCCCodeSystem#936863.100004300 "Margin Status for Precursor Lesions of Squamous Cell Carcinoma and / or Paget Disease"
* $CAPeCCCodeSystem#936868.100004300 "Margin(s) Involved by Squamous Precursor Lesion(s)"
* $CAPeCCCodeSystem#350749.100004300 "Margin(s) Involved by HSIL"
* $CAPeCCCodeSystem#936875.100004300 "Margin(s) Involved by dVIN"
* $CAPeCCCodeSystem#936880.100004300 "Margin(s) Involved by VAM / HPVi (p53wt) vaVIN"
* $CAPeCCCodeSystem#379755.100004300 "Margin(s) Involved by Paget Disease"
* $CAPeCCCodeSystem#350755.100004300 "Margin Comment"
* $CAPeCCCodeSystem#378496.100004300 "Regional Lymph Node Status#"
* $CAPeCCCodeSystem#936882.100004300 "Number of Nodes with Metastasis Greater than 5 mm"
* $CAPeCCCodeSystem#936883.100004300 "Number of Nodes with Metastasis 5 mm or Less but Greater than 2 mm"
* $CAPeCCCodeSystem#936884.100004300 "Number of Nodes with Micrometastasis 2 mm or Less but Greater than 0.2 mm (excludes isolated tumor cells)"
* $CAPeCCCodeSystem#59812.100004300 "?Number of Nodes with Isolated Tumor Cells (0.2 mm or Less, or Single Cells, or Cell Clusters not more than 200 Cells in a Single Node Cross-section) (required only if applicable)#"
* $CAPeCCCodeSystem#936890.100004300 "Size of Largest Pelvic Nodal Metastatic Deposit"
* $CAPeCCCodeSystem#57425.100004300 "Nodal Site(s) with Tumor"
* $CAPeCCCodeSystem#936904.100004300 "?Additional Lymph Node Findings (required only if applicable)"
* $CAPeCCCodeSystem#45431.100004300 "Total Number of Lymph Nodes Examined"
* $CAPeCCCodeSystem#58756.100004300 "Nodal Site(s) Examined"
* $CAPeCCCodeSystem#46730.100004300 "?Number of Sentinel Nodes Examined (required only if applicable)"
* $CAPeCCCodeSystem#358326.100004300 "Regional Lymph Node Comment"
* $CAPeCCCodeSystem#350770.100004300 "?Distant Site(s) Involved, if applicable"
* $CAPeCCCodeSystem#936941.100004300 "?Modified Classification (required only if applicable)"
* $CAPeCCCodeSystem#936972.100004300 "pT Category"
* $CAPeCCCodeSystem#936983.100004300 "?T Suffix (required only if applicable)"
* $CAPeCCCodeSystem#936987.100004300 "pN Category"
* $CAPeCCCodeSystem#937003.100004300 "?N Suffix (required only if applicable)"
* $CAPeCCCodeSystem#937009.100004300 "?pM Category (required only if confirmed pathologically)"
* $CAPeCCCodeSystem#937011.100004300 "FIGO Stage (2021 FIGO staging for carcinoma of the vulva)"
* $CAPeCCCodeSystem#937025.100004300 "Additional Findings"
* $CAPeCCCodeSystem#350763.100004300 "Ancillary Studies (specify)"
* $CAPeCCCodeSystem#350764.100004300 "p16 Immunohistochemistry"
* $CAPeCCCodeSystem#365831.100004300 "p53 Immunohistochemistry"
* $CAPeCCCodeSystem#365838.100004300 "HPV-ISH"
* $CAPeCCCodeSystem#15191.100004300 "?Comment(s)"
